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Summary
In X-ray crystallography, validation tools assess the quality and the reliability of the struc-
tural models that crystallographers build and refine. These tools check both the consistency
of physical, chemical and statistical properties of the model with the prior knowledge avail-
able in structural databases, and the agreement of the model with the diffraction data.
B factors give important information about the spatial disorder of each atom around
its rest position in a crystal, allowing one to infer the precision of atomic coordinates and
dynamical properties of the macromolecule.
The first part of the thesis work is focused on the development of a new validation tool
for the distribution of isotropic B factors in crystallographic models. By means of a Bayesian
approach the shifted Inverse-Gamma distribution (IGD*) is proposed as a reference distri-
bution and a validation protocol is designed and developed to test this hypothesis. Starting
from an empirical B factor distribution, the protocol returns the parameters estimates of the
IGD* that best fits the B factor distribution and a p-value that is used to label the distribution
as acceptable or suspicious. The protocol is then tested on a large data set of high-resolution
protein structures from the PDB. From the distribution of the IGD* parameters it is possible
to identify different groups of outliers, each characterized by peculiar features. Moreover,
from the analysis of the distribution of p-values, the majority of the structures analysed
have an acceptable B factor distribution and the agreement to the IGD* follows a hierar-
chical organization (whole asymmetric unit content, single chains and single domains). B
factor distributions that do not satisfy the IGD* assumption usually correspond to models
with problems with the deposited coordinates or diffraction data. In light of these results
the developed protocol is proposed as an effective tool for the validation of B factor dis-
tributions in macromolecular crystallography. Furthermore, provided that the diffraction
data are deposited in the PDB, a standard re-refinement protocol is confirmed to be a valid
approach to rescue a B factor distribution from suspicious to acceptable, and to improve the
quality of the results of the ensemble analysis performed with the ESCET framework if the
starting data set contains models with suspicious B factor distributions.
The validation protocol for B factor distributions finds a direct application in the sec-
ond part of the thesis work, which is focused on the ensemble analysis with the ESCET
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framework of a selected data set of twenty-nine 30S ribosomal subunits from Thermus ther-
mophilus. Thirteen refinement protocols are tested to improve, normalise and de-bias the
selected structures, and to rescue models with suspicious B factor distributions. A compar-
ative ensemble analysis is performed between the ribosomal models as deposited into the
PDB and those obtained from the best refinement protocol in terms of refinement statistics
and distribution of B factors. The cluster analysis is confirmed to be an effective method
to automatically rationalise the structural information content of the data set. The obser-
vation that after re-refinement some structures moved to a different cluster confirms the
existence of structural bias in the originally deposited structures and leads to the discovery
of electron density that was not modelled in the deposited structure. Improvements of re-
finement statistics after re-refinement result in lower coordinate uncertainty estimates with
positive effects on the results of the rigid body analysis. The main rigid bodies found on the
16S rRNA correspond to the domains known in the literature to move during the decoding
process.
Final remarks are given about the possible application of the presented validation tool
for B factor distributions and about the importance of the availability of experimental data.
Zusammenfassung
In der Röntgenkristallographie werden Validierungswerkzeuge benutzt, um die Qualität
und Zuverlässigkeit von Strukturmodellen, die Kristallographen erstellen und verfeinern, zu
bemessen. Diese Werkzeuge überprüfen sowohl die Konsistenz physikalischer, chemischer
und statistischer Parameter des Modells mit denen bereits bekannter Strukturen, als auch
die Übereinstimmung mit den Beugungsdaten.
Die B-Faktoren enthalten wichtige Informationen über die Genauigkeit der räumlichen
Positionierung rund um die im Kristall bestimmte Position. Dies ermöglicht einerseits die
Analyse der Genauigkeit der Atomkoordinaten und andererseits eine Einschätzung der dy-
namischen Eigenschaften des Makromoleküls.
Der erste Teil dieser Dissertation beschätigt sich mit der Entwicklung eines neuen Werk-
zeugs zur Validierung der Verteilung isotroper B-Faktoren in kristallographischen Model-
len. Ausgehend von einem bayesschen Ansatz wird die “shifted Inverse-Gamma distributi-
on” (IGD*) als Referenzverteilung vorgeschlagen und ein Validierungsprotokoll zum Testen
dieser Hypothese entwickelt. Ausgehend von der empirisch ermittelten Verteilung der B-
Faktoren, schätzt das Protokoll die Paramter der IGD*, welche die B-Faktor Verteilung am
besten beschreiben, und berechnet einen p-Wert, um die Verteilung als aktzeptabel oder
verdächtig zu klassifizieren. Das Protokoll wird gegen einen grossen Datensatz hochauflö-
sender Strukturen aus der PDB getestet. Aus der Verteilung der IGD*-Parameter lassen sich
verschiedene Gruppen von Ausreissern erkennen, die sich durch charakteristische Eigen-
schaften von anderen abgrenzen. Darüber hinaus zeigt die Analyse der p-Werte, dass die
meisten der untersuchten Strukturen eine akzeptable Verteilung der B-Faktoren aufzeigen.
Die Übereinstimmung mit der IGD* folgt hierbei einer hierarchischen. Organisation (ge-
samte asymmetrische Einheit, einzelne Molekülketten und einzelne Domänen). Modelle,
deren B-Faktorverteilung nicht der IGD*-Annahme entsprichen, zeigen meist auch Unre-
gelmässigkeiten bei den in der Datenbank hinterlegten Koordinatendaten oder aber auch
bei den Streuungsdaten. Basierend auf den erhaltenen Ergebnissen wird das entwickelte
Protokoll als effektives Werkzeug für die Validierung der B-Faktor Verteilung in der makro-
molekularen Kristallographie vorgeschlagen. Des Weiteren wird bestätigt, dass ein Standard
Protokoll zum Re-Refinement (erneute Verfeinerung) ein geeignetes Instrument ist, die B-
Faktor Verteilung von verdächtig nach akzeptabel zu korrigieren. Dies führt ausserdem zu
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einer Qualitätsverbesserung der Ergbnisse für die Ensemble Analyse mit dem ESCET Pa-
ket für Fälle, bei denen der Startdatensatz Modelle mit verdächtigen B-Faktor Verteilungen
enthält.
Im zweiten Teil dieser Arbeit wird das Protokoll zur Validierung der B-Faktor Vertei-
lung angewandt, um eine Ensemble Analyse mit dem ESCET Paket für 29 Datensätze der
30S Untereinheit des Ribosoms aus Thermus thermophilus durchzuführen. Dreizehn Pro-
tokolle werden getestet, um die jeweiligen Strukturen zu verbessern, zu normalisieren,
Beeinflussungen durch benutzte Modelle zu korrigieren und Modelle mit verdächtiger B-
Faktor Verteilung anzupassen. Es wird eine vergleichende Ensemble Analyse zwischen den
in der PDB hinterlegeten Strukturmodellen und den optimal verfeinerten (Refinement Sta-
tistik / B-Faktor Verteilung) Modellen vorgestellt. Es wird bestätigt, dass die Cluster Analyse
die geeignete Methode ist, um automatisch die strukturspezifischen Informationen des Da-
tensatzes systematisch zu erfassen. Durch das Re-Refinement werden einzelne Strukturen
anderen Clustern zugeordnet, was zum einen die Existenz von strukturellen Fehlern in den
hinterlegten Daten zeigt, und zum anderen zur Identifikation von Elektronendichte führt,
die nicht zum Erstellen des veröffentlichten Strukturmodells benutzt wurde. Die Verbes-
serung der Verfeinerungsstatistiken führen zu höherer Genauigkeit der Koordinaten, was
wiederum einen positiven Effekt auf die Ergebnisse der Rigid-Body Analyse hat. Die wich-
tigsten Rigid-Bodies der 16S rRNA, die gefunden wurden, korrespondieren mit den Domä-
nen, für die in der Literatur eine koformationelle Bewegung während des Dekodierungs
Prozesses beschrieben ist.
Die Arbeit schliesst mit einem Ausblick auf mögliche Anwendungsfelder für das vorge-
stellte Protokoll zur Valdierung der B-Faktor Verteilung ab. Hierbei wird insbesondere die
Bedeutung der Verfügbarkeit experimenteller Daten hervorgehoben.
Chapter 1
Introduction
1.1 X-ray Crystallography in Structural Biology
The determination of the three-dimensional structure of biological macromolecules plays
an important role in molecular biology since their functions are strongly related to their
structures [63,96,116]. Thus, structural information can be used to infer the mechanism of
function of a given macromolecule (whether it is purely structural or enzymatic), to validate
experimental data obtained from different experimental techniques, and to formulate new
hypotheses for further experiments (e.g. with applications in drug discovery [6,88]).
X-ray crystallography is a well established experimental technique [43,106] that allows
the determination of the three-dimensional structure of macromolecules by taking advan-
tage of the interaction between X-rays and the scattering matter in a crystal (a description
of the crystallographic experiment is given in section 3.1.1). At the moment it is still the
most widely used experimental method for the determination of atomic models of bio-
logical macromolecules as shown by the total number of models deposited in the Protein
Data Bank (PDB) [14] (as of October 2011, 67414 out of 77101 deposited models where
determined using X-ray crystallography). X-ray crystallography has a wide applicability
ranging from small organic molecules [5] to large macromolecular complexes of several
mega daltons like the ribosome [73,102,114] (from 2.5 to 3.3 MDa) or the fatty acid syn-
thase [64] (∼ 2.6 MDa). The analysis of the results obtained from structural genomics
projects allowed recently to quantify the difficulties of each step of the structure determi-
nation process using X-ray crystallography [124]. The main drawback of this technique
still resides in the difficulty to obtain diffracting crystals for highly flexible macromolecules
or large complexes due to the high structural order required in the crystal for generating
high-resolution diffraction data. For these reasons X-ray crystallography can be comple-
mented by other techniques used in structural biology like Nuclear Magnetic Resonance
(NMR) [52], cryo-Electron Microscopy (cryo-EM) [53] and Small Angle X-ray Scattering
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(SAXS) [81] that have the advantage that no crystals are required. Amongst these tech-
niques NMR is the only one that allows the determination of macromolecular structures at
atomic level, but it has limitations in the maximum size of the macromolecule under anal-
ysis and until now the number of structures determined using NMR and deposited in the
PDB are much lower than those obtained using X-ray crystallography (as of October 2011,
9149 out of 77101 deposited models where determined using NMR).
Atomic resolution models obtained using X-ray crystallography or NMR are important
for the interpretation of the results obtained from low resolution experimental techniques
like cryo-EM and SAXS for the production of the so called “hybrid models” [118]. Further-
more, also predictive methods like homology modeling, threading and ab-initio modeling
benefit from the availability of atomic models from X-ray crystallography or NMR [7]. The
increase in number of the structures deposited in the PDB allows the extraction of more
accurate features that can be consequently used to improve the quality of the model pre-
dictions.
It follows that it is of extreme importance to have tools that check for the reliability and
quality of the deposited models.
1.2 Validation of Crystallographic Structures
Given the scientific importance of crystallographic structures, it is necessary to have val-
idation tools for new crystallographic models prior to deposition and for those already
deposited in the PDB. The reliability of the deposited structures is in fact indispensable for
the extraction of physical, chemical and biological information from the structures [42].
Structure validation has also become a significant and routine step in automatic model
building [1,35].
The atomic model deposited in the PDB is the result of the interpretation by the crystal-
lographer of the average electron density in a crystal obtained during the crystallographic
experiment, and as such it is the result of a subjective interpretation of the experimental
data. Validation tools or quality indicators are then necessary to assess the validity of the
models and to limit the subjectivity introduced during model building and refinement in fa-
vor of a more objective interpretation of the experimental data [22,42,70,107]. Such goal
is achieved by judging how well a given model is in agreement with the prior knowledge
available from small and large molecules structural databases [39, 77] and by evaluating
the agreement between the model and the collected diffraction experimental data [72,128].
The quality indicators used in macromolecular crystallography can be divided in two
main classes: global and local statistics [70]. The first class includes all those statistics
that provide information about the overall quality of the model like: Rwork and R f ree statis-
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tics, average, minimum, maximum and root mean square of local statistics, percentage of
outliers for each local statistics [70]. This statistics are used to monitor the progress of
model building and refinement. The second class includes all those statistics that provide
information at amino-acid or atomic level like: real-space fit, Ramachandram plot, pep-
flip value, rotamer side chain fit value, hydrogen-bonding analysis, unusual B factors, un-
usual occupancies, unusual bond lengths or angles, unusual torsion angles, atomic clashes.
This statistics are especially useful during model building to identify local problems in the
model [70].
Depending on their use in model building and refinement these quality indicators can
be also divided in ‘weak’ and ‘strong’ validation criteria [70, 71]. The first category assess
how well a model reproduces the information that was used during model building (e.g.
deviations from ideal geometry, Rwork ). Since these statistics have no predictive power
they are classified as ‘weak’. The second category instead tests how well a model predicts
information that was not used in the model building process (e.g. R f ree , patterns of non-
bonded interactions, conformational torsion-angle distributions). Since these statistics have
predictive power they are classified as ‘strong’ and make the model more reliable [71].
The availability of the experimental diffraction data is of extreme importance in the val-
idation process, since they are the only evidence that can be used to evaluate the quality of
a given model and to explain any outlier identified by local statistics (i.e. an outlier for a
local statistic is not necessary an error if it is supported by experimental data). Moreover,
it has been shown that an automatic re-refinement of the models deposited in the PDB, for
which experimental data are available, can deliver better models thanks to the improve-
ment of the crystallographic software [65,66,104]. The lack of deposited structure factors
thus not only represents a huge loss in the validation process, making the deposited model
less reliable, but it also limits the possibility to derive better models in the future. Fortu-
nately this problem will be not present in the future since the deposition of diffraction data
is now mandatory for X-ray crystallography [104].
Since the number of structures deposited in the PDB increased of nearly one order-
of-magnitude from the time the current validation tools were introduced, new and more
advanced validation criteria have been recently proposed [104].
1.3 B Factors and their use in Structural Analysis
The result of a crystallographic experiment is an average over time and space of the electron
density content in a crystal [43,106]. This means that any disorder in the crystal will affect
the final average electron density: well ordered regions will result in in well defined and
strong electron density, while disordered regions will result in noisy and weak electron den-
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sity. However, because the obtained electron density is the result of an averaging process,
any information about the nature of the disorder is lost, this is either due to thermal vibra-
tions (dynamic disorder) or to alternative conformations (static disorder) of the atoms of
the macromolecules inside the crystal. The goal of a crystallographer is then to interpret the
electron density by building an atomic model in agreement with it (see also section 3.1.1).
For each atom of the model, together with the three-dimensional coordinates, a fourth pa-
rameter called B factor is used to model the disorder of the electron density and thus to
model the uncertainty of to atomic position (see also section 3.1.3). The higher the B factor
of an atom, the lower the probability the atom is located at the coordinates given in the
model, indicating a lower degree of order. In addition, depending on the data to param-
eter ratio, different models have been proposed for the B factors [2, 133]. From low- to
high-resolution crystal structures the most common B factor models are: global isotropic or
anisotropic overall B factor, TLS groups, grouped B factor, individual isotropic or anisotropic
B factor. In the past, several studies tried to interpret the disorder of the electron density
by generating ensemble of structures in agreement with the experimental data instead of
only one model. However the interpretation of this ensembles is still debatable. It is in
fact not clear if the generated ensemble is representative of all the different conformations
of the macromolecule in the crystal or if, alternatively, each model in the ensemble is an
agreement with the crystallographic data but not necessarily it represents a conformation
present in the crystal [8,40,41,55,74,123].
B factors give then important information about the flexibility of a macromolecule in-
side a crystal and can be used to infer structural and mechanical properties. Since they are
related to the positional uncertainty of the atomic coordinates, several statistical methods
were proposed in the past for the use of B factors in the structural comparison of models
of the same macromolecule obtained from different crystals [19,33,59,98]. However, one
of the main drawbacks of the crystallographic experiment is that no direct measure about
the precision of the atomic coordinates is available. Even if B factors are related by the
theory of thermal vibrations to the atomic displacements in a crystal, they are nevertheless
the result of the fitting of a model to the experimental diffraction data and they are not
measured directly, becoming dependent on the model used to describe them and on the
parameterisations used by the refinement program. Thus, it follows that B factors from
different structural models should not be directly compared and used as a direct measure
of the coordinate uncertanties of the model. In small molecule crystallography a routine
approach to estimate the precision of coordinates in a model consists at the inversion of the
Hessian matrix at convergence of refinement [15,36]. However this approach is not feasible
in macromolecule crystallography since the inversion of the Hessian matrix becomes com-
putationally a gigantic task. To partially overcome this problem, the diffraction-component
precision index (DPI) [36] was introduced to estimate the coordinate error for an atom
whose B factor is equal to the average B factor of the model (see also section 3.1.4), al-
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lowing the comparison on a common scale of the errors in different models. Assuming
a linear relationship between the coordinate uncertainty of an atom and its B factor, the
DPI was used in the statistical framework ESCET to estimate the standard uncertainties of
the atomic coordinates in crystallographic model, allowing the analysis and comparison of
ensemble of structures [84,110–112] (see also section 3.1.5).
Despite the fact B factors give important information about the flexibility and the un-
certainties of the coordinates of a macromolecule in a crystal, at the moment a validation
tool for their distribution still does not exist. The only controls performed on B factors are
focused on extreme values (too low or too high) or on their average value in a crystallo-
graphic model when compared to structures solved at a similar resolution [127]. However
the analysis of their distribution in a structure could give important information about the
quality of the model. Firstly it could be useful to identify artefacts introduced by the re-
finement procedures. Secondly the validation of the distribution of B factors would be
very important in methods that use them to compare different models like in the ESCET
framework. In fact, if the distribution of B factors contains strong artefacts it will affect the
subsequent analysis. In the best scenario this will just introduce noise in the data, making
the interpretation of the results more difficult. In the worse scenario it could also intro-
duce artefacts in the output of the ensemble analysis leading to wrong conclusions from
the interpretation of the results. In the past different models have been proposed for the
distribution of B factors in macromolecules obtained via X-ray crystallography [38,97,130]
but they were never used for the validation of the distribution itself.
1.4 The Ribosome Complex
The ribosome complex, which is responsible for the synthesis of proteins in all living or-
ganisms, is one of the most exciting structures of the last two decades obtained by X-ray
crystallography, as illustrated by the 2009 Nobel prize in chemistry. The integration of
the crystallographic models [75, 79, 109, 117] with the results from cryo-EM [51, 82, 129]
and single-molecule fluorescence resonance energy transfer (smFRET) [99] allowed the
rationalization of the dynamics of the protein synthesis process from a structural point of
view [46].
Ribosomes from eukaryotes and archaea consist of a large (50S) and a small (30S)
subunit, which together compose the 2.5 MDa 70S ribosome. The 50S subunit consists of
23S rRNA, 5S rRNA and about 30 proteins. The 30S subunit consists of 16S rRNA and
about 20 proteins [109, 117]. Similarly, the eukaryotic ribosomes consist of a large (60S)
and a small (40S) subunit, which together compose the 3.3 MDa 80S ribosome. The 60S
consists of 25S-28S rRNA, 5.8S rRNA, 5S rRNA and about 46 proteins. The 40S consists
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18S rRNA and about 32 proteins [12,73,102,103].
The rRNA moieties are the largest components of the ribosome complex and are respon-
sible for the the main functional steps of protein synthesis, while the ribosomal proteins
have mostly a regulatory and a structural function by assisting the correct folding of the
ribosomal subunits and at the same time by stabilizing with positively charged amino-acids
the negative charges of phosphate groups of the RNA backbone [24,60,69,121].
The current knowledge about ribosomal structures and their dynamics is mainly based
on bacterial stuctures since only recently the structures of the 80S ribosome from Tetrahy-
mena thermophila [73, 102] and Saccharomyces cerevisiae [12] have been obtained via X-
ray crystallography. Despite the fact that the core structure of the ribosome is conserved
amongst all three domains of life, the increased complexity of the eukaryotic ribosome
reflects functional differences between between prokaryotes and eukaryotes and a more
involved regulation of the protein synthesis process [73,102]. Further structures at atomic
resolution of the eukaryotic ribosome in different functional states are nevertheless neces-
sary to reach the same level of knowledge available for the bacterial counterpart.
In bacteria the small 30S subunit binds the mRNA and contains the decoding center,
which is responsible for the recognition and discrimination of the codon-anticodon inter-
action [91, 92, 94]. The large 50S subunit contains instead the peptidyl-transferase center
(PTC), which is responsible for the synthesis of the peptide bond between two amino-acids.
The fact that no proteins are present in the PTC brought to the conclusion that the ribo-
some is a ribozyme since only RNA moieties are involved in the peptide-bond synthesis
reaction [9]. In addition, the PTC has been proposed as the most ancient component of the
ribosome [3,11,17].
The interface between the two subunits consists mainly of RNA and the molecule of
mRNA binds in a cleft between the head and body domains of the 30S subunit, where
its codons interact with the anticodons of tRNA molecules. Both subunits contain three
binding sites for tRNA molecules that are in three different functional states: The A site
binds the aminoacyl-tRNA that is going to be added to the growing polypeptide chain, the
P site holds the peptidyl-tRNA attached to the nascent polypeptide chain and the E site is
occupied the deacylated tRNA before it is ejected from the ribosome [109,117].
Initiation, elongation and termination are the three main stages in which translation
can be divided in bacteria [109].
In the initiation phase the selection of the start site on the mRNA is facilitated by base
pairing between the Shine-Dalgarno (SD) sequence upstream the start codon on the mRNA
and the anti-Shine-Dalgarno (aSD) sequence at the 3’ end of 16S rRNA of the small sub-
unit [75,115]. Initiation requires the ribosome to position the initiator fMet-tRNAfMet over
the start codon of mRNA in the P site [109]. Three initiation factors (IF1,IF2 and IF3) are
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required in this process [79]. The elongation cycle consists of the steps involved in sequen-
tially adding amino acids to the polypeptide chain, starting from a 70S ribosome containing
a peptidyl-tRNA with a nacent polypeptide chain in the P site and an empty A site [109].
Decoding is the first step of the elongation and ensures that the correct aminoacyl-tRNA
is selected in the A site. The amino acid is delivered in a ternary complex of elongation
factor Tu (EF-Tu), GTP and aminoacyl-tRNA [109]. Decoding is followed by peptide-bond
formation, where the amino acid carried by the aminoacyl-tRNA is added to the nascent
polypeptide chain. During translocation, the third and last step of elongation, the elonga-
tion factor G (EF-G) promotes the movement of the tRNAs and mRNA with respect to the
30S subunit. The deacylated tRNA moves from the P site to the E site and the peptydil-tRNA
moves from the A site to the P site. At the end of this process a new codon is presented in
the empy A site. The elongation cycle continues until an mRNA stop codon moves into the
A site, signalling the end of the coding sequence [109]. Termination is the last phase of the
translation process. When the stop codon is positioned in the A site, a class I release factor
recognizes it and cleaves the nascent polypeptide chain from the P-site tRNA, resulting in
the release of the newly synthesized protein from the ribosome [109].
Protein synthesis is intrinsecally a dynamic process since it requires both small-scale
and large-scale movements of tRNA and mRNA moieties [75]. In addition, also the two
30S and 50s subunits are charachterized by movements and structural changes at differ-
ent scale levels [75]. On the large-scale, the 30S subunit has been observed to rotate in
respect of the 50S subunit in all three phases of protein translation. The most studied of
these movements is the ratchet-like rotation of the 30S subunit relative to the 50S subunit
in the direction of the mRNA movement induced by the binding of EF-G to the ribosome
during the translocation phase. After hydrolisis of the GTP the 30S subunit rotates back to
the classic conformation [54,75,109,129]. On the small-scale, the most characterized and
significant movements are observed in the small subunit during the decoding mechanism.
The decoding center is located in the A site of the 30S ribosomal subunit and is surrounded
by four different domains: the head, shoulder, platform and helix 44 on the ribosome body.
Crystal structures have revealed that 16S RNA bases of the decoding centre specifically con-
tact the cognate codon-anticodon pair by an induced fit [91–94]. Nucleotides G530 from
the shoulder domain, and A1492 and A1493 in helix H44 come together to span the minor
groove of the codon-anticodon duplex at the first two codon positions. This results in a
closed conformation of the 30S subunit, in which the shoulder, the head and the platform
domains are rotated towards the subunit centre, compared to a more open structure when
the A site is unoccupied [92, 134]. The sensing of the Watson-Crick base-pairing by nu-
cleotides G530, A1492 and A1493 is responsible for the high accuracy of the ribosome in
the discrimination between cognate and near-cognate codon-anticodon pairing and it has
been proposed that the stabilization of a closed conformation is required for the tRNA selec-
tion. The cognate codon-anticodon pairing is characterized by Watson-Crick base pairing in
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the first two codon positions, while a certain degree of variability (non-Watson-Crick base
pairing) is allowed at the third codon position, called also wobble position. The allowed
variability for the wobble position is due to the fact that the contacts of the ribosome at
this position do not depend upon the precise shape of the minor groove [92]. Near-cognate
codon-anticodon pairing is characterized instead by non-Watson-Crick base-pairing in the
first or in the second codon position, affecting the geometry of the minor groove of the
codon-anticodon helix. This mismatch has been shown to be unfavorable for a transition
to a closed conformation of the small subunit and therefore the near-cognate tRNA is not
selected. The antibiotic Paromomycin affects the rates of aminoacyl-tRNA selection by in-
ducing a conformational change for A1492 and A1493 similar to the one observed when
cognate tRNA is present in the decoding site. This results in a lower accuracy in the se-
lection of the aminoacyl-tRNA and in the closure of the small subunit also in presence of
near-cognate tRNA. [92]
Many structures are now available for procaryotic ribosomes, representing a vast amount
of structural information. The novelty and the complexity of the ribosomal structure makes
then the ribosome an interesting case for a structural comparative analysis performed with
the ESCET framework.
Chapter 2
Aim of the work
The ESCET framework [110–112] has been developed for the comparative analysis of en-
sembles of structural models (protein or RNA macromolecules) obtained via X-ray crystal-
lography.
Amongst the crystallographic parameters taken into account by ESCET, the B factors
play and important role since they are used for the estimation of the coordinate uncertain-
ties at atomic level, which are then propagated through the subsequent steps of the analysis.
In order to avoid aftefacts being introduced into the results of the analysis the correctness
of the B factors must be assessed. Since a validation tool for B factor distributions is still
missing, the first part of the thesis is focused on the development of a new method for
the validation of the distribution of isotropic B factors in crystallographic structural
models.
In addition, provided that the diffraction data are deposited into the PDB together with
the atomic model, a re-refinement procedure is tested as a valid approach to improve those
models with suspicious B factor distributions.
The methods developed for the validation of B factors find a direct application in the
second part of the thesis, which is focused on the ensemble analysis of a selected data set
of 30S ribosomal subunits from T. thermophilus. Here, suspicious structures are detected
and remedied via re-refinement. Different re-refinement protocols are tested and a compar-
ative analysis is performed between the results of the ensemble analysis of the ribosomal
models before and after re-refinement.
An outline of the actions performed in the two studies follows.
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2.1 New Validation Method for B Factor Distributions
• A reference distribution for the distribution of isotropic B factors in crystallographic
models is proposed.
• A validation protocol for the distribution of isotropic B factors is proposed, designed
and implemented in R language.
• The validation protocol is tested on a data set of 15998 protein models at high reso-
lution (equal to or higher than 2 Å).
• Guidelines for discriminating between acceptable and suspicious isotropic B factor dis-
tributions are given.
• A standard re-refinement protocol is tested as a valid procedure to rescue B factor
distributions from suspicious to acceptable.
• A set of 12 L-alanine dehydrogenase (L-AlaDH) protein models from Mycobacterium
tubercolosis, whose B factor distributions are rescued or improved after re-refinement,
is selected for a comparative analysis of the outcome of the ensemble analysis per-
formed on the models before and after re-refinement, characterized by suspicious and
acceptable B factor distributions, respectively.
This study is the first to develop a validation procedure for B factor distributions in macro-
molecular X-ray crystallography.
2.2 Ensemble Analysis of Ribosomal Structures
• A working data set of 30S ribosomal structures from Thermus thermophilus is selected
from the PDB.
• To improve, normalise and de-bias the selected structural models, 13 different refine-
ment protocols are applied.
• The refinement protocol that provides the best models in terms of refinement statistics
and distribution of isotropic B factors (judged with the validation protocol described
above) is selected.
• A comparative analysis is performed on the outcomes of The ESCET framework ap-
plied to the deposited models and to those selected at the previous point. Particular
emphasis is given to the de-biasing effect of the selected re-refinement procedure on
the 30S structural models.
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• The results obtained from the clustering and the rigid body analyses are related to
the structural and functional information available in the literature.
• Considerations are made on the efficacy of the re-refinement as a tool to improve,
normalise and de-bias low-resolution structural models and on how it affects the
results obtained from the ESCET framework.
The novelty of this study is twofold:
1. It is the first assessment of the performance of the ESCET framework on a large data
set of RNA structural models at low-resolution.
2. It is the first study on the effect of a re-refinement protocol on the results obtained
from the ensemble analysis performed with the ESCET framework.

Chapter 3
Theoretical Background
In this chapter the crystallographic and statistical bases of the methods used in the thesis work
are presented.
3.1 Crystal Structures and their Analysis
3.1.1 The Crystallographic Experiment
A macromolecular crystal can be defined as a periodic assembly in three-dimensional space
of identical molecules [43, 106]. The unit cell is the building block from which the whole
crystal is generated by applying translation operations, while the asymmetric unit is the
smallest unit of a crystal structure from which by applying the space group symmetry oper-
ations the unit cell of the crystal is generated [106].
The goal of a crystallographic experiment is to compute from the diffraction pattern
in reciprocal space, which is given by the interaction of X-rays with the scattering matter
inside a crystal, an interpretable electron density distribution in real space that can be used
to build a reasonable atomic model of the content of the asymmetric unit of the crystal (see
Figure 3.1).
After the integration [78] and the scaling [50] of the collected diffraction images [20,
37], an inverse Fourier transformation can be used to compute from the observed diffrac-
tion amplitudes Fobs(h, k, l) the electron density ρ(x , y, z) via the electron density func-
tion [43,106], defined as:
ρ(x , y, z) =
1
V
￿
hkl
Fobs(h, k, l)exp[−2πi(hx + k y + lz −αhkl)], (3.1)
where x , y, z are coordinates in real space, V is the volume of the unit cell and αhkl is
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the phase angle of each reflection. The observed structure factor amplitude Fobs(h, k, l)
is proportional to the square root of the measured intensity of the diffraction reflection,
defined by h, k, l coordinates in reciprocal space. Since in a crystallographic experiment
the phase αhkl cannot be directly measured together [122] with the diffraction intensities
(also known as “crystallographic phase problem”) other methods were developed to over-
come this drawback. The three main classes of methods are: direct methods, experimental
phasing and molecular replacement.
Once an interpretable electron density is calculated, several cycles of model building
and refinement are usually necessary to obtain a model in a good agreement with the
experimental data. The agreement between the observed data and the model is measured
in reciprocal space by comparing the observed structure factors with those computed from
the atomic model with a Fourier transformation via the structure factor equation
Fcalc(h, k, l) =
n￿
i=1
qi fi exp[2πi(hxi + k yi + lzi)]exp[−Bi sin2 θ/λ2], (3.2)
where n is the total number of atoms in the unit cell, qi, fi and Bi are the occupancy value,
the atomic scattering factor and the isotropic B factor of the i th atom (see section 3.1.3),
respectively, θ is the scattering angle and λ is the wave length of the X-ray beam used
during data collection. The R factor is the main measure used to evaluate the agreement
between Fobs(h, k, l) and Fcalc(h, k, l) (see section 3.1.2).
After each cycle of refinement, new phases are computed from the new coordinates and
used in equation (3.1) to compute an updated electron density. The refinement is basi-
cally an optimization procedure that tries to maximise the agreement between Fobs(h, k, l)
and Fcalc(h, k, l) in the reciprocal space by varying the parameter of the model. When no
substantial changes are observed in the parameters between two consecutive refinement
iterations, the refinement is said to have reached convergence [72,125].
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Figure 3.1: Summary of the crystallographic process. On the left a diffraction image is shown. On
the right the computed electron density and the model fitted inside the electron density are shown.
The blue density is the σ weighted map 2mFo-DFc contoured at +1.0 σ, the green density is the
σ-weighted mFo-DFc contoured at +3.0 σ, the red density is the σ-weighted mFo-DFc contoured
at -3.0 σ. The electron density figure was made with the Coot program [49]. The diffraction and
the electron density images were kindly provided by Florian Sauer and they refer to the pdb-entry
3PUC, a structure of the titin domain M7 at 0.96 Å resolution.
3.1.2 The R Factors
The main statistic used to measure the global agreement between a crystallographic model
and the experimental data is the R-value, defined as [26,28,106]:
R=
￿
h,k,l |Fobs(h, k, l)− Fcalc(h, k, l)|￿
h,k,l Fobs(h, k, l)
, (3.3)
where h, k, l are the reciprocal lattice points of crystal, Fobs(h, k, l) and Fcalc(h, k, l) are the
observed and calculated structure factor amplitudes, respectively [26,28].
Two different versions of the R factor are nowadays used: the Rwork and the R f ree . The
first is computed with the structure factors that are used in model refinement. The second
is computed with a smaller subset of structure factors (usually 5% or not less then 1000)
that are omitted in the building and refinement process [26, 28]. The R f ree is used as a
cross-validation tool to monitor the degree of potential over-refinement. Analogously with
the cross-validation method of testing statistical models the R f ree can be considered as a
parameter that express the prediction power of the model [26, 28, 106]. Moreover it has
been shown that it is related to the mean phase error [27,106] and thus it can be used as
a measure of the quality of the model.
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3.1.3 The Isotropic B Factor
The atomic isotropic B factor (Biso) is directly related to the the mean square isotropic dis-
placement 〈u2iso〉 of an atom from its equilibrium position due to static or dynamic disorder
inside the crystal lattice [106,126]:
Biso = 8π2〈u2iso〉. (3.4)
In the approximation mostly used in macromolecular crystallography the atomic displace-
ment is considered to be isotropic and a univariate Gaussian centred in the rest position of
the atom is used to model it. The choice of the Gaussian distribution is supported by the
harmonic approximation used to describe lattice dynamics [126,133].
The effect of the B factor is to attenuate the magnitude of the atomic scattering factor in
the structure-factor equation via the Debye Waller factor (see Figure 3.1), defined as [126]:
Tiso = exp[−8π2〈u2iso〉(sin2 θ )/λ2]. (3.5)
The effect of increasing values of B factors on the atomic scattering factor for selected
atomic types is shown in Figure 3.2. The higher the B factor, the higher the attenuation of
the atomic scattering factors, with significant effects especially at high resolution.
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Figure 3.2: Effect of B factors on atomic scattering factors of the most common atoms in biological
macromolecules (reproduced from Figure 6.13 in [106]). The atomic scattering factors for selected
atom types were taken from Table 6.1.1.1 in [25]. The attenuated atomic scattering factor f Biso is
computed as f Biso = f · Tiso = f · e−Biso(sinθ/λ)2 , where f is the atomic scattering factor in absence
of thermal vibration, Tiso is the isotropic Debye-Waller factor of equation (3.5). The abscissa at
the bottom is plotted in units of sinθ/λ = 1/2d (Å
−1
), where θ is the scattering angle and d is
the interplanar spacing of the diffracting lattice planes [106]. The abscissa at the top reports the
corresponding nominal resolution dmin in Å.
3.1.4 The Diffraction Precision Index (DPI)
The diffraction-component precision index (DPI) is an empirical formula that allows the
calculation of the coordinate error σ(x , 〈B〉) for an atom whose B factor is equal to the
average B (〈B〉) in a macromolecular crystal structure [36]. The DPI formula based on the
R f ree value is [36]:
σ(x , 〈B〉) = (Ni/nobs)1/2C−1/3Rf reedmin, (3.6)
where Ni is the number of sites in the model, nobs is the number of reflections measured, C
and dmin are the completeness and the maximum resolution of the diffraction data used in
refinement and R f ree is the free R value for the final model. The two main advantages of
the DPI are that it can be computed without having the diffraction data available and that
it allows to put onto a common absolute scale the errors in different models [36,110].
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3.1.5 The ESCET Framework
ESCET is a statistical framework that automatically identifies invariant and flexible regions
in an ensemble of macromolecular crystal structures by taking into account experimental
coordinate uncertainties [110–112]. The main workflow of the framework is as follows.
Starting from an ensemble of structural models (of the same or homologous macro-
molecules), for each pair of models a and b, an error-scaled difference distance matrix
(EDD matrix) is used as an objective measure of the structural differences without super-
position between the two structures [110]:
Eabi j =
∆abi j
σ(∆abi j )
, (3.7)
where ∆abi j = d
a
i j − dbi j is the difference distance matrix (DD matrix) that corresponds to
the difference in distance between atoms i and j in the two conformations a and b, and
σ(∆abi j ) is the related experimental uncertainty. The experimental uncertainty σ(∆
ab
i j ) can
be computed by error propagation from the coordinate uncertainties σai ,σ
a
j ,σ
b
i and σ
b
j of
the individual atoms i and j in models a and b as follows:
σ(∆abi j ) = [(σ
a
i )
2 + (σaj )
2 + (σbi )
2 + (σbj )
2]1/2. (3.8)
A modified version of the DPI [36] (equation (3.6)) is then used to estimate the coordinate
uncertainty of each atom of the models in the ensemble. By assuming a linear relationship
between the coordinate uncertainty of an atom i and its B value, Bi, an error estimate σˆx ,i
for the coordinate error σx ,i can be obtained as [110,112]:
σˆx ,i =
σ(x , 〈B〉)
〈B〉 Bi =
Bi
〈B〉(Ni/nobs)
1/2C−1/3Rf reedmin (3.9)
and used in equation (3.8). In ESCET, the error model shown in equation (3.9) takes the
name of DPIU.
Recently a new conformational similarity index (CSI) was introduced in the framework
(data not published) to quantitatively measure the similarity of two structural models. The
CSI is defined as:
CSI=
nid
ntot
, (3.10)
where ntot is the total number of interatomic distances analysed in the EDD matrix (see
equation 3.7) and nid is the number of interatomic distances identical within the error
εlow (a threshold εlow of ±2σ is usually chosen for protein models). If two models are
identical within the error, the CSI is equal to 1.0. If two models show instead significant
conformational differences the CSI is smaller than 1.0.
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The CSI is then used to compute the similarity between each pair of models in the
ensemble and the resulting similarity matrix is analysed with an agglomerative hierarchical
clustering algorithm [56]. An adaptive cutting ruled based in the KGS penalty function [68]
is then used to cut the dendrogram obtained from the cluster analysis and to partition the
ensemble of models in clusters of similar conformers.
From each cluster a representative structure is selected (usually the one with the lowest
mean estimated standard uncertainty). The obtained subset of representative structures
are then analysed by a genetic algorithm [111] for the identification of invariant regions,
or rigid bodies, and flexible regions. In ESCET an invariant region or rigid body is defined
as a group of atoms whose interatomic distances are identical within error. It follows that
depending on the value of the threshold εlow the number and the dimension of the identified
rigid bodies change. In general, larger the threshold εlow, fewer and larger rigid bodies are
found.
3.2 Bayesian Statistics and Hypothesis Testing
3.2.1 Frequentist versus Bayesian Approach
Two main interpretations of probability are used by statisticians: the frequentist, or classical
approach, and the Bayesian approach [18,105,113].
In the frequentist approach, the probability of an event is taken to be equal to the limit of
the relative frequency of the chosen event with respect to all possible events as the number
of trials goes to infinity [113]. In addition, the parameters, or numerical characteristics,
of the population under analysis are considered fixed but unknown and thus they are not
random quantities. Since probability statements are only allowed for random quantities, in
the frequentist approach it is not possible to make probability statements about the value
itself of the parameters. Instead, a sample is drawn from the population and the sample
statistic is computed [18].
In the Bayesian approach, degrees of belief or knowledge are included in the statistical
propositions [113]. This means that, since there is no certainty about the true value of
the parameters, they are considered as random variables. In contrast to the frequentist
approach, the laws of probability are directly used to make inferences about the parameters
and the outcomes are interpreted as degrees of belief (i.e. no certainty is guaranteed).
Moreover, every time new data are available the beliefs about the parameter are revised
by using the Bayes’ theorem, reflecting the dynamical nature of the Bayesian approach.
While in the Bayesian approach the inference is based only on the occurring data, in the
classical approach it is based on all possible data sets that could have occurred for the fixed
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parameters [18].
Apart from a change of emphasis, the majority of the statistical procedures of the two
approaches are identical since the axioms used to define the mathematical properties of
probability remain unchanged [113].
3.2.2 Bayes’ Theorem
Given two events A and B the Bayes’ theorem is defined as [80,106]:
P(A|B) = P(A)× P(B|A)
P(B)
, (3.11)
where the probability P(A|B), which is called posterior probability, is the probability of the
event A conditioned to the occurrence of the event B. The probability P(A), which is called
prior probability, is the probability of the event A without any knowledge about the occur-
rence of the event B. The probability P(B|A), which is called likelihood probability, is the
probability of the event B conditioned to the occurrence of the event A. The probability
P(B) is instead a proportionality constant, which ensures that the posterior probability is
a valid probability with values between zero and one. The likelihood probability is usu-
ally known or can be easily computed, while the posterior probability is inferred from the
combination of the prior probability with the likelihood probability. The terms prior and
posterior refer to the change of knowledge about the event A after the occurrence, or the
observation, of the event B [106].
In the context of a crystallographic experiment the Bayes’ theorem can be rewritten as:
P(model|data) = P(model)× P(data|model)
P(data)
, (3.12)
where the posterior probability P(model|data) is the probability of the model after the
observation of the data, the prior probability P(model) is the probability of the model
before the observation of the data, and the likelihood probability P(data|model) is the
probability of the observed data given the model under consideration [80, 106]. Since in
experimental situation P(data) is usually constant [80] and the goal of a crystallographic
experiment is to maximise the probability of the model given the collected data (posterior
probability), a version of the Bayes’ theorem without P(data) is normally used:
P(model|data)∝ P(model)× P(data|model). (3.13)
Bayes’ theorem is also called the rule of inverse probability since it shows how to turn
P(data|model), that can by easily computed, into P(model|data) [80]. The Bayes’ the-
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orem of equation 3.13 is applied at different stages of a crystallographic experiment from
phasing to refinement. The power of Bayesian statistics is to incorporate prior information
in the computation of the posterior probability. This is quite important at refinement stage
where it is quite common to not have enough observations to refine all the parameters
included in the model. In this case the prior distribution is given by the stereochemistry
knowledge available from structures solved at higher resolution and coded under the form
of restraints during refinement [80].
3.2.3 Conjugate Prior Distributions
One of most controversial concept in Bayesian statistics is the one corresponding to prior
distributions since they express the degree of belief of the statistician regarding the distri-
bution of the unknown parameter before actually seeing the data (i.e. if no information is
available a uniform distribution can be used, otherwise any other distribution that express
the belief of the statistician about the functional form of the prior distribution is accept-
able).
The conjugate distributions in Bayesian statistics are a mathematical convenient choice
for the functional form of the prior distribution. In general, arbitrary priors make for in-
tractable mathematics. Since knowledge of the functional form of the prior is itself often
vague, this has led to the development of a class of conjugate prior distributions, for which
the prior and the posterior are of the same functional form [119]. It follows that the main
advantage of using a conjugate prior distribution is that the posterior distribution can be
computed analytically since it is of the same functional form of the conjugate prior distri-
bution [95].
3.2.4 The Normal (or Gaussian) Distribution
The normal, or Gaussian distribution, N(µ,σ2) is a continuous distribution with probability
density function (pdf) defined as [83]:
f (x |µ,σ2) = 1￿
2πσ
exp
￿
−(x −µ)
2
2σ2
￿
, (3.14)
where µ, defined in −∞ < µ < +∞, and σ2, defined in σ2 > 0, are the mean and variance
parameters, respectively [83].
The Gaussian distribution is a very common and widely used distribution function in
physical sciences, since random errors are expected to be normally distributed [15].
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3.2.5 Inverse-Gamma Distribution (IGD)
The Inverse-Gamma distribution (IGD) is known from statistical theory to be a valid conju-
gate prior for the variance parameter σ2 in a normal model N(µ,σ2) with known mean µ
and unknown variance σ2 [95]. The IGD belongs to the family of continuous exponential
distributions and its probability density function (pdf) is defined as [95]:
f (x |α,β) = IG(α,β) = β
α
Γ(α)
x−α−1 exp
￿
−β
x
￿
∀α,β , x > 0 (3.15)
where α and β are called the shape and scale parameters of the distribution, and Γ(α)
stands for the gamma function with argument α (some representative IGDs are shown in
figure 3.3).
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Figure 3.3: Examples of IGDs with variable α and constant β (panel (a)) and with constant α and
variable β (panel (b)).
The mean value µ and the variance σ2 for a given IG(α,β) can be computed based on
the α- and β -parameters [95] as:
µ=
β
α− 1 ∀α ∈ ￿ > 1 (3.16)
and
σ2 =
β2
(α− 1)2(α− 2) ∀α ∈ ￿ > 2. (3.17)
It should be noted that if 0 < α ≤ 1 the distribution is proper but the mean does not exist,
while the variance exists only for α> 2 [95].
If the statistics µ and σ2 of an IGD are defined (note the existence conditions on α in
equations (3.16) and (3.17)) and known, equations (3.16) and (3.17) can be rearranged
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such that it is possible to calculate the shape (α) parameter
α=
µ2
σ2
+ 2 ∀σ ∈ ￿ > 0 (3.18)
and the scale (β) parameter
β = µ(α− 1) ∀α ∈ ￿ > 1 (3.19)
from the known quantities.
3.2.6 Shifted Inverse-Gamma Distribution (IGD*)
A shifted version of the IGD, called shifted Inverse-Gamma distribution and denoted here-
after as IGD* or IG*(α,β ,γ), can be derived from equation (3.15). Its pdf is defined as:
f ∗(x |α,β ,γ) = IG∗(α,β ,γ) = β
α
Γ(α)
(x − γ)−α−1 exp
￿
− β
(x − γ)
￿
(3.20)
where α and β are the shape and scale parameters, respectively, Γ(α) is the gamma function
with argument α, and γ is the new shifting parameter. The new conditions of existence
become: ∀γ ∈ ￿ ≥ 0 and ∀x > γ, ∀α,β ∈ ￿ > 0. The effect of the third parameter γ is
simply to translate a classic IG(α,β) towards higher values of x . It should be noted that,
while the classic IGD is defined only for positive values of its argument x , the interval on
which the IGD* is defined becomes now from γ to +∞.
From the combination of equations 3.18 and 3.19 together with the properties of mean
and variance (see appendix B) it is possible to obtain the definitions of the shape (α) and
the scale (β) parameters for the IGD*:
α=
(µ− γ)2
σ2
+ 2 ∀σ ∈ ￿ > 0,∀γ ∈ 0≤ ￿ < µ (3.21)
and
β = (µ− γ)(α− 1) ∀γ ∈ 0≤ ￿ < µ,∀α ∈ ￿ > 1 (3.22)
A similar formulation of the IGD* has been recently used as appropriate prior distribution
for the unknown scaling of signal coefficient variances relative to noise variance for noise-
floor estimation in archived audio recordings [57].
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3.2.7 Maximum Likelihood Estimation (MLE)
Given n independent observations from the same distribution, the joint probability of the
observations as a function of a single unknown parameter θ is called the likelihood function
(LF) of the of the sample [120]:
L(x |θ ) = f (x1|θ ) f (x2|θ ) · · · f (xn|θ ) =
n￿
i=1
(xi|θ ). (3.23)
The principle of Maximum Likelihood states that among different choices for the unknown
parameter θ the one (θˆ) that maximises the likelihood function in equation (3.23) should
be chosen [119]:
L(x |θˆ )≥ L(x |θ ). (3.24)
Computationally it is often more convenient to work with the logarithm of the likelihood
function because in this way the product in equation (3.23) becomes a sum and then it
is easier to handle within the machine precision. This approach takes advantage of the
property of logarithms and of the fact that, being the logarithm a monotone function, the
likelihood function and its logarithm have maxima at the same values of their arguments
[120]. From equation (3.23) the so-called log-likelihood function is defined as:
log L(x |θ ) =
n￿
i=1
log L(xi|θ ) (3.25)
A normalized version of equation (3.25), called average-log-likelihood, is often used and
defined as:
￿=
1
n
log L(x |θ ) = 1
n
n￿
i=1
log L(xi|θ ) (3.26)
where the log likelihood of equation (3.25) is normalized by the size of the sample. The ad-
vantage of the average-log-likelihood is that it allows one to compare log-likelihood values
obtained from samples of different sizes.
By definition the goal of the MLE is to find the estimator θˆ that maximises equation
(3.25). However, by changing the sign of the log-likelihood function, the problem is re-
versed to find the estimator θˆ that minimizes that function, allowing the use of the avail-
able optimization algorithms. Here, the so-called negative average-log-likelihood function
is defined as:
− ￿= −1
n
log L(x |θ ) = −1
n
n￿
i=1
log L(xi|θ ). (3.27)
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3.2.8 Tests of Hypotheses
A statistical hypothesis is an assertion about the distribution of one or more random vari-
ables [83] and it is called hypothesis since it is not known in advance whether it is true or
not [105].
If the parameters of the underlying distribution are fully specified the test of hypotheses
is called parametric and non-parametric otherwise. Further, if not even the underlying form
of the distribution is specified, then the test is called distribution-free.
Usually in hypotheses-testing problems two hypotheses are discussed [83]: the null
hypothesis (H0) and the alternative hypothesis (H1). H0 corresponds to the hypothesis
being tested, while H1 corresponds in general to its negation. In fact, the main idea is that
if H0 is false than H1 is true and vice versa [83].
The outcome of a test of hypothesis is the acceptance or the rejection of the null hy-
pothesis H0. In this decision making process two errors can occur. The first, called type
I error, is the rejection of H0 when it is true, while the second, called type II error, is the
acceptance of H0 when it is false [83]. The usual approach is to reject H0 only when very
unlikely. The objective of a statistical test is then not to explicitly determine whether or not
the hypothesis under analysis is true but rather to determine if its validity is consistent with
the data [105]. To accomplish that a value α, called the level of significance of the test, is
specified before performing the statistical test and it is required that the test has the prop-
erty that whenever H0 is true its probability of being rejected is never greater than α. This
corresponds to say that the probability of a type I error can never be greater than α [105].
3.2.9 Kolmogorov-Smirnov Test (KS-test)
The two-sided two-sample Kolmogorov-Smirnov test (KS-test) belongs to the category of
nonparametric statistical methods [61]. It is a distribution-free test of the general null hy-
pothesis that two samples are identical in all respects or, in other words, that they are drawn
from the same distribution [61]. In terms of hypothesis testing this can be reformulated as:
• H0: The two samples belong to the same distribution
• H1: The two samples do not belong to the same distribution
The basic assumption of the test is that if two samples X = x1, x2,. . . , xm and Y = y1, y2,
. . . , yn are drawn from the same distribution their cumulative distribution functions
Fm(t) =
number of sample X ’s≤ t
m
(3.28)
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and
Gn(t) =
number of sample Y ’s≤ t
n
(3.29)
should be identical or at least very similar [61]. The largest distance between the two
cumulative distribution functions is then computed as:
D = max−∞≤t≤+∞ |Fm(t)− Gn(t)| (3.30)
and the KS-test statistics J∗ computed by weighting the distance D with the size of the two
samples as follows:
J∗ =
￿
m× n
m+ n
× D =
￿
m× n
m+ n
× max−∞≤t≤+∞ |Fm(t)− Gn(t)| (3.31)
It’s worth noting that this is the definition of KS-test statistics that has been used in the
thesis work and it is supported by the large-sample approximation. In case of small samples
the equation (3.31) takes a slightly different form (see pages 178-179 in Hollander M. and
Wolfe D.A. (1999) [61]). For each comparison between two samples X and Y the test
returns a p-value that is an estimate of the probability to obtain by chance a KS-test statistic
J∗ at least as extreme as the one computed, assuming that H0 is true. For large samples
an asymptotic distribution is used for the estimation of the p-value. Thus, the lower the
p-value the less likely the null hypothesis is. If the p-value is lower then the the level of
significance α, then the null hypothesis is rejected and considered very unlikely that the
two samples belong to the same population.
Chapter 4
Materials and Methods
4.1 Selection of Protein Structures Data Set
For the selection of a large data set of protein crystal structures at high resolution from the
Protein Data Bank (PDB) [14] the following criteria were applied :
• The resolution dmin of the crystal structure is equal to 2.0 Å, or higher.
• Experimental structure factors are available.
• The model contains more than 1000 non-hydrogen (non-H) protein atoms with oc-
cupancy equal to one and B factors higher than zero. Only atoms that belong to
standard amino-acids are taken into consideration.
• Models refined with one constant B factor for all atoms are excluded.
• Models for which only backbone atoms were refined are excluded.
• Models for which TLS-refinement had been applied are excluded.
The analyses based on full models of crystal structures which can contain multiple chains
are denoted as all-chains and analyses based on individual chains as single-chains.
For the single-chains data set a lower bound limit 500 atoms was fixed as a compromise
to guaranty robustness of the statistical tools applied and at the same time to take into
account as many structures as possible for the analysis.
The advanced search query tool of the RCSB PDB (www.pdb.org) [14] was used to
retrieve the PDB codes of the protein structures that fulfill the resolution and availability of
the structure factors criteria.
The coordinate files with the respective structure factors were downloaded from the
worldwide PDB (www.wwpdb.org) [13].
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Perl (www.perl.org) and Python (www.python.org) scripts were used to download the
structure coordinates and structure factors, and to extract refinement information from the
downloaded coordinate files. The selection for the number of atoms was done during the
analysis phase with in R [101]. The R package bio3d [58] was used to upload and extract
information from the pdb-files.
4.2 Re-refinement of Protein Structures
The CCP4 software suite [135] was used for all the steps required for the re-refinement of
the protein structures. A modified version of the pdb_redo.csh script (version 2.5) from the
PDB_REDO project [65] was used to coordinate and perform the conversion of structure
factors files and the refinement of PDB models.
The main changes introduced in the script are in the setup of the refinement protocol.
Before refinement the B factors of the PDB model were set to the Wilson B value computed
with the sfcheck program [128] to avoid possible bias from the B factors present in the
deposited model. The refinement of each protein model was then performed with the
REFMAC5.6 version 75 [89,90]. The following parameterisations were used: The allowed
B factor range was defined from 0.1 Å2 to 500 Å2; The number of cycles of refinement
was set to 50 to guarantee convergence of the refinement procedure; the automatic de-
twinning procedure implemented in REFMAC5.6 was activated to properly handle twinned
structures during the refinement.
A fresh re-refinement of the deposited structures was preferred to the re-refined struc-
tures available from the PDB_REDO [65] project for several reasons. Firstly the structures
available for download were not usually refined with the same protocol. Secondly the ma-
jority of these structures were obtained by applying TLS refinement. This contradicts the
last criterion used for the selection of the data set of protein structures (see section 4.1).
4.3 Validation of B Factor Distributions
Starting from the assumption that the IGD* is the reference distribution to be used for
validating B factor distributions (see section 5.1), a validation protocol was designed and
implemented in R language [101] (see Fig. 4.1 and the script is available in Appendix A).
A detailed description of each step of the protocol follows.
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Figure 4.1: Validation protocol flowchart. The main steps of the validation protocol are here sum-
marized.
4.3.1 Determination of IGD* Parameters
Given a sample of isotropic B factors Bobs from a protein model, a Maximum Likelihood
Estimation (MLE) procedure (see section 3.2.7 and script in Appendix A) was used to obtain
the estimators αˆ, βˆ and γˆ for α, β and γ parameters of the IGD* that best fit the empirical
distribution of Bobs.
From equation (3.20) the negative log likelihood function and the average negative
log-likelihood function (as defined in section 3.2.7) are respectively:
− log L(x |αˆ, βˆ , γˆ)
= −n αˆ log(βˆ) + n log (Γ(αˆ)) + (αˆ+ 1)
n￿
i
log(xi − γˆ) + βˆ
n￿
i
1
xi − γˆ (4.1)
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and
−￿= −1
n
log L(x |αˆ, βˆ , γˆ)
= −αˆ log(βˆ) + log (Γ(αˆ)) +
(αˆ+ 1)
n￿
i
log(xi − γˆ) + βˆ
n￿
i
1
xi − γˆ
n
, (4.2)
where n is the size of the B factors sample and x is defined as x = Bobs− γˆ. Equation (4.2)
is the target function used in the minimization procedure performed by using an L-BFGS-B
quasi-Newton method [136]. This algorithm needs initial estimates of α, β and γ param-
eters at the start of the optimization. However, as shown in equations (3.21) and (3.22),
both α and β parameters of the IGD* are functions of γ parameter. In order to make the
estimation of the optimal IGD* parameters more robust and avoid that the minimization
procedure becomes trapped in a local minimum the minimization procedure was combined
with a grid search along a set of reasonable γ parameter values as follows:
1. Define a set of initial values γ0 for the γ parameter in the interval [0,min(Bobs) −
0.01], by using a step size of 2 Å2.
2. For each of the initial γ0 parameters computed in step 1:
(a) Compute the initial values α0 and β0 for estimates of α and β parameters from
equations (3.21) and (3.22). The sample mean and the variance of the exper-
imental B factors were respectively used as estimates for the population mean
(µ) and variance (σ2) in equations (3.21) and (3.22).
(b) Minimize function (4.2) starting from γ0 and from α0 and β0 parameter esti-
mates computed at step 2a.
(c) Store final IGD* parameters estimates αˆ, βˆ , γˆ, and the relative negative average-
log-likelihood.
3. Choose the set of final IGD* parameter estimates αˆ, βˆ and γˆ, that give the lowest
value of equation (4.2).
4.3.2 Evaluation of the Goodness of Fit
A two-sample two-sided Kolmogorov-Smirnov test (KS-test) [61] (see section 3.2.9) was
used to quantitatively evaluate the agreement between the observed B factor distribution
and the fitted IGD* obtained via MLE.
In the context of the validation of B factor distributions the null hypothesis (H0) and the
alternative hypothesis (H1) are defined as follows:
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• H0: The B factor distribution under analysis belongs to an IGD* whose parameters α,
β and γ were estimated via MLE.
• H1: The B factor distribution under analysis does not belong to an IGD* whose pa-
rameters α, β and γ were estimated via MLE.
Since the parameters of the IGD* are estimated from the target sample, the null hypothesis
is not anymore simple but becomes composite. This complicates the evaluation of the p-
value from the KS-test [83,119]. To obtain a robust estimation of the p-value under these
circumstances, the following parametric bootstrap [47,48] approach was applied:
1. Obtain via MLE the estimates αˆ, βˆ and γˆ for the α, β and γ parameters of the IGD*
that best fit the empirical B factor distribution.
2. For 1000 times:
(a) Assuming that n is the size of the B factors’ sample Bobs, draw n points from an
IG*(αˆ, βˆ , γˆ) where αˆ, βˆ and γˆ parameters were computed at step 1.
(b) Perform a two-sample two-sided KS-test by comparing the B factors’ sample and
the population of n points generated at step 2a.
(c) Store the p-value given by the KS-test.
3. Compute a bootstrapped estimate of the p-value by averaging the 1000 p-values pro-
duced at step 2.
Since in R 2.220446e−16 is the lowest positive floating-point number x for which 1+x ￿= 1
[34,101], if the bootstrapped estimate of the p-value is lower than this number, ‘< 2.2e−16’
is returned by the protocol instead of a precise estimate. The iteration of the bootstrap
procedure was fixed to 1000 as a compromise between a reasonably low standard deviation
of the estimated average p-value and acceptable CPU time consumption.
For the interpretation of the p-value a significance level of 0.01 is used. If the mean
p-value resulting from the bootstrap procedure is less than 0.01, the null-hypothesis is
rejected and the distribution of B factors flagged as suspicious; conversely, if the mean
p-value is equal to or higher than 0.01, the null-hypothesis is not rejected, and the the
distribution of B factors flagged as acceptable.
In hypothesis testing four different categories of situations are identifiable:
1. True positives are those structures that do not follow an IGD* and have a p-value
lower than 0.01. We refer to them as suspicious structures.
2. True negatives are those structures that follow an IGD* and have a p-value equal or
higher than 0.01. We refer to them as acceptable structures.
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3. False positives (incorrectly called suspicious) are those structures that globally follow
an IGD* but that have a p-value lower than 0.01. They populate the type I error.
4. False negatives (incorrectly called acceptable) are those structures that do not follow
an IGD* but have a p-value equal or higher than 0.01. They populate the type II error.
It should also be noted that an exact p-value from a KS-test can only be calculated in the
absence of ties, where ties stand for repeated values [61]. Since we are dealing with exper-
imental distributions such as the observed B factor distributions, here ties are a common
phenomenon (see below). When ties are present, the measured D will be larger or equal to
the D measured in the absence of ties. Correspondingly, the derived p-values will become
a lower limit estimate of the true p-value. In the context of this study an underestimated
p-value will give rise to false positives, i.e. acceptable structures will be incorrectly cat-
egorized as suspicious. Such cases actually do not create a problem since they can be
re-categorized by eye or by applying orthogonal statistics (see below).
4.3.3 Orthogonal Statistics
The estimates of α, β and γ parameters of the fitted IGD* and the p-value from the KS-test
are the main measures for the detection of structures with a suspicious B factor distribution.
Two orthogonal statistics were introduced to further characterise the suspicious B factor
distributions detected by a p-value lower than 0.01.
• B factor equal to or lower than zero. The IGD* is defined only for positive values (see
equation (3.20)) and then, if present, B factors equal to or lower than zero are not
included in the MLE analysis and later in the KS-test step. B factors equal to zero
are meaningless since they would correspond to atoms steady in space that are not
vibrating. Such an event is impossible. Their presence in a protein model can be due
to errors introduced during the refinement or model building (i.e. wrong atom type).
• Strong ties. Depending on the magnitude and the nature of the process that produced
them, their presence will negatively bias the outcome of the KS-test (see above).
In the protocol the statistic Bnull is used to take into account the presence of B factors equal
to or lower than zero. It is defined as:
Bnull =
n￿
i=1
f (Bi) (4.3)
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where
f (Bi) =
1 if Bi ≤ 0,0 if Bi > 0. (4.4)
and n is the total number of non-H atoms, while Bi is the B Factor value of the i th atom.
Every time a structure has Bnull > 0 a warning flag should be raised.
To detect strong ties the following procedure was introduced. Let Bobs be the set of
experimental B factors from a crystallographic structure with n non-H atoms and Bunique be
the subset of Bobs where all the duplicated values have been removed. If n is the size of Bobs
and j the size of Bunique, it follows by definition that j ≤ n. Let us introduce now a third
set called Bt ies of size j, the same as Bunique, that counts the number of times each value in
Bunique appears in Bobs. Any i th element in Bt ies is defined as follows:
Bties, i =
n￿
k=1
f (Bobs,k) (4.5)
where
f (Bobs,k) =
1 if Bobs,k = Bunique, i,0 if Bobs,k ￿= Bunique, i. (4.6)
Considering that B Factors are rounded until the second decimal digit in a PDB model,
that they contain noise and errors, and that they are usually restrained during refinement
(i.e. two atoms close to each other in three-dimensional space or connected by a bond
have similar B factors) there is a non-zero probability to find duplicated values. This is
particularly true when the number of refined atoms is large (i.e. large complexes, multiple
chains). In this study only those structures that are strongly biased by the presence of ties
were identified. To achieve this an empirical rule based on a z-score approach was applied
by considering as outliers those structures for which the highest value in Bt ies is higher than
the arithmetic mean of Bt ies plus 9 times its standard deviations. This gives the equation:
if max(Bt ies)>
￿〈Bt ies〉+ 9￿Var(Bt ies)￿⇒ Bt ies is suspicious (4.7)
The multiplicative coefficient of 9 was chosen empirically in order to maximize the detec-
tion of large ties at the lower and upper ends of the B factors range.
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4.4 Selection of Ribosomal Structures
For the selection, downloading and analysis of all ribosomal structures available at a resolu-
tion equal to or higher than 4 Å, the SOAP and RESTful web services at RCSB PDB database
were used [14].
The program blastn was used to query the PDB. The sequences of chains A from PDB
codes 1J5E and 1J01 were used to retrieve all 30S and 50S subunits from Thermus ther-
mophilus, respectively, the sequences of chains A from PDB codes 2QAL and 2QAM were
used to retrieve all 30S and 50S subunits from Escherichia coli, respectively, the sequences
of chains 0 from PDB codes 1NKW and 1VQ8 were used to retrieve all 50S subunits from
Deinococcus radiodurans and Haloarcula marismortui, respectively.
Python scripts were used to automate and coordinate the analysis process.
4.5 Re-refinement of Ribosomal Structures
The coordinates and the structure factors of the 29 selected ribosomal structures reported
in table 7.2 were downloaded from the PDB. The phenix.cif_as_mtz program [1] was used
to convert the structure factors from the mmCif format to the mtz format.
The phenix.refine program [1] was then used to refine the ribosomal structure. The
following 13 different protocols were applied:
• Protocol 1:
– Processed all input PDB files with phenix.ready_set [1] program before refine-
ment
– Run 3 macro-cycles of phenix.refine program
– Assigned Bwil to all atoms before refinement
– Refined individual ADP and occupancies
• Protocol 2:
– Taken as input files the output files from protocol 1
– Run 5 macro-cycles of phenix.refine program
– Refined individual ADP, TLS groups (1 group per chain), individual sites, occu-
pancies
– Applied simulated annealing refinement for individual sites (2nd and 4rd macro-
cycles)
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• Protocol 3:
– Taken as input files the output files from protocol 1
– Run 5 macro-cycles of phenix.refine program
– Refined individual ADP, individual sites, occupancies
– Applied simulated annealing refinement for individual sites (2nd and 4rd macro-
cycles)
• Protocol 4:
– Taken as input files the output files from protocol 1
– Run 5 macro-cycles of phenix.refine program
– Refined individual ADP, occupancies
• Protocol 5:
– Taken as input files the PDB files as deposited in the PDB
– Run 3 macro-cycles of phenix.refine program
– Computed only bulk solvent contribution
• Protocol 6:
– Processed all input PDB files with phenix.ready_set program before refinement
– Run 3 macro-cycles of phenix.refine program
– Assigned Bwil to all atoms before refinement
– Refined grouped ADP (2 groups per residue), occupancies
• Protocol 7:
– Taken as input files the output files from protocol 6
– Run 5 macro-cycles of phenix.refine program
– Refined grouped ADP (2 groups per residue), occupancies
• Protocol 8:
– Taken as input files the output files from protocol 6
– Run 5 macro-cycles of phenix.refine program
– Refined grouped ADP (2 groups per residue), individual sites, occupancies
– Applied simulated annealing refinement for individual sites (2nd and 4rd macro-
cycles)
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• Protocol 9:
– Processed all input PDB files with phenix.ready_set program before refinement
– Run 3 macro-cycles of phenix.refine program
– Assigned Bwil to all atoms before refinement
– Refined grouped ADP (1 group per residue), occupancies
• Protocol 10:
– Taken as input files the output files from protocol 9
– Run 5 macro-cycles of phenix.refine program
– Refined grouped ADP (1 group per residue), occupancies
• Protocol 11:
– Taken as input files the output files from protocol 9
– Run 5 macro-cycles of phenix.refine program
– Refined grouped ADP (1 group per residue), individual sites, occupancies
– Applied simulated annealing refinement for individual sites (2nd and 4rd macro-
cycles)
• Protocol 12:
– Processed all input PDB files with phenix.ready_set program before refinement
– Run 3 macro-cycles of phenix.refine program
– Computed only bulk solvent contribution
• Procotol 13:
– Taken as input files the output files from protocol 12
– Run 5 macro-cycles of phenix.refine program
– Refined individual sites, occupancies
– Applied simulated annealing refinement for individual sites (2nd and 4rd macro-
cycles)
Python scripts were used to automate and coordinate the re-refinement processes.
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4.6 ESCET Protocols
4.6.1 Protein Structures
The framework ESCET was used for the analysis of the ensemble of L-Alanine dehydroge-
nase (L-AlaDH) structures from M. tubercolosis discussed in chapter 6.
Since the R f ree values are available in the deposited and re-refined structures, the DPIU
error model (see section 3.1.5) was used to assign coordinate uncertainties to all atoms in
the structures.
The CA-atoms were used as representative atoms for the structural comparison between
the structures in the ensemble and for the identification of rigid bodies and flexible regions.
The minimum size for a rigid body was set to 10 amino-acids and a εlow of 2 was used
for the rigid body analysis.
The ensemble type was set to similar to identify the consistent CA-atoms in the ensemble
of protein structures with the structural alignment algorithm implemented in RAPIDO [84,
85]. This guaranteed that the comparisons were made by using only structural information
and no bias in sequence order or numbering would affect the final results.
4.6.2 Ribosomal Structures
The ESCET framework was used for the analysis of the ensemble of 29 30S ribosomal
subunit structures from T. thermophilus discussed in chapter 7.
Since the R f ree values are available in the deposited and re-refined structures, the DPIU
error model (see section 3.1.5) was used to assign coordinate uncertainties to all atoms in
the structures.
The P-atoms from the 16S rRNA moieties were used as representative atoms for the
comparison between the structures in the ensemble and for the identification of rigid bodies
and flexible regions. The phosphate atoms were chosen as the representative atoms for the
analysis because they are the strongest scatterers present in the ribosomal structures as
shown in Figure 4.2. Since the outcome of a crystallographic experiment is an electron
density map and the phosphate atoms give the strongest signal, they are considered the
most reliable atoms for structural comparisons.
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Figure 4.2: Wall-eye stereo picture of the σ-weighted 2mFO-DFc electron density map for the pdb-
entry 1J5E after re-refinement with protocol 2 (section 4.5) contoured at 6.5σ and carved at 2 Å
from each non-ion atom in the asymmetric unit. The 16S rRNA is shown in ribbon representation
and gray coloured. It should be noted that clear density is visible only for phosphate atoms along
the ribbon representation of the rRNA moiety. No density is visible for any protein present in the
30S complex.
The minimum size for a rigid body was set to 20 nucleotides and a εlow of 1.5 was used
for the rigid body analysis.
The ensemble type was set to similar to identify the consistent P-atoms in the ensemble
of 16S rRNA ribosomal structures with the structural alignment algorithm implemented in
RAPIDO [84,85]. This guaranteed that the comparisons were made by using only structural
information and no bias in sequence order or numbering would affect the final results.
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4.7 Graphics
All three-dimensional figures of protein and ribosomal structures shown in this thesis were
created with Pymol (www.pymol.org), or with Coot if differently specified [49]. The graph-
ical output of the validation method for B factors, bar-plots and scatter-plot were pro-
duced with R. For correlograms the R package corrgram was used. Microsoft PowerPoint R￿,
Adobe R￿ Illustrator R￿ and Adobe R￿ Photoshop R￿ suites were used for the final preparation
of the images present in this thesis.
4.8 Computational Resources
All the analyses reported in this thesis were performed by using the following computa-
tional infrastructures: iMac with Intel R￿ CoreTM 2 Duo CPU at 2.4 GHz, Linux workstation
with 8 CPUs Intel R￿ Xeon R￿ at 2.80GHz, Linux cluster with 68 Dual-Core AMD OpteronTM
Processors at 2.01 GHz.

Chapter 5
A New Validation Method for B Factor
Distributions
This chapter describes the statistical assumption on which the validation method for B factor
distributions is built. To test the validity of the new approach proposed here, a large data set
of protein structures at high resolution was selected and analysed with the validation protocol.
The results obtained from the analysis are then discussed.
5.1 The Statistical Rationale
In order to develop a validation protocol for B factor distributions, it is first necessary to
identify a suitable distribution to be used as a reference in the validation process. In the
attempt to find such a distribution, the model used to describe isotropic displacements in a
crystal is related to some statistical concepts from Bayesian statistics.
5.1.1 The Frequentist View
From the definition of the isotropic B factor Bi for the i th atom in a crystal structure with n
atoms [126]
Bi = 8π2〈u2i 〉, (5.1)
it follows that
Bi = 8π2〈u2i 〉= 8π2s2i ≈ 8π2σ2i ∝ σ2i , (5.2)
where 〈u2i 〉 is the mean square displacement of the i th atom around its rest position, s2i and
σ2i are the corresponding sample variance and population variance, respectively. If the size
of the sample tends to infinity then the sample variance converges to the population vari-
ance, as the case for many unit cells over the duration of the crystallographic experiment.
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It should be noted that from now on the expression ‘B factors’ will imply isotropic B factors,
unless differently specified. As shown in equation (5.2), the atomic B factor Bi of the i th
atom is, by definition, proportional to the population variance σ2i of its atomic displace-
ments. If σ2 is defined as the set of variances of atomic displacements in a protein model
and B as the set of the corresponding B factors, it follows that any consideration about the
nature of the distribution of σ2 is also valid for the distribution of B.
Let us assume that it would be possible in a crystallographic experiment to record the
individual atomic positions for all the atoms while they are vibrating and/or displaced
around their rest position, and let c i,1, . . . , c i,k be the k hypothetical observations for the i th
atom in the protein model. For sake of convenience, each c i stands for a three-dimensional
vector with the xi, j, yi, j and zi, j coordinates of the single observation with j = 1, . . . , k.
In the Gaussian approximation, which is used for the isotropic refinement of B factors,
the atomic displacements of the i th atom are modelled with a uni-variate Gaussian distribu-
tion N(µi,σ2i ). The mean parameter µi is usually set to zero since the Gaussian distribution
is supposed to be centred at the rest position of the i th atom, while the variance σ2i is a
parameter that needs to be estimated.
5.1.2 The Bayesian View
Following a Bayesian approach, the atomic displacements for the i th atom in a protein
model can be described by a Bayesian normal model with known mean µi and unknown
variance σ2i . By means of Bayes’ theorem, the distribution of the variance parameter σ
2
i of
the i th atom given the c i observation can be written as
posterior probability ∝ prior probability × likelihood probability
⇒ f (σ2i |c i,1, . . . , c i,k)∝ f (σ2i )× f (c i,1, . . . , c i,k|σ2i ). (5.3)
Given that the distribution of the atomic displacements in an isotropic model is consid-
ered to be Gaussian, the Inverse-gamma distribution (IGD) can be chosen as a possible
conjugate prior distribution for the σ2i parameter (see section 3.2.5). It then follows that
f (σ2i )∼ IGD. Moreover, thanks to the definition of conjugacy (see section 3.2.3), the poste-
rior distribution f (σ2i |c i,1, . . . , c i,k) is expected to follow an IGD. According to the Gaussian
model used to describe the atomic displacements in a protein model, it follows that for each
atom the variance that describes the atomic disorder is expected to belong to a certain IGD.
In a first approximation the IGD that describes the distribution of the variances of atomic
displacements σ2 in a protein model is assumed to be the same for all atoms. It should be
noted that this does not mean that all the variances σ2 are identical, but simply that they
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are considered to be independent and identically distributed according to a common IGD:
f (σ2)∼ IGD. (5.4)
The fact that the unknown parameter σ2i in the posterior probability f (σ
2
i |c i,1, . . . , c i,k) of
equation (5.3) is not considered to be a constant value but instead an unknown, random
variable is an intrinsic feature of Bayesian statistics.
Since any consideration about the nature of the distribution of σ2 is also valid for the
distribution of B, it follows that
f (B)∼ IGD. (5.5)
The idea that the distribution of isotropic B factors in a protein model follows an IGD has
been previously proposed [38], but never used to validate the B factor distribution itself.
5.1.3 The Reference Distribution
In the previous paragraph the central assumption of the proposed validation method was
that isotropic B factors in protein X-ray structures should follow an IGD (see equation
(3.15)):
f (x |α,β) = β
α
Γ(α)
x−α−1 exp
￿
−β
x
￿
However, experimental B factor distributions are often systematically shifted towards higher
B factor values. This can be due to the fact that the average B factor of a structural model
is related to the resolution dmin to which the respective crystal diffracted, or it can be a
consequence of not fully accounting for systematic error in data collection, such as those
caused by X-ray absorption [38, 62]. To model such systematic shifts, a third parameter γ
is introduced into the classic equation of the IGD and the result is a shifted inverse gamma
distribution (see equation (3.20)):
f ∗(x |α,β ,γ) = β
α
Γ(α)
(x − γ)−α−1 exp
￿
− β
(x − γ)
￿
hereafter named IGD* or IG*(α,β ,γ), to distinguish it from the classic IGD.
Assuming that the IGD* is the reference distribution to be used for the validation of
B factor distribution in protein structures, a protocol was designed and implemented in R
language as described in section 4.3.
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5.2 Comparison of Observed B Factor Distributions to IGD*
The search protocol described in section 4.1 was applied to retrieve a large data set of
protein structures that fulfilled all the required criteria as of June 2010. The query resulted
in 15998 crystal structures containing a total of 30441 protein chains with more than 500
non-H atoms. For sake of clarity, it should be acknowledged that the analyses based on full
models of crystal structures, which can contain multiple chains, are denoted as all-chains
and analyses based on individual chains as single-chains.
The validation protocol described in section 4.3 was then applied to both all-chains and
single-chains data sets. For each of the 15998 protein structures and 30441 protein chains
the protocol delivered the α, β and γ parameters of the IGD* that best fit the empirical
B factor distribution and a p-value that expresses the goodness of fit. The outcome of the
validation protocol is summarised by a graphical plot for inspection and analysis as shown
in Figure 5.1.
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Figure 5.1: Example of graphical output from the validation protocol. Examples of acceptable (a)
and suspicious (b) B factors distributions from pdb-entries 1U5B and 1DOI, respectively. Each plot
produced by the validation protocol described in section 4.3 contains the following information.
For comparison, the histogram of the observed B factors normalized to the total number of atoms,
the curve representing its kernel density estimation (black line), and the density curve of the IGD*
with the best fit to the observed B factors (red line) are represented together. The PDB code, the
identifiers for the polypeptide chains under analysis, the p-value as derived from the KS-test, the
number of B-values lower than or equal to zero, the total number of non-H atoms, and the α, β
and γ parameters used for the calculation of the IGD* are noted at the top of the plot. In case the
p-value is higher than or equal to 0.01, the B factor distribution is considered acceptable and the
histogram is coloured grey (e.g. panel (a)); if instead the p-value is smaller than 0.01, the B factor
distribution is considered suspicious and the histogram is coloured orange (e.g. panel (b)). Strong
ties in the B-factor distribution are indicated by filled blue bars (e.g. panel (b)).
Analysis of α, β and γ IGD* Parameters 49
5.3 Analysis of α, β and γ IGD* Parameters
Estimates for α, β and γ parameters were determined for 15998 B factor distributions
for entire crystal structures (all-chains data set) and for 30441 B factor distributions for
individual peptide chains (single-chains data set) via MLE as described in section 4.3.1. The
correlations between the IGD* parameters and some selected statistics were computed and
a correlogram plot for the all-chains data set is shown in Figure 5.2. In this section the
observed trends for the IGD* parameters are discussed.
Figure 5.2: Correlogram for selected statistics from the all-chains data set. Along the diagonal
the name of the statistic under analysis is reported. For each statistic the minimum and maximum
values are shown on the lower-left and upper-right corners, respectively. On the lower matrix a
scatter-plot representation is shown for each pair of statistics, while in the upper matrix a pie-chart
representation is used to express the correlation between each pair of statistics. Blue and red colours
indicate positive and negative correlation, respectively. A white and empty pie chart corresponds to
a correlation of zero, while a full pie chart corresponds to a correlation of 1 (if blue) or -1 (if red).
The intensity of the colours is proportional to magnitude of the correlation: greater the absolute
value of the correlation, greater the intensity of the colour. Similar trends are observed for the
single-chains data set (not shown).
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The γ parameter is constrained by definition (see section 3.2.6) to assume values be-
tween 0.0 Å2 and the minimum B factor found in the protein model under analysis. This
gives rise to fitted γ parameters, varying between 0.0 Å2 and 32.9 Å2 for the all-chains data
set and between 0.0 Å2 and 45.6 Å2 for the single-chains data set. From the analysis of
the correlogram plot computed for some selected statistics from the protein data set (see
Figure 5.2) it is possible to observe that the γ parameter is slightly positively correlated to
the 〈B〉 of the structure (Pearson correlation coefficient of 0.43 and 0.39 for the all-chains
and single-chains, respectively). Such positive correlation is in agreement with the fact that
experimental B factor distributions are often systematically shifted towards higher B factor
values as discussed in section 5.1.3.
Moving to the analysis of α and β IGD* parameters, they both vary over several orders
of magnitude. The α parameter varies from 0.24 to 176.72 with mean 5.89± 3.95 for the
all-chains data set and from 0.23 to 499.57 with mean 6.38 ± 5.39 for the single-chains
data set, while the β parameter varies from 0.01 to 6335.27 with mean 96.15 ± 123.14
for the all-chains data set and from 0.01 to 10668.74 with mean 111.66± 170.19 for the
single-chains data set. In addition, they are strongly correlated to each other, resulting
in a Pearson correlation coefficients of 0.90 and 0.88 for all-chains and single-chains data
sets, respectively. They both show also a slightly positive correlation with the maximum
resolution of the deposited structures and with the 〈B〉 (see Figure 5.2). This is in agreement
with the fact that structures at higher resolution are usually characterized by lower 〈B〉 as
shown by the positive correlation between the resolution and the 〈B〉 in Figure 5.2.
The strong correlation between α and β parameters becomes clear if the two quantities
are plotted against each other in a logarithmic scale as shown in Figure 5.3.
Figure 5.3: Distribution of the β IGD* parameter versus the α IGD* parameter for all-chains (panel
(a)) and single-chains (panel (b)) data sets. A logarithmic scale is used for both abscissa and ordi-
nate. Two vertical gray dashed lines denote the two empirical boundaries at 1.5 and 50 used for
the detection of outliers in function of the α parameter and four different groups of outliers are
highlighted with a coloured ellipse. For further details please refer to text in section 5.3.
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From the conditions of existence of equation (3.20), in principle any combination of
positive α and β parameters is allowed. However, in protein structures such strong corre-
lation is somehow expected for the following reasons.
In equation (3.21), the mean value µ and the variance σ2 of the underlying IGD* can be
approximated by the observed mean B value 〈B〉 and the observed variance s2B, respectively:
α=
(µ− γ)2
σ2
+ 2≈ (〈B〉 − γ)
2
s2B
+ 2∝ 〈B〉 − γ
sB
. (5.6)
Given that the range for the mean B values is limited to positive and physically reasonable
values and that the variances are consequently limited to a defined range as well, the
variation in the possible values for α is also limited. Besides, as shown in Figure 5.2 the
mean and variance of B factors in protein structures at high resolution show a positive
correlation that is propagated in equation (5.6). In addition, from equation (3.22) the β
parameter is related to the α parameter by a constant factor (µ−γ) that in turn can assume
only a limited range of values:
β = (µ− γ)(α− 1)≈ (〈B〉 − γ)(α− 1)∝ α. (5.7)
The advantage of such strong linear correlation between α and β is that it is usually suffi-
cient to use only one of them (i.e. α) for the detection of suspicious B factor distributions in
terms of α and β IGD* parameters. Here, for practical purposes in the distribution of α and
β parameters of Figure. 5.3, two empirical boundaries for low and high α parameters are
defined respectively at 1.5 and 50. All the structures whose B factor distributions are fitted
by a IGD* with an α parameter lower than 1.5 or higher than 50 are considered outliers or
suspicious. This results in 48 and 11 structures for the all-chains data set and in 78 and 24
structures for the single-chains, respectively. From the analysis of the localization of these
outliers in the distribution of α and β parameters it is possible to identify three different
groups (groups 1, 2 and 4 in Figure 5.3). A fourth group is identified in a set of four
pdb-entries whose α parameter is in the allowed range (except one), but the β parameter
is much lower than expected (group 3 in Figure 5.3). A discussion on the composition of
these groups for the all-chains data set follows.
5.3.1 Outliers, Group 1
This group, highlighted by a cyan ellipse in Figure 5.3, contains a total of forty protein
structures with B factor distributions usually characterized by a strong tie at the lowest B
factor value.
The pdb-entry 2YYH is an illustrative example of outlier from this group (see Fig-
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ure 5.4).
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Figure 5.4: Example of an outlier structure from group 1: analysis of the pdb-entry 2YYH as taken
from the PDB (a) and after re-refinement (b). For a description of the plot generated by the valida-
tion protocol please refer to Figure 5.1.
The deposited structure (panel (a) in Figure 5.4) is an extreme example of a protein
model with a large number of B factors equal to zero (2514 out of 4293). It should be noted
that even if B factors equal to zero are not taken directly into consideration during the MLE
procedure (since they are physically meaningless and contradict the existence conditions
of the IGD*), their presence in the the model greatly affects the overall distribution of the
remaining B factors in the model, resulting in a p-value lower than 0.01 and thus in a
suspicious distribution. To see if a standard refinement protocol is sufficient to recover the
distribution of B factors, the refinement protocol described in section 4.2 was applied to the
deposited 2YYH model and the distribution of B factors from the re-refined model is shown
in panel (b) of Figure 5.4. After re-refinement all B factors in the model were observed to
be higher than zero and the overall distribution of B factors was labeled as acceptable, with
a p-value from the KS-test of 0.37. It is also worth noting that the α and β parameters
increased from 0.44 and 0.51 to 4.1 and 53.86 respectively, in agreement with the trend
of the majority of the α and β parameters computed from the protein data set and shown
in Figure 5.3. No significant difference was observed in R factors from the default and
the re-refined structure. The Rwork and R f ree went from 0.21 and 0.25 to 0.19 and 0.24,
respectively.
Another example of a suspicious structure from this group is the pdb-entry 1DOI shown
previously in panel (b) of Figure 5.1. Also in this case a strong tie is present at the lowest B
factor value (214 out of 1007 atoms have a B factor of 2 Å2).
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For both pdb-entries 2YYH and 1DOI the p-value from the KS-test was enough to flag
their B factor distributions as suspicious. This is due to the fact that usually a strong tie
at the lowest B factor value significantly affects the estimation of the IGD* that best fits
the empirical distribution of B factors by lowering the values of α and β parameters. Fur-
thermore, the observation that a default re-refinement protocol was sufficient to fix the
distribution of B factors for the pdb-entries 2YYH (see Figure 5.4) and 1DOI (not shown)
can be explained by the fact that strong ties localized at the lowest B factor value in the
deposited structures are usually artefacts introduced in the refinement stage before the
deposition of the structures.
5.3.2 Outliers, Group 2
This group, highlighted by a blue ellipse in Figure 5.3, contains a total of eleven structures
samples with narrow and symmetric B factor distributions characterized by very high α and
β parameters. The reason for such narrow distributions is at the moment not clear, but it
is suspected that during the refinement of these structures the B factors were too tightly
restrained.
The pdb-entry 1XT8 is an extreme example of an outlier from this group (see Fig-
ure 5.5). In the all-chains data set it is the structure with the highest α and β IGD* pa-
rameters, respectively equal to 176.72 and 6335.27.
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Figure 5.5: Example of outlier structure from group 2: analysis of PDB code 1XT8 as taken from
the PDB (a) and after re-refinement (b). For a description of the plot generated by the validation
protocol please refer to Figure 5.1.
The deposited model (panel (a) in Figure 5.5) is the structure with the highest α and
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β IGD* parameters in the all-chains data set with values equal to 176.72 and 6335.27, re-
spectively. Similar to section 5.3.1, the deposited model was re-refined with the refinement
protocol described in section 4.2 and the distribution of B factors from the re-refined model
is shown in panel (b) of Figure 5.5. Also in this case the distribution of B factors became ac-
ceptable after re-refinement and the α and β parameters lowered from 176.72 and 6335.27
to 8.02 and 177.18, respectively. It should be noted that the gap between R f ree and Rwork
slightly increased after re-refinement. In fact, the Rwork and R f ree factors went from 0.18
and 0.23 to 0.18 and 0.25, respectively.
5.3.3 Outliers, Group 3
This group, highlighted by a black ellipse in Figure 5.3, contains four structures (PDB codes:
1H7R, 4GCR, 1IDS and 1PPO) for which the α parameters lie in the acceptable range
between 1.5 and 50 (except for the pdb-entry 1PPO, with α = 1.27), but the β parameters
are systematically shifted to lower values if compared to the expected trend in Figure 5.3.
The common feature of the four structures is that their B factors are very low, ranging
between 0 and 2.5 Å2.
A careful analysis of the four structures reveals that they were all refined using the
refinement program RESTRAIN [44], which has an option to write mean square displace-
ments 〈u2〉 instead of B factors to the pdb-file containing the refined model. Apparently this
option had been used to produce the model deposited in the PDB. In fact, multiplying the
numbers given in the B factor column of the respective pdb-files by a constant of 8π2 and
repeating the analysis, the obtained α and β parameters fall in the expected range, except
for the pdb-entry 1PPO (data not shown). This is explained by the fact that a multiplicative
constant applied to the B factors affects only the β parameter of the fitted IGD* (a deriva-
tion of how a scaling of B factors by a multiplicative constant is reflected in the estimated
α and β parameters can be found in appendix C).
A representative example for this group is the pdb-entry 4GCR (see Figure 5.6).
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Figure 5.6: Example of an outlier structure from group 3: analysis of the pdb-entry 4GCR as taken
from the PDB (a) and after re-refinement (b). For this structure 〈u2〉 values were erroneously stored
instead of B values. If the 〈u2〉 in (a) are converted to B factors by multiplying them by a constant of
8π2, the p-value from the KS-test applied to the obtained B factors is 0.011 (data not shown). The
fact that the p-value did not significantly change (0.01￿ 0.011) is expected, as shown in appendix C.
For a description of the plot generated by the validation protocol please refer to Figure 5.1.
Panel (a) in Figure 5.6 shows the distribution of 〈u2〉 values for the deposited 4GCR
model. The mean square displacement values lie in the range between 0.06 and 0.80 Å2
resulting in a p-value for the agreement between the fitted IGD* and the observed 〈u2〉
values of 0.01 and thus an acceptable distribution. When the 49 atoms with 〈u2〉 higher than
0.75 Å2, giving rise to the second maximum in the B factor distribution are removed from
the model, the β parameter still remains rather small (0.45) while the p-value increases
to 0.023 (data not shown) indicating that, in principle, the agreement to the fitted IGD* is
good, despite the fact that the 〈u2〉 values are much too small if compared to the expected
B factors. Also in this case the deposited model was re-refined with the refinement protocol
described in section 4.2 and the distribution of B factors from the re-refined model is shown
in panel (b) of Figure 5.6. After re-refinement the B factors lie in a reasonable range
between 6.09 Å2 and 73.87 Å2, resulting in an acceptable distribution with a p-value from
the KS-test of 0.25. Since the deposited structure factors did not contain the free set it
is difficult to say if the R factor statistics improved or worsened. Nevertheless, after re-
refinement the Rwork and R f ree went from 0.18 and na to 0.16 and 0.21, respectively.
The standard re-refinement protocol was applied also to the other three protein models
in this group. For two of them (PDB codes: 1H7R and 1IDS) the re-refinement protocol
significantly altered the B factor distributions resulting in p-values > 0.25 throughout. For
1PPO the refinement protocol failed, indicating a serious problem with the model and/or
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the diffraction data.
5.3.4 Outliers, Group 4
This group, which is highlighted by a red ellipse in Figure 5.3, includes seven structures
(PDB codes: 3B8D, 3ENV, 3KRG, 3ENW, 1EPT, 1YJB and 3F3R) that share the feature of
giving rise to very low β parameters of 0.01 (the lower limit allowed for this parameter by
the MLE-procedure).
The corresponding B factor distributions all exhibit strong ties at a value of 2 Å2 which
corresponds to the lower limit imposed by several refinement programs, indicating prob-
lems with the parameterisation of the models. The number of atoms with a B factor of
2 Å2 are: 2600 out of 11004 atoms (∼ 24%) for 3B8D, 841 out of 3204 atoms (∼ 26%)
for 3ENV, 666 out of 3055 atoms (∼ 22%) for 3KRG, 1363 out of 3204 atoms (∼ 43%) for
3ENW, 774 out of 1526 atoms (∼ 51%) for 1EPT, 863 out of 1934 atoms (∼ 45%) for 1YJB,
995 out of 1592 atoms (∼ 63%) for 3F3R.
As an example of an outlier structure from this group, the B factor distribution for the
pdb-entry 3B8D is shown in Figure 5.7
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Figure 5.7: Example of an outlier structure from group 4: analysis of pdb-entry 3B8D as taken from
the PDB (a) and after re-refinement (b). For a description of the plot generated by the validation
protocol please refer to Figure 5.1.
For four out of the seven structures (PDB codes: 3ENV, 3ENW, 3F3R and 1DOI), the
standard refinement protocol described in section 4.2 was successful to bring α and β
parameters into the expected range. Three models were not rescued by the re-refinement
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procedure (as shown in panel (b) of Figure 5.7 for the pdb-entry 3B8D). These models
had a very low Bwil including one case (PDB code 1YJB) with a negative Bwil of -4.0 Å2,
as determined by the phenix.xtriage program [1]. This clearly indicates problems with the
diffraction data (e.g. errors in detector calibration or incorrect absorption corrections being
applied to the data).
5.4 Agreement Between B Factor Distributions and the IGD*
After estimation of the α, β and γ parameters of the IGD* that best fit the B factor dis-
tributions for the 15998 structures of the all-chains data set and the 30441 chains in the
single-chains data set, a parametric bootstrapped two-sample two-sided KS-test was ap-
plied to evaluate the goodness of fit between the observed B factor distributions and the
estimated IGD*, as described in section 4.3.2. This resulted in 15998 p-values from the
all-chains data set and 30441 p-values from the single-chains data set.
5.4.1 Distribution of P-values
As described in section 4.3.2, the null hypothesis H0 adopted in the KS-test states that
the experimentally determined B factors follow a IGD* whose parameters are obtained via
MLE, while the alternative hypothesis is its negation (i.e. the the experimental B factors
do not follow a IGD*). A significance level of 0.01 (1%) was used for the interpretation
of the outcome from the KS-test. If the p-value obtained from the KS-test is smaller than
1% the null-hypothesis is rejected, indicating that it is highly improbable that the observed
distribution is well represented by the estimated IGD*. This corresponds to what in statistics
is called a positive case and the B factor distribution under analysis is labelled as suspicious.
If instead the p-value is greater than or equal to 1% the null-hypothsis is not rejected. This
corresponds to what in statistics is called a negative case and the B factor under analysis is
labelled as acceptable.
For 12694 out of 15998 crystal structures from the all-chains data set, the p-value is
equal to or greater than 0.01, indicating that for the majority of structures inspected (i.e
79%) the null-hypothesis should not be rejected and the corresponding B factor distribu-
tions are considered acceptable. This observation became even more pronounced when the
distributions for individual chains were inspected. In this case, 26962 out of 30441 single
chains analysed from the single-chains had a p-value higher than or equal to 0.01, leading
to 89% of the structures having B-factor distributions that could be satisfactorily described
by a IGD* and then considered acceptable (see Figure 5.8).
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Figure 5.8: Distribution of p-values for all-chains and single-chains data sets. Blue and green colours
are used to distinguish the all-chains data set from the single-chains data set, respectively. A vertical
red line is used to highlight the boundary between the suspicious structures (to the left) and the
acceptable structures (to the right).
5.4.2 Some Observations about Sample Size Bias
It should be noted that, during the analysis of the distribution of p-values from the protein
data set, the KS-test showed a different stringency in function of the sample size. Even if a
correction for the size of the samples is present in the KS-test statistic with the multiplicative
factor
￿
(m× n)/(m+ n) (see equation 3.31), there are cases in which the test seems too
permissive, especially with samples of small size, and other cases in which the test seems too
strict, especially with samples of large size (see Figure 5.9 for some indicative examples).
This can give rise to false negatives in the first case (see panel (d) in Figure 5.9) or false
positives (see panel (a) in Figure 5.9). It must be noted anyway that all these cases lie
in the category of B factor distributions with a p-value of 0.01. Such significance level
should be considered a sort of “twilight zone” and all the structures with a p-value close to
0.01 should be checked manually. Complementarily, the orthogonal statistics discussed in
section 5.5 can be useful for the detection of false negatives.
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Figure 5.9: Examples of the effect of the population size on the outcome of the KS-test. In panels
(a) and (b) two examples of large B factor samples of 30384 and 25081 atoms, respectively; in
panels (c) and (d) two examples of small B factor samples of 1461 and 1308 atoms, respectively. It
is worth noting that all four distributions have a p-value close to the significance level 0.01: the B
factor distribution from the pdb-entry 1O02 is considered suspicious since its p-value is lower than
0.01, while the B factor distributions from the pdb-entries 2CM4, 3E89 and 219L are considered
acceptable since their p-values are all higher than 0.01. However the qualitative agreement between
the empirical distributions and the fitted IGD* greatly changes when moving from large (panels (a)
and (b)) to small (panels (c) and (d)) B factor samples.
The fact that the stringency changes with the size of the sample is an intrinsic property
of statistical tests. This has also a logical basis: by randomly drawing a low number of
points from a IG*(α, β , γ) it is quite probable that the empirical distribution will look quite
different from the expected one and usually it will be affected by multimodality. Instead,
when drawing a larger number of points, the empirical distributions will get closer to the
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expected distribution. This is intrinsically related to the random process that is used to
draw the points.
For practical purposes one could decide to use different significance levels, depending
on the size of the sample of B factors under analysis, in order to finely tune the outcome
of the KS-test. It should be noted that this would be a completely pragmatic approach
without any support from the statistical theory. It would be an attempt to find a compromise
between theory and real life but at the risk of breaking the statistical assumptions behind
hypothesis testing.
Since some approximations were already introduced to adapt the KS-test for the valida-
tion of B factors (see section 4.3.2), for the analysis of the p-values from the KS-test only
one significance level of 0.01 was used.
5.4.3 Refinement Programs Distribution
The distribution of p-value was studied as a function of the refinement program used to
refine the structures in the all-chains data set to see if any interesting trend was detectable
(see Figure 5.10). For this analysis only those refinement programs for which at least more
than one hundred structures are available in the data were taken into considerations. This
resulted in the selection of the following refinement programs: REFMAC (6607 structures),
CNS (5535 structures), SHELXL (1194 structures), X-PLOR (1124 structures), TNT (609
structures), PHENIX (391 structures), PROLSQ (175 structures) and CNX (166 structures).
Together they account for 98.8% of the total number of structures in the all-chains data
set. From the analysis of the p-value distribution in panel (a) of Figure 5.10 it emerges
that SHELXL and PHENIX depart mostly from the general trend shown by the other refine-
ment programs. Their p-value median are centered respectively at 0.29 and 0.20, while
the p-value median for the other programs is centered around 0.1 (REFMAC at 0.11, CNS
at 0.09, X-PLOR at 0.11, PROLSQ at 0.10, CNX at 0.11). The reason for such difference,
especially for SHELXL, becomes clear if the distribution of resolution is taken into consider-
ation (panel (b) in Figure 5.10). It fact, protein structures that were refined with SHELXL
are on average characterized by a higher maximum resolution (1.4 Å) when compared to
structures refined with the other refinement programs (∼ 1.7 Å). This is reflected also by
the lowest percentage of suspicious structures with a p-value lower than 0.01 (84 out of
609, corresponding to 7%). For PHENIX the average resolution of the structures (1.8) is
not as high as for SHELXL. Nevertheless the percentage of suspicious structures (47 out of
391, corresponding to 12%) is lower than the average of suspicious structures present in
the data sets (∼20%) refined with the remaining refinement programs. This observation
can be partially biased by the rather small size of the data set since it contains only 391
structures.
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Figure 5.10: Distribution of p-value (panel (a)) and resolution (panel (b)) as a function of the
refinement program used to refine the protein structures in the all-chains data set. On the right side
of the distribution of p-value (panel (a)) the total amount of structures for each program is reported
in black digits, while on the left side the relative percentage of structures with a p-value lower than
0.01 is reported in gray digits. On the right side of the distribution of resolution (panel (b)) the
average resolution is reported for each refinement program in black digits.
5.4.4 Multimodality 1, Chain Level
After dealing with the structures which are outliers in terms of α and β IGD* parameters
(see section 5.3), there were still many structures which gave rise to a bad agreement be-
tween observed B factor distributions and derived IGD* as measured by the p-value (see
Figure 5.8). Of particular interest is the observation that, when moving from the analysis
of the all-chains data set to the analysis of the single-chains data set, the percentage of ac-
ceptable structures increases from 79% to 89%. Looking at the distribution of B factors of
those structures from the all-chains data set with a p-value lower than 0.01 it became clear
that the majority of them were affected by a strong multimodality. Nevertheless, for some
of them, each single chain in the asymmetric unit satisfied the IGD* assumption if anal-
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ysed independently, showing a p-value higher than 0.01. This explains the difference in
percentage of suspicious structures shown in Figure 5.8 between the all-chains data set and
the single-chains data set. The presence of multimodal B factor distributions is physically
reasonable as often different molecules in the same asymmetric unit are in a different pack-
ing environment, giving rise to different global and/or local disorder/mobility, resulting in
systematically different B factor distributions.
An extreme example from this category of structures is the pdb-entry 2R8Y [16] (see
Figure 5.11). The asymmetric unit of this structure contains 16 molecules of YrbI phos-
phatase from E. coli containing 188 amino acid residues each. If the B factor distribution
from all chains (21549 atoms) is analysed the resulting p-value is lower than 0.01 and thus
the distribution is considered suspicious (see panel (b) in Figure 5.11). If the model is di-
vided into 16 chains of ca. 1350 atoms each, all 16 chains exhibit p-values equal or higher
than 0.01 and then they are all considered acceptable (see panels (d) and (f) in Figure 5.11
and in Table 5.1, default columns). Similar results are obtained if the model is re-refined
with the protocol described in section 4.2 (see Table 5.1, re-refined columns).
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default re-refinedchain
α β γ p-value α β γ p-value
A 6.22 63.68 8.21 0.31 4.75 51.42 8.10 0.54
B 10.83 120.11 6.26 0.21 6.06 62.53 7.35 0.18
C 9.38 105.61 6.40 0.51 5.46 57.26 7.57 0.23
D 8.70 132.42 5.55 0.15 5.24 72.28 7.28 0.65
E 7.32 85.81 7.74 0.37 5.37 66.83 7.30 0.55
F 7.63 89.40 6.66 0.30 5.11 56.89 7.54 0.57
G 9.56 110.38 5.27 0.31 5.44 56.75 6.73 0.30
H 8.81 120.03 6.13 0.25 5.43 69.02 7.33 0.62
I 10.52 180.84 16.05 0.07 7.11 136.06 13.91 0.48
J 9.26 182.47 14.15 0.03 6.16 125.33 13.18 0.33
K 32.54 1281.22 0.00 0.03 11.56 331.59 9.68 0.50
L 27.94 1099.99 0.69 0.10 11.22 338.42 8.84 0.60
M 14.76 313.45 11.16 0.24 8.06 159.95 12.40 0.57
N 17.04 285.10 11.94 0.42 9.55 166.16 11.30 0.30
O 24.90 820.73 0.61 0.01 8.85 202.27 9.95 0.46
P 18.17 277.77 14.92 0.32 10.38 195.73 11.43 0.07
A-P 7.71 187.99 0.00 < 2.2e-16* 6.94 173.08 0 < 2.2e-16*
Table 5.1: IGD* statistics for single chains from the pdb-entry 2R8Y. For each of the 16 chains
present in the asymmetric unit the α, β and γ IGD* parameters are reported, together with the p-
value from the KS-test for the default structure and for the re-refined structure. The last row refers
to the whole deposited model. P-values lower than 0.01 are highlighted with and asterisk ‘*’ symbol.
5.4.5 Re-refinement of Suspicious Structures
Since the standard refinement protocol described in section 4.2 was found to be sufficient
to rescue the majority of those structures that were considered outliers for the distribution
of α and β parameters (see section 5.3), the same refinement protocol was used to re-refine
2255 structures, which based on their p-value were classified as suspicious for the all-chains
data set and suspicious for at least one chain in the single-chains data set.
For 1959 structures the refinement protocol converged, while for the remaining 296
structures it was not successful, indicating problems with the diffraction data and/or the
deposited model. The R factor statistics before and after the re-refinement procedure follow
the same general trend observed in similar comparative analysis available in the literature
[65, 66] (data not shown). The distribution of p-values for the resulting models is shown
in Figure 5.12. 69% and 89% of the all-chains and single-chains cases respectively resulted
in p-values higher than 0.01 and could therefore be re-classified as acceptable. This is a
quite impressive result if it is considered that before re-refinement all the structures in the
selected subset were considered suspicious.
Also in this case, the percentage of suspicious structures lowers while moving from the
all-chains data set to the single-chains data set as previously observed for the complete data
sets (see Figure 5.8). As expected, such difference in percentage was due to multimodal
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B factor distributions that could be decomposed into unimodal B factor distributions if the
single chains were taken into consideration.
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Figure 5.12: Distribution of p-values for all-chains and single-chains data sets after re-refinement
of a selected subset of suspicious structures. Blue and green colours are used to distinguish the all-
chains data set from the single-chains data set, respectively. A vertical red line is used to highlight
the boundary between the suspicious models (to the left) and the acceptable models (to the right).
5.4.6 Multimodality 2, Domain Level
However, even if the re-refinement procedure rescued the distribution of B factors for
around 70% of the structures in the all-chains data set, there were still 11% of suspicious
B factor distributions in the single-chains data set (see suspicious structures in Figure 5.12).
Looking at these distributions it became clear that also in the single-chains data set it was
possible to identify some strong multimodal distributions. They usually corresponded to
structures where it is possible to fit a IGD* to the B factors from individual domains of the
protein.
An extreme example for this class of structures is the GroEl complex (PDB code 1KP8
[131]) where the whole complex and all the single-chains in the deposited model have a
p-value close to zero (see Table 5.2, default columns). If the structure of the complex is
visualized in a cartoon representation and coloured according to the atomic B-factors, it is
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possible to notice a different distribution of B factors among the three different domains
composing each protein chain (data shown only for the re-refined model, see below). The
B factors seem in fact to follow a gradient. From low values in the equatorial domain to
higher values in intermediate and apical domains. In particular, for all chains the equatorial
domain the B factors seem to be colder than in the other two domains. The distribution of
B factors was then analysed at single domain level and it was observed that the equatorial
and the intermediate domains usually satisfy the IGD assumption. However, none of the
apical domains comply to the IGD*. Is should be noted that a gradient similar to the
one observed for the B factors was detected also for the α and β parameters of the IGD*
fitted on the B factor distributions of each domain. The average α and β parameters are
equal to 8.18 ± 1.02 and 191.63 ± 40.95 for the equatorial domains, 36.04 ± 16.12 and
3007.89±1622.81 for the intermediate domains, 62.43±39.83 and 7612.66±5749.09 for
the apical domains, respectively (see Table 5.2, default columns).
After re-refinement, a strong multimodality was still detected on the B factor distribu-
tion at both all-chains and single-chains levels. However, differently from the deposited
model, all the individual domains satisfied the IGD* assumption (see Table 5.2, re-refined
columns) and then could be classified as acceptable. The gradient of B factors values from
the equatorial to the apical domains was still noticeable (see Figure 5.13, panels (e) and
(f)). The same holds for the distribution of α and β parameters from the IGD* fitted to
each domain. After re-refinement the average α and β parameters are equal to 6.57±0.45
and 154.51±22.08 for the equatorial domains, 15.74±5.83 and 1128.54±614.97 for the
intermediate domains, 22.92±7.44 and 2377.65±1060.90 for the apical domains, respec-
tively (see Table 5.2, re-refined columns). From these results it seems that the magnitude
of the α and β parameters is related to the optical resolution of the domains that in turn
is related to the quality of the electron density map and thus to the magnitude of the B
factors.
The fact that the multimodal behaviour at all- and single-chain level did not disappear
after re-refinement means that the observed multimodality is an intrinsic property of the
distribution of B factors of the structure and it is related to the disorder due to the mobility
of the domains in the crystal lattice. It is in fact known that the GroEl complex undergoes
conformational changes during its activity [131]. The same behaviour was observed in
other structures where it is possible to identify in the same chain more than one domain
with different level of disorder. It would be then possible to improve the statistics by iden-
tifying among the suspicious structures those where each single domain satisfies the IGD
assumption. However, unless an automated procedure is implemented, this step must be
conducted manually.
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default re-refinedchain domain
α β γ p-value α β γ p-value
A
equatorial 8.68 207.84 15.23 0.60 6.79 162.92 12.28 0.25
intermediate 27.88 2240.54 0.00 0.27 16.27 1167.85 0.00 0.57
apical 45.25 4631.00 0.00 2.3e-04* 20.97 1909.09 0.00 0.41
all 4.67 267.19 0.00 < 2.2e-16* 4.52 236.79 0.00 1.1e-12*
B
equatorial 6.76 131.59 14.86 0.27 5.97 125.42 11.04 0.10
intermediate 25.43 2029.86 0.00 0.14 16.56 1191.99 0.00 0.62
apical 69.37 9026.66 0.00 1.1e-05* 25.72 2973.30 0.00 0.25
all 1.87 71.48 11.46 < 2.2e-16* 2.49 112.29 3.77 < 2.2e-16*
C
equatorial 8.06 203.29 15.18 0.20 6.51 164.01 11.66 0.57
intermediate 42.36 3782.38 0.00 0.01 19.50 1560.82 0.00 0.59
apical 102.62 12976.23 0.00 4.7e-03* 29.90 3326.68 0.00 0.19
all 3.65 224.64 0.00 < 2.2e-16* 3.54 197.45 0.00 < 2.2e-16*
D
equatorial 10.01 233.49 12.19 0.16 6.53 135.71 11.35 0.04
intermediate 10.31 439.66 12.98 0.10 6.67 249.04 13.02 0.25
apical 16.30 1181.78 0.00 1.2e-03* 9.02 517.60 5.94 0.10
all 4.65 175.56 8.3 2.0e-05* 4.34 152.29 6.71 5.2e-03*
E
equatorial 6.74 130.15 13.52 0.35 5.93 119.74 10.41 0.27
intermediate 23.65 1691.67 0.00 0.07 10.87 625.07 7.45 0.41
apical 52.64 6031.11 0.00 2.2e-04* 23.72 2391.02 0.00 0.26
all 2.37 96.84 7.49 < 2.2e-16* 3.01 136.99 1.2 < 2.2e-16*
F
equatorial 7.93 193.19 13.57 0.21 6.68 166.93 10.26 0.43
intermediate 29.24 2497.76 0.00 0.02 19.15 1439.93 0.00 0.61
apical 66.03 8621.81 0.00 2.7e-03* 25.76 2985.99 0.00 0.17
all 2.77 146.91 4.33 < 2.2e-16* 3.18 171.51 0.00 < 2.2e-16*
G
equatorial 7.43 142.83 16.32 0.25 7.00 154.83 11.05 0.02
intermediate 9.72 399.74 17.26 0.16 6.10 214.54 16.54 0.29
apical 14.71 1164.91 0.00 1.3e-03* 10.50 729.44 0.00 0.07
all 3.51 122.45 11.72 4.0e-07* 4.00 144.91 7.23 2.6e-04*
H
equatorial 7.54 154.76 16.51 0.60 6.33 136.59 13.18 0.12
intermediate 27.76 1888.23 0.00 0.08 9.27 432.51 15.52 0.58
apical 36.94 3621.96 0.00 4.1e-04* 21.44 1857.73 0.00 0.20
all 3.87 180.79 5.67 < 2.2e-16* 4.72 234.55 0.08 7.9e-11*
I
equatorial 6.94 156.35 18.19 0.21 5.94 135.10 14.92 0.54
intermediate 50.95 4289.64 0.00 0.24 21.24 1624.24 0.00 0.52
apical 60.22 6824.89 0.00 8.7e-04* 26.99 2699.66 0.00 0.24
all 4.39 265.76 0.00 < 2.2e-16* 4.33 240.38 0.00 < 2.2e-16*
J
equatorial 8.66 212.69 18.73 0.26 6.27 149.28 16.00 0.19
intermediate 55.89 5052.82 0.00 0.07 23.67 1931.64 0.00 0.58
apical 104.70 12916.52 0.00 2.3e-03* 32.05 3454.02 0.00 0.32
all 4.29 276.42 0.00 < 2.2e-16* 4.28 251.74 0.00 < 2.2e-16*
K
equatorial 9.06 239.41 17.52 0.19 6.77 171.48 15.06 0.52
intermediate 54.78 5348.94 0.00 0.04 21.84 1890.20 0.00 0.63
apical 161.62 22356.28 0.00 3.4e-03* 33.38 4093.37 0.00 0.22
all 3.43 218.20 2.58 < 2.2e-16* 3.64 222.67 0.00 < 2.2e-16*
L
equatorial 8.40 200.36 16.32 0.29 6.71 161.12 13.09 0.40
intermediate 46.47 3762.17 0.00 0.14 15.02 938.69 10.72 0.66
apical 30.73 3319.30 0.00 9.1e-04* 16.09 1530.19 0.00 0.16
all 4.40 225.08 0.74 < 2.2e-16* 4.35 234.76 0.00 2.6e-10*
M
equatorial 8.63 231.30 15.79 0.41 7.13 194.66 12.38 0.51
intermediate 44.15 4298.20 0.00 0.03 21.60 1872.84 0.00 0.46
apical 77.02 10285.01 0.00 6.4e-06* 27.45 3250.13 0.00 0.10
all 3.59 233.71 0.00 < 2.2e-16* 3.60 215.27 0.00 < 2.2e-16*
N
equatorial 9.64 245.52 15.06 0.40 7.42 185.29 12.83 0.25
intermediate 55.94 4388.81 0.00 0.21 12.63 660.15 16.93 0.68
apical 36.82 3619.73 0.00 2.4e-07* 17.93 1568.82 0.00 0.23
all 5.35 308.75 0.00 < 2.2e-16* 5.19 276.14 0.00 1.0e-09*
A-N all 3.38 172.99 4.56 < 2.2e-16* 3.75 192.26 0.83 < 2.2e-16*
Table 5.2: IGD* statistics for single domains from the pdb-entry 1KP8. For each of the 14 chains
the α, β and γ IGD* parameters are reported together with the p-value from the KS-test for each
domain and for the whole chain. The last row refers to the whole deposited model. P-values lower
than 0.01 are highlighted with and asterisk ‘*’ symbol.
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5.4.7 Hierarchical Agreement to the IGD*
From the results obtained so far it is possible to state that the IGD* assumption is satisfied
at different hierarchical levels as summarized in Figure 5.14. As shown in Figure 5.8 for the
retrieved data set of protein structures around 79% of the all-chains data set satisfy the IGD*
assumption. The agreement increases to 89% if single-chains are taken into consideration.
If the remaining 11% of suspicious structures for the single-chains data set is re-refined (see
section 5.4.5), around 89% of the re-refined structures satisfy the IGD* assumption at chain
level (see Figure 5.12). This result increases the total percentage of agreement to a IGD*
by around 9% (89% of 11%). The remaining 2% (11% of 11%) are instead suspicious cases
characterized by multimodal distribution of B factors or for which the distribution of B
factors is in disagreement with the IGD* assumption, indicating problems in the model or
in the deposited data.
Figure 5.14: Hierarchical organization of the agreement to the IGD* assumption in protein struc-
tures at high resolution. The cumulative percentage of structures that satisfy the IGD* is shown
for all-chains and single-chains data sets. Please note that the percentages are used interchangeably
between the all-chains and single-chains data sets. For an explanation of the graph please refer to
text in section 5.4.7.
From a combined analysis of the results obtained for the all-chains and single-chains
data sets, four different categories of deposited structures can be identified, depending on
the outcome of the KS-test from the all- and single-chains data sets:
1. Structures that are acceptable for both all- and single-chains data sets.
2. Structures that are acceptable for all-chains data set and suspicious for at least one
chain in the single-chains data set.
3. Structures that are suspicious for all-chains data set and acceptable for all individual
chains in the single-chains data set.
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4. Structures that are suspicious for all-chains data set and at least one chain in the
single-chains data set.
Category 1 is populated by structures made of only one chain or if they contain multiple
chains they are homogeneously packed in the crystal lattice. Category 2 is populated by
those structures that contain multiple chain and one or more of them are individually sus-
picious, but when analysed together they are masked by those chains that satisfy the IGD*
(an example will be shown in chapter 6). An alternative scenario is the one where all the
chain are suspicious, but they complement each other when analysed together. Category 3 is
mainly populated by those structures that show a multimodal B factor distribution at chain
level. These usually correspond to crystal structures where the level of order and packing
inside the crystal lattice is different for the individual chains, as shown in section 5.4.4 for
the pdb-entry 2R8Y. Category 4 is mainly populated by two different subgroups of struc-
tures. The first subgroup contains those structures that are affected by serious artefacts in
the B factor distribution. The second subgroup contains instead those structures that show
a multimodal B factor distribution at domain level. These usually correspond to multido-
main crystal structures where the individual domains have a different packing order in the
crystal lattice, as shown in section 5.4.6 for the pdb-entry 1KP8.
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5.5 Common Features of Suspicious Structures
Detailed inspection of the structures marked as suspicious identified some common patholo-
gies of these structures. In Tables 5.3 and 5.4 the distribution of outliers for ties at the
minimum or maximum B factor, null B factors and extremely low (< 1.5) or high (> 50)
α IGD* parameter are reported in function of p-value ranges (the same used in Figures 5.8
and 5.12).
p-value range # total # ties min(B) # ties max(B) # null B # α < 1.5 # α > 50 # p-value
]0, 0.01[ 3304 193 158 30 47 6 2918
[0.01, 0.05[ 2448 24 105 4 1 1 2313
[0.05, 0.1[ 1886 8 92 3 0 0 1783
[0.1, 0.2[ 2640 10 85 5 0 2 2538
[0.2, 0.3[ 2077 6 39 2 0 1 2029
[0.3, 0.4[ 1304 5 15 2 0 1 1281
[0.4, 0.5[ 1172 3 11 2 0 0 1156
[0.5, 0.6[ 824 3 6 2 0 0 813
[0.6, 0.7[ 335 0 1 4 0 0 330
[0.7, 0.8[ 8 0 0 0 0 0 8
[0.8, 0.9[ 0 0 0 0 0 0 0
[0.9, 1] 0 0 0 0 0 0 0
Table 5.3: Distribution of outliers for orthogonal statistics and α parameter values for all-chains
data set. Column content: ‘# total’ stands for total number of structures in the selected p-value
range; ‘# ties min(B)’ stands for number of structures with a strong tie at the lowest B factor value;
‘# ties max(B)’ stands for number of structures with a strong tie at the highest B factor value; ‘#
null B’ stands for number of structures with one or more B factors equal to or lower than zero; ‘#
α < 1.5’ stands for number of structures whose fitted IGD* has an α parameter lower than 1.5; ‘#
α > 50’ stands for number of structures whose fitted IGD* has an α parameter higher than 50; ‘#
p-value’ stands for number of structures selected solely by the p-value.
p-value range # total # ties min(B) # ties max(B) # null B # α < 1.5 # α > 50 # p-value
]0, 0.01[ 3479 239 251 50 77 13 2922
[0.01, 0.05[ 3775 44 139 2 0 6 3584
[0.05, 0.1[ 3309 17 110 3 0 0 3179
[0.1, 0.2[ 5066 21 111 6 0 3 4925
[0.2, 0.3[ 4835 20 57 4 1 1 4752
[0.3, 0.4[ 3340 16 23 5 0 1 3295
[0.4, 0.5[ 3223 8 18 3 0 0 3194
[0.5, 0.6[ 2264 6 16 2 0 0 2240
[0.6, 0.7[ 1122 0 5 4 0 0 1113
[0.7, 0.8[ 28 0 0 0 0 0 28
[0.8, 0.9[ 0 0 0 0 0 0 0
[0.9, 1] 0 0 0 0 0 0 0
Table 5.4: Distribution of outliers for orthogonal statistics and α parameter values for single-chains
data set. For a description of the content of each column please refer to Table 5.3.
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It is worth noting that the significance level of 0.01 is sufficient to detect automatically
the majority of the structures whose B factor distributions result to be outliers for the or-
thogonal statistics (null B factors, and strong ties) and extreme α parameter values. In
detail the p-value range between 0 and 0.01 contains around 77% (193 out of 252 struc-
tures for the all-chains data set) and 64% (239 out of 371 structures for the single-chains
data set) of the outliers for strong ties at the lowest B factor value, around 31% (158 out of
512 structures for the all-chains data set) and 34% (251 out of 730 structures for the single-
chains data set) of the outliers for strong ties at the highest B factor value, around 56% (30
out of 54 structures for the all-chains data set) and 63% (50 out of 79 structures for the
single-chains data set) of the outliers for null B factors (equal to or lower than zero), around
98% (47 out of 48 structures for the all-chains data set) and 99% (77 out of 78 structures
for the single-chains data set) of the outliers for α IGD* parameter lower than 1.5, around
55% (6 out of 11 structures for the all-chains data set) and 54% (13 out of 24 structures for
the single-chains data set) of the outliers for α IGD* parameter higher than 50. For cases
with a p-value lower than 0.01, the orthogonal statistics provide further information on the
possible problems that caused the B factor distributions to be considered suspicious.
However there are still some outliers for orthogonal statistics that are characterized by
a p-value higher than 0.01. An analysis of such cases revealed that they usually correspond
to protein structures with a low number of atoms (as shown in section 5.9) or where the
artefacts do not greatly affect the overall distribution of B factors (e.g. less than 5 atoms
with B factors equal to zero). As discussed in section 5.9 the stringency of the KS-test is
different depending on the size of the samples. This implies that for small sample sizes the
statistical test is more permissive.
Regarding the presence of ties at the extremes of the B factor distributions, it should be
noted that for cases characterized by a p-value higher than 0.01 the number of structures
with strong ties at the highest B factor value is always higher than the number of structures
with strong ties at the lowest B factor value (see Tables 5.3 and 5.4). This reflects the
fact that in general, ties at the highest B factor value are caused by a constraint in the
refinement parameterisations and they do not affect the distribution of the remaining B
factors in the sample (unless the size of the sample is large), resulting in a higher number
of structures with p-value higher than 0.01. These ties result from the fact that high B
factors, which would be located along the tail of a fitted IGD*, are refined to a common
unique value. Differently, ties at the lowest B factor value, even if still caused by a constraint
in the refinement parameterisation, usually reflect an anomalous tendency of B factors to
move towards unreasonable values (zero or negative). This can explain why their number
is lower in models characterized by a p-value from the KS-test higher than 0.01.
Outlier structures for orthogonal statistics with a p-value higher than 0.01 can be con-
sidered a sort of false negatives since they contain artefacts that are not detected by the
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p-value. Nevertheless these artefacts usually do not severely affect the distribution of B
factors and can be fixed by performing a re-refinement of the protein model, provided the
experimental data are available. In addition these outliers correspond to a small percentage
of the total number of structures present in the considered p-value ranges (with a maximum
of 5% for the ties at the maximum B factor in the p-value range [0.05, 0.1[).
The p-value range ]0, 0.01[ contains 2918 and 2922 structures from the all-chains and
the single-chains data sets, respectively, flagged as suspicious solely by the p-value. An
analysis of the B factor distributions from these structures revealed that the majority of
them are affected by a strong multimodality. These cases have been already taken into
considerations and discussed in sections 5.4.4 and 5.4.6. A smaller part of the distributions
showed instead a unimodal distribution similar to the one shown in panel (a) of Figure 5.5
but with smaller α and β parameters. As explained in section 5.3.2 the reason for the
presence of such distribution is still not clear at the moment. A possible interpretation for
such outliers is that tight restraints were used for the refinement of B factors.
As a closing remark, it should be noted that since the KS-test is a statistical test, and thus
it obeys to the law of probability, there is always a non-zero chance to find false negatives
in the analysis. Moreover a p-value of 0.5 does not mean automatically that a B factor
distribution is “truly” acceptable, but instead “very likely” to be acceptable. The lack of
absolute certainty is intrinsic to the nature of any statistical test and it should be accepted
as it is.

Chapter 6
Ensemble Analysis of a Set of Protein
Structures
In this chapter it is investigated to which extent a re-refinement protocol improves the results
of an ensemble analysis performed with ESCET when the starting structures are affected by
suspicious B factor distributions. A test case is selected from the large protein sample analysed
in section 5.2 and the validation protocol introduced and discussed in section 5.1 is used to
evaluate the quality of the B factor distributions before and after re-refinement. A comparative
analysis with ESCET is then performed on both deposited and re-refined models.
6.1 The Selected Protein Structures
A test case was identified in the comparison of two protein complexes of the L-alanine dehy-
drogenase (L-AlaDH) from Mycobacterium tubercolosis (PDB codes 2VHW and 2VHX). This
enzyme catalyzes the NADH-dependent reversible conversion of pyruvate and ammonia to
L-alanine and it has been observed to undergo a conformational change upon coenzyme
binding from an open to a closed conformation [4].
As shown in Figure 6.1 and described in the accompanying paper, each macromolecule
of L-AlaDH consists of two distinct domains: The substrate-binding domain (residues 1–
128 and 309–371) and the NAD-binding domain (residues 129–308). This two domains
are connected by a hinge region consisting of two α-helices, here called H1 (residues 126–
133) and H2 (residues 304–320). The authors report that this hinge region was determined
by the program DynDom [4,100].
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Figure 6.1: Domain composition for the L-AlaDH. In panel (a) the three-dimensional structure for
the chain E from the pdb-entry 2VHX is shown in cartoon representation. The NAD-binding domain,
the substrate-binding domain and the hinge region are green, blue and yellow coloured, respectively.
For consistency, this color code is kept constant thoughout the chapter. In panel (b) the topology
diagram obtained from PDBsum is shown. The two helices of the hinge region are depicted as yellow
boxes along the topology diagram.
In solution, the L-AlaDH is a hexamer and the binding of the NADH moiety stabilizes the
closed conformation of the holo-enzyme where the substrate-binding domains are rotated
by about 16 ◦ toward the dinucleotide binding domains, compared to the open structure of
the apo-enzyme [4].
The pdb-entry 2VHW contains the hexameric holo-form of the L-AlaDH in complex with
NADH at 2.0 Å resolution. Chains A, B, C and D are in open conformation, while chains E
and F are in closed conformation. The pdb-entry 2VHX contains the hexameric holo-form
of L-AlaDH in complex with NAD+ and pyruvate at 2.0 Å resolution. Chains A, B, C and D
are in open conformation and they bind only pyruvate, while chains E and F are in closed
conformation and they bind both NAD+ and pyruvate.
6.2 Analysis of B Factor Distributions
The validation protocol for B factor distributions described in section 4.3 and extensively
tested in chapter 5 was applied to the B factor distributions from pdb-entries 2VHW and
2VHX before and after re-refinement, respectively. The result of the analysis is shown in
Analysis of B Factor Distributions 77
Figure 6.2.
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Figure 6.2: B factor distributions for PDB codes 2VHW and 2VHX as deposited into the PDB (panels
(a) and (c)) and after re-refinement (panels (b) and (d)) respectively. For a description of the plot
generated by the validation protocol please refer to Figure 5.1.
When the whole crystal structures in the asymmetric unit are taken into consideration
for the analysis (all-chains data set), the B factor distribution of the default 2VHW structure
is acceptable, with a p-value of 0.093, while the B factor distribution of the default 2VHX
structure is suspicious, with a p-value lower than 0.01. After the re-refinement process, the R
factor statistics Rwork and R f ree increased from 0.176 and 0.212 to 0.181 and 0.234 respec-
tively for the pdb-entry 2VHW and from 0.172 and 0.210 to 0.174 and 0.225 respectively
for the pdb-entry 2VHX. After re-refinement both structures have a p-value higher than the
significance level of 0.01 (0.012 and 0.096 for PDB codes 2VHW and 2VHX, respectively)
78 Ensemble Analysis of a Set of Protein Structures
and therefore can be considered acceptable.
Following the hierarchical model proposed in section 5.4.7 for the agreement of the B
factor distributions in a protein model to the IGD* assumption, if the analysis is performed
at single chain level (single-chains data set) three chains out of six from the pdb-entry
2VHW result to have suspicious B factor distributions (see Table 6.1). For the pdb-entry
2VHX all six chains have a suspicious B factor distribution (see Table 6.2). The standard
refinement protocol is anyway sufficient to move all suspicious distributions to acceptable
and confirm those that were already acceptable. It should be noted that especially for the
pdb-entry 2VHW all B factor distributions from single chains as deposited into the PDB are
characterized by a relatively high individual α parameter. The mean of the α parameter
(〈α〉 = 46.52± 6.81) is in fact close to the upper bound limit of 50 defined in section 5.3,
indicating that probably too tight restraints were used for the refinement of B factors. After
re-refinement they all show a lower value of α parameter (〈α〉 = 9.07 ± 1.91), more in
agreement with the general trend observed during the analysis of a large data set of protein
structures at high resolution (see Figure 5.3).
default re-refinedchain atoms
α β γ p-value α β γ p-value
A 2719 48.46 2217.24 0.00 0.043 9.63 345.71 2.07 0.240
B 2698 40.18 1504.62 2.15 0.038 8.17 213.00 5.11 0.560
C 2719 51.90 2449.36 0.00 0.021 6.90 212.77 7.74 0.380
D 2714 44.56 1720.59 1.83 0.003* 7.32 180.18 7.38 0.400
E 2731 38.22 1858.12 0.00 1.4e-05* 11.59 471.20 0.00 0.056
F 2726 55.82 2299.16 0.00 0.007* 10.82 316.73 3.92 0.130
Table 6.1: IGD* α, β and γ parameters and p-value from the KS-test for each single chain from
the PDB code 2VHW before (default column) and after re-refinement (re-refined column). P-values
lower than 0.01 are highlighted with an asterisk ‘*’ symbol.
default re-refinedchain atoms
α β γ p-value α β γ p-value
A 2679 5.75 87.84 0.00 6.4e-10* 7.06 186.90 3.70 0.450
B 2695 3.63 43.15 0.00 1.4e-09* 5.74 125.93 4.53 0.620
C 2682 6.46 99.04 0.00 8.3e-07* 5.16 116.09 7.31 0.380
D 2680 5.22 68.20 0.00 1.2e-05* 4.59 83.16 8.01 0.290
E 2736 7.83 141.19 0.00 4.6e-11* 8.54 259.15 1.22 0.150
F 2736 7.25 98.95 0.00 1.3e-04* 8.00 182.88 3.77 0.400
Table 6.2: IGD* α, β and γ parameters and p-value from the KS-test for each single chain from
the PDB code 2VHX before (default column) and after re-refinement (re-refined column). P-values
lower than 0.01 are highlighted with an asterisk ‘*’ symbol.
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6.3 Rigid Body Analysis with ESCET
The protocol described in section 4.6 was used to perform ensemble analysis with ESCET on
the total data set of twelve chains of L-AlaDH (six from the pdb-entry 2VHW and six from
the pdb-entry 2VHX). The analysis was performed separately on the structures as found in
the PDB (default data set) and after re-refinement (re-refined data set).
In the default data set the average of the mean estimated standard uncertainties is
0.14± 0.01 Å. Chain B from PDB code 2VHW is the chain with the lowest mean estimated
standard uncertainty (0.12 Å), while chain E from PDB code 2VHX is the chain with the
highest mean estimated standard uncertainty (0.16 Å). The mean CSI for all 66 pair-wise
comparisons (((12 x 12) - 12) / 2) , which can be used as a global measure of the structural
diversity inside the ensemble, for the default data set is equal to 0.741± 0.186.
The cluster analysis based on the CSI matrix gave three different clusters of structures:
the first two clusters contain structures in two slightly different open conformations, while
the third cluster contains structures in closed conformations (data not shown). Three rep-
resentative structures with the lowest mean estimated standard uncertainty (chains B, C
and F from 2VHX) from each of the clusters were then used by the genetic algorithm to
identify flexible and structurally invariant regions (i.e. rigid bodies). The result of the rigid
body analysis is shown in panel (a) of Figure 6.3.
Using a εlow of 2.0, the rigid body analysis identified five different rigid bodies. The
first rigid body consists of 170 amino-acids (blue fragment in panel (a) of Figure 6.3) and
corresponds to the substrate-binding domain; the second rigid body comprises 101 amino-
acids (green fragment in panel (a) of Figure 6.3) and corresponds to the NAD-binding
domain; the third rigid body (salmon fragment in panel (a) of Figure 6.3) corresponds to
a small loop 11 amino-acids long (residues 149–159) located in the NAD binding domain;
the fourth rigid body (yellow fragment in panel (a) of Figure 6.3) corresponds to a loop
(residues 123–129) and an α-helix (residues 305–317) that have the function of hinge
region between the NAD-binding domain and the substrate-binding domain; the fifth rigid
body (cyan fragment in panel (a) of Figure 6.3) corresponds to an α-helix 11 amino-acids
long (residues 200–210) located in the NAD-binding domain.
In the re-refined data set the average of the mean estimated standard uncertainties is
0.15 ± 0.01 Å. This indicates that the uncertainties are slightly increased if compared to
the ones from the default data set. The increase in the mean of estimated standard uncer-
tainties is due to the fact that after re-refinement the R factor statistics slightly worsened,
especially the R f ree that is used in the DPIU error model. Moreover some inconsistencies for
the reflection data were detected between the deposited model and the obtained after re-
refinement. In fact for the pdb-entry 2VHW the completeness of deposited reflection data
moved from 99.40% for the deposited model to 94.40% for the re-refined model, causing
80 Ensemble Analysis of a Set of Protein Structures
an increase of the computed DPI (see section 3.1.5 for more details about the error model).
The clusters obtained from the cluster analysis were the same as for the default data set
regarding their members and the conformations they represented (data not shown). The
only difference detected was the selection of the chain B from the pdb-entry 2VHW instead
of the chain B from the pdb-entry 2VHX as representative structure for the first cluster. The
genetic algorithm was then applied to find rigid bodies and the result is shown in panel (b)
of Figure 6.3.
Using a εlow of 2.0, the rigid body analysis identified four different rigid bodies. The
first rigid body consists of 172 amino-acids (blue fragment in panel (b) of Figure 6.3) and
corresponds to the substrate-binding domain; the second rigid body consists of 130 amino-
acids (green fragment in panel (b) of Figure 6.3) and corresponds to the NAD-binding
domain; the third rigid body (cyan fragment in panel (b) of Figure 6.3) corresponds to
an α-helix 11 amino-acids long (residues 200–210) and is the same rigid body as the fifth
rigid body in the default data set; the fourth rigid body comprises 19 amino-acids (yellow
fragment in panel (b) of Figure 6.3) and as in the default data set it corresponds to the
hinge region between the substrate-binding domain and the NAD-binding domain.
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Figure 6.3: Identification of rigid bodies using PDB codes 2VHW and 2VHX before (panel (a)) and
after re-refinement with REFMAC5.6 (panel (b)). In the center of each panel a schematic view of
the L-AlaDH is shown using a cartoon representation. Each rigid body is coloured with a different
colour. NAD+ and pyruvate molecules are shown as stick models in purple and orange, respectively.
Flexible regions are light grey coloured. For each rigid body, the superposition of the 12 fragments
is shown in a ribbon representation together with the number of amino-acids and the average CSI
for all 66 pair-wise comparisons.
The results obtained from the rigid analysis are in agreement with the overall archi-
tecture of the L-AlaDH reported in the original publication [4], consisting of two domains
(substrate-binding domain and NAD domain) connected by an hinge domain. Neverthe-
less the hinge region identified with ESCET is slightly different from the one reported by
the authors and determined by the program DynDom [100]. In fact the DynDom program
identified the hinge region in two α-helices (residues 126–133 and residues 304–320 cor-
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responding to fragments H1 and H2, respectively), while the ESCET framework identified
it in one loop (residues 124–129, corresponding to fragment H1) and an α-helix (residues
305–317, corresponding to fragment H2). It should be noted that when describing the
results obtained from ESCET, the numbering refers to the results from the re-refined data
set. The biggest difference between the results from DynDom and ESCET is in the first
fragment. In the results from ESCET it ends before the long α-helix defined from Pro132
to Leu149. In the analysis of the re-refined data set this helix is part of the rigid body
corresponding to the NAD-binding domain. This is consistent with the literature since it
is reported that the pyrophosphate moiety of the NAD molecule makes a hydrogen bond
with the side chain of Ser134 and the nicotinamide ring is bound in a pocket that includes
residues Met133, Ser134, Ala137 [4] (see Figure 6.4). It is then reasonable to assume that
the fragment H1 of the hinge region ends at Leu129 before Pro132, since from Met133
a number of interactions with the NAD molecule stabilize the nascent helix in a compact
form with the NAD-binding domain. Moreover the amino acid proline is known to cause
bends when located in alpha-helices and to be characterized by a low conformational free-
dom [21] (Pro132 is the first amino-acid in the second rigid body corresponding to the
NAD-binding domain after the H1 fragment of the hinge region, separated by a flexible
stretch consisting of Leu130 and Ala131).
Figure 6.4: Interactions between the NAD+ molecule and Ser134. The overal L-AlaDH model is
shown in cartoon representation. The NAD+ and Ser134 moieties are shown in stick representation
and their σ-weighted 2mFo-DFc electron density contoured at 2 σ and carved at 1.5 Å is shown
in blue. The same color code of panel (b) in Figure 6.3 is used. Dashed yellow lines are used
to highlight the two hydrogen bond between Ser134 and the pyrophosphate group of the NAD+
molecule.
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It should be noted that after re-refinement, the rigid bodies found are on average larger
in size and lower in number if compared to those obtained in the default data set (e.g.
the third rigid body found in the default data set was not found in the re-refined data set.
Instead it was included in the second rigid body) and in general the flexible regions are
less and smaller. This can be interpreted as a reduction of noise in the weighted distance
matrices used by ESCET, where the B factors and then their distributions play an important
role.
The RMSDs without superposition for CA-atoms before and after refinement for the
pdb-entries 2VHW and 2VHX are 0.10 Å and 0.10 Å, respectively. Since the mean estimated
standard uncertainties for the default and re-refined data sets are 0.135 and 0.149 respec-
tively, the coordinate differences are within the error. Thus, it is reasonable to consider the
differences observed in the cluster analysis as the result of different estimated uncertain-
ties combined with different B factor distributions. However it is difficult to decouple the
contribution of each of them since they are related to each other (i.e. the distribution of
B factors has effects on the refinement statistics from which the DPI and subsequently the
DPIU error model are computed).

Chapter 7
Ensemble Analysis of Ribosomal
Structures
In this chapter a data set of 29 crystal structures of the 30S ribosomal subunit from T. ther-
mophilus is defined. Since in chapter 6 it was shown that a re-refinement of the deposited
models can improve both B factor distributions and results from the ESCET framework, 13
different refinement protocols are applied to the selected ribosomal structures. To find the pro-
tocol that provides the best re-refined models, the results from the re-refinement procedures
are analysed together with the results from the validation protocol for B factor distributions,
described in chapter 5, applied to each re-refined model. The ESCET framework is then used
to perform a comparative ensemble analysis between the default data set and the best data set
from the refinement procedure.
7.1 Selection of Ribosomal Structures
In the attempt to draw a summary picture of all the available ribosome structures at medium
resolution, the protocol described in section 4.4 was used to query the PDB. As of June 2010
it resulted in 197 ribosomal complexes at a resolution of 4 Å or higher, resulting in a total of
263 individual subunits deposited into the PDB. A complete list of the retrieved structures
is available in Table E.1 in Appendix E and a summary of the composition of the data set is
shown in Table 7.1.
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organism 70S 50S 30S total
E. coli 28 [3.2Å, 4.0Å] 28 [3.2Å, 4.0Å]
T. thermophilus 38 [2.8Å, 3.8Å] 32 [2.5Å, 3.8Å] 70 [2.5Å, 3.8Å]
H. marismortui 67 [2.2Å, 3.5Å] 67 [2.2Å, 3.5Å]
D. radiodurans 32 [2.9Å, 3.8Å] 32 [2.9Å, 3.8Å]
total 66 [2.8Å, 4.0Å] 99 [2.2Å, 3.8Å] 32 [2.5Å, 3.8Å] 197 [2.2Å, 4.0Å]
Table 7.1: Summary of available ribosomal structures at resolution equal to or higher than 4.0 Å.
For each data set the highest and the lowest resolution available are reported in square brackets.
During some preliminary analysis no relevant conformational changes were detected
in the 50S data sets from D. radiodurans and H. marismortui organisms. Moreover it was
found that some of these models are incomplete (e.g. in the pdb-entry 2AAR [10] all the
protein moieties are missing). This affects the reliability of the deposited structures since
the reported refinement statistics should be reproducible by default or at least after re-
refinement, which is impossible if the deposited models are incomplete or the structure
factors were not deposited.
The choice of the ribosomal data sets to analyse moved then to the 30S subunits from
the 70S complexes or the 30S complexes, because it is known from the literature that it
is the 30S subunit that is mostly affected by conformational changes during the protein
synthesis process.
However during the characterization of the retrieved structures it was found that the
majority of the deposited structures were solved by molecular replacement or by difference
Fourier methods. Considering the average resolution of the available structures (3.38 ±
0.29 Å) it is likely that the search model used to solve the new structures introduced a
bias in the final model. Furthermore, the search model is usually the same for all the
structures from an organism and it usually corresponds to the first structure ever solved for
that particular organism.
One possible way to efficiently deal with structural bias is to re-refine the structures with
an aggressive refinement protocol (e.g. by using simulated annealing refinement). However
the refinement of ribosome structures becomes a large task while moving from 30S to 70S
complexes. In fact the 70S complexes usually contain two complete copies of the entire 70S
ribosome per asymmetric unit. This causes an increase in the CPU time (i.e. three macro
cycles of refinement with phenix.refine program including simulated annealing refinement
in the second macro cycle took ca. eight hours for a 30S complex and ca. two days for
a 70S complex on a Linux workstation with 8 CPUs Intel R￿ Xeon R￿ 2.80 GHz) and in the
memory (the maximum peak of memory usage is around 5.7 GB for the 30S subunit and
around 19.7 GB for the 70S complex) required for the refinement. In addition, for the 70S
complexes a larger number of macro-cycles is probably required to reach convergence if
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compared to the 30S subunit. For sake of convenience and efficiency the analysis was thus
focused on the 32 T. thermophilus 30S ribosomal subunits from 30S complexes (a list of
structures is listed in Table7.2).
The working data set was further reduced from 32 to 29 structures since for three
structures (PDB codes: 1I94, 1FKA and 2F4V) the structure factors are not available and
it is then impossible to perform any re-refinement (see Table 7.2). The relatively small
size of the data set makes it ideal for studying the effect of different refinement protocols.
Moreover the 30S complexes from T. thermophilus are the structures that have been used
to study the decoding process and the conformational changes related to it.
In ascending order of deposition date, the final data set of 29 30S subunit structures
from Thermus thermophilus is defined as follows. The pdb-entry 1J5E is the first structure
of 30S subunit ever solved at medium resolution (3.05 Å) [134] and it corresponds to a
30S subunit in open conformation without any ligand (group I in Table 7.2). It should be
noted that the deposition date (04/08/02) is misleading since this structure supersedes the
pdb-entry 1FJF (deposited on 08/08/00). The main difference is that the pdb-entry 1J5E
contains a more complete model for the 16S rRNA, especially for the 3’ folded back along
the mRNA path. The pdb-entry 1FJG was solved to study the interaction of three different
antibiotics (paromomycin, streptomycin and spectinomycin) [32] (group II). Similarly, the
pdb-entries 1HNW, 1HNX and 1HNZ were used to study the structural basis for the mech-
anism of action of other three antibiotics (tetracycline, pactamycin and hygromycin) [23]
(group IV). The pdb-entry 1HR0 was solved to obtain the first structure of a 30S subunit
from T. thermophilus in complex with the initiation factor 1 (IF1) [31] (group V). The pdb-
entries 1IBK, 1IBL and 1IBM were the structures used to study the recognition of cognate
tRNA in the decoding center [91] (group VII). The pdb-entries 1N32, 1N33, 1N34 and 1N36
were used to study the transition from an open to a closed conformation of the 30S subunit
during the selection of tRNA [93] (group VIII). The pdb-entries 1XMQ and 1XMO were
determined to study the role of base modifications in codon discrimination by tRNA [87]
(group IX), while the pdb-entries 1XNR and 1XNQ were used to study the structure of a
purine-purine wobble base pair in the decoding center of the ribosome [86] (group X). The
pdb-entry 2HHH was used to study the mechanism of action of the antibiotic kasugamycin
that inhibits translation initiation of canonical but not of leaderless messenger RNAs [108]
(group XII). The pdb-entry 2E5L was solved to study the structural mechanism of the inter-
action between the Shine-Dalgarno (SD) sequence present in the 5’ of the mRNA with the
anti-Shine-Dalgarno (aSD) sequence present in the 3’ or the 16S rRNA [67] (group XIII).
The pdb-entries 2UU9, 2UUA, 2UUB and 2UUC were used to study the mechanism for ex-
panding the decoding capacity of tRNA by modification of uridines in the first position of
the anticodon which is involved in the formation of the wobble base-pair [132] (group XIV).
The pdb-entries 2UXC, 2UXD and 2UXB were used to study structures of tRNA with an ex-
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panded anticodon loop in the decoding center of the 30S ribosomal subunit. All anticodons
used for these structures recognise codons four nucleotides long [45] (group XV). The two
pdb-entries 2VQE and 2VQF were solved to study the wobble base pair when the first posi-
tion of the anticodon on the tRNA contains the modified base 5-taurinomethyluridine [76]
(group XVI). The pdb-entry 2ZM6 contains the crystal structure of an empty 30S ribosomal
structures from Thermus thermophilus (group XVII). However no reference is available for
this structure and the only source of information is the header section of the corresponding
pdb-file.
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id PDB gr dmin Rwork R f ree SF dep sol SM <esu>† [Å] <esu>‡ [Å] ∆<esu>
1 1J5E I 3.05 0.21 0.25 yes 4/8/02 MIRAS / 0.378 0.332 ￿
2 1FJG II 3.00 0.22 0.26 yes 8/8/00 DF 1J5E 0.362 0.318 ￿
3 1FKA III 3.30 0.30 0.30 no 8/9/00 MIRAS / na na na
4 1HNW IV 3.40 0.22 0.26 yes 12/8/00 DF 1J5E 0.511 0.365 ￿
5 1HNX IV 3.40 0.23 0.28 yes 12/8/00 DF 1J5E 0.579 0.423 ￿
6 1HNZ IV 3.30 0.22 0.26 yes 12/8/00 DF 1J5E 0.516 0.410 ￿
7 1HR0 V 3.20 0.22 0.26 yes 12/20/00 DF 1J5E 0.448 0.368 ￿
8 1I94 VI 3.20 0.20 0.24 no 3/18/01 MIR / na na na
9 1IBK VII 3.31 0.23 0.28 yes 3/28/01 DF 1J5E 0.522 0.445 ￿
10 1IBL VII 3.11 0.23 0.28 yes 3/28/01 DF 1J5E 0.433 0.366 ￿
11 1IBM VII 3.31 0.23 0.29 yes 3/28/01 DF 1J5E 0.528 0.430 ￿
12 1N32 VIII 3.00 0.23 0.27 yes 10/25/02 DF 1J5E 0.379 0.350 ￿
13 1N33 VIII 3.35 0.22 0.28 yes 10/25/02 DF 1J5E 0.619 0.520 ￿
14 1N34 VIII 3.80 0.24 0.31 yes 10/25/02 DF 1J5E 0.967 0.758 ￿
15 1N36 VIII 3.65 0.26 0.32 yes 10/25/02 DF 1J5E 0.905 0.783 ￿
16 1XMO IX 3.25 0.23 0.28 yes 10/4/04 MR 1J5E* 0.515 0.443 ￿
17 1XMQ IX 3.00 0.22 0.24 yes 10/4/04 MR 1J5E* 0.317 0.319 ￿
18 1XNQ X 3.05 0.23 0.27 yes 10/5/04 MR 1J5E* 0.395 0.347 ￿
19 1XNR X 3.10 0.23 0.27 yes 10/5/04 MR 1J5E* 0.421 0.379 ￿
20 2F4V XI 3.80 0.26 0.32 no 11/24/05 MR 1J5E na na na
21 2HHH XII 3.35 0.26 0.29 yes 6/28/06 MR ? 0.478 0.484 ￿
22 2E5L XIII 3.30 0.26 0.30 yes 12/21/06 MR ? 0.563 0.475 ￿
23 2UU9 XIV 3.10 0.23 0.27 yes 3/1/07 MR 1J5E 0.377 0.385 ￿
24 2UUA XIV 2.90 0.22 0.25 yes 3/1/07 MR 1J5E 0.312 0.288 ￿
25 2UUB XIV 2.80 0.22 0.24 yes 3/1/07 MR 1J5E 0.269 0.256 ￿
26 2UUC XIV 3.10 0.21 0.24 yes 3/1/07 MR 1J5E 0.355 0.314 ￿
27 2UXB XV 3.10 0.30 0.33 yes 3/28/07 DF 1J5E* 0.494 0.403 ￿
28 2UXC XV 2.90 0.22 0.26 yes 3/28/07 DF 1J5E* 0.320 0.302 ￿
29 2UXD XV 3.20 0.24 0.28 yes 3/28/07 DF 1J5E* 0.481 0.342 ￿
30 2VQE XVI 2.50 0.26 0.28 yes 3/13/08 MR 1J5E 0.226 0.203 ￿
31 2VQF XVI 2.90 0.22 0.26 yes 3/14/08 MR 1J5E 0.325 0.279 ￿
32 2ZM6 XVII 3.30 0.29 0.32 yes 4/11/08 MR 2E5L 0.606 0.534 ￿
Table 7.2: Thermus thermophilus 30S working data set. The following abbreviations are used in
the column names: PDB stands for PDB identification code, gr stands for group (a cardinal roman
number is used to group together structures that appeared in the same publication), dmin stands for
maximum resolution, Rwork stands for refinement R factor for the working reflection data set, R f ree
stands for refinement R factor for the validation reflection data set, SF stands for structure factors
availability, dep stands for deposition date, sol stands for solution method, SM stands for search
model, <esu>† stands for mean estimated standard uncertainty for the structures as found in the
PDB, <esu>‡ stands for mean estimated standard uncertainty for the structures after re-refinement
with protocol 2 (see section 4.5 for details), ∆<esu> stands for gradient of the difference between
<esu>‡ and <esu>†. For the solution method the following abbreviations are used: MR stands
for molecular replacement, DF stands for difference fourier, MIRAS stands for multiple isomorphous
replacement with anomalous scattering, MIR stands for multiple isomorphous replacement. Regard-
ing the search model used for the solution of the structure, a question mark (?) is used when it was
not possible to find any information in the literature . An asterisk (*) is instead used to mark the
most probable search model used, but for which no clear and explicit evidence is present in the PDB
file nor in the accompanying article. Since for the pdb-entries 1I94, 1FKA and 2F4V the structures
factors are not available, it was not possible to perform any re-refinement protocol and thus they
were not used for the ensemble analysis. For that reason the <esu>† and the <esu>‡ were set to
na (not available) and their PDB codes were crossed out. It is worth noting that, except for the
PDB codes 1XMQ, 2UU9 and 2HHH, in all cases the mean estimated uncertainty lowered after re-
refinement with protocol 2 (described in section 4.5). For the definition of the groups see text in
section 7.1.
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7.2 Refinement of Selected Ribosomal Structures
In order to find the refinement strategy that gives the best R factor statistics and at the same
time produces the highest number of structures with B factor distribution in agreement
with the IGD* assumption described in chapter 5, the 13 refinement protocols defined in
section 4.5 were applied to the data set of 29 30S ribosomal subunit reported in Table 7.2.
The re-refinement procedure led to a final pool of 377 models (29× 13). A complete list
of the R factor statistics for the 29 structures before and after re-refinement is reported in
Table D.1 in appendix D.
In Figure 7.1 the distribution of the R factor statistics for selected refinement protocols
is analysed for each PDB code. For sake of clarity, only the default structures and those from
refinement protocols 2, 3, 8, 11 and 12 were taken into consideration for this comparative
analysis. Protocols 2, 3, 8, 11 and 12 can in fact be considered as the representative
protocols for the different refinement parameterisations tested in this study (for a definition
of the refinement protocols please refer to section 4.5).
The refinement protocol 2 is the one that gives the lowest average Rwork and R f ree statis-
tics in the data set (0.20±0.02 and 0.25±0.02, respectively), indicating a better agreement
between the re-refined models and the deposited experimental data. This is due to the fact
that TLS refinement was used in combination with individual ADP refinement, where ADP
stands for atomic displacement parameter (term used in phenix.refine program to refer to
B factors). The fact that in general TLS refinement gives better R factor statistics is in
agreement to what was observed in the outcomes of the PDB_REDO project [65,66] and in
some comparative analyses made by the PHENIX team for different ADP parameterisations
applied to several real cases at medium and low resolutions [2].
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Figure 7.1: R factors Rwork and R f ree for default and re-refined ribosomal structures from selected
re-refinement protocols. Triangles pointing upwards are used to represent Rwork values, while tri-
angles pointing downwards are used to represent R f ree values. Different colours are used for the
different protocols (see legend). A dashed gray line indicates the limit of 0.30 which is usually used
to discriminate between reliable (< 0.30) and unreliable (≥ 0.30) models. Rwork and R f ree for the
default structures and for the results of protocol 2 are highlighted with a solid and a dashed line,
respectively. The insert shows a box-plot for the Rwork values. The following abbreviations are used
in the annotation of the box-plot for the refinement protocols: DEF stands for default and P2, P3,
P8, P11, P12 stand respectively for protocols 2, 3, 8, 11 and 12.
Looking at the comparative distributions of Rwork and R f ree statistics it is worth noting
that a simple update of the bulk solvent correction as in protocol 12 gives on average better
R factor statistics if compared to those from the default structures. The only exception in
this respect is the pdb-entry 2UUB, for which a re-refinement of the atomic coordinates
xyz is necessary to obtain R factors close to the ones deposited in the PDB (see protocol
13 in Table D.1 in Appendix D). This is verified also in protocols 2, 3, 8 and 11 shown
in Figure 7.1. In agreement with the average R factors computed for the data sets, the
refinement protocol 2 outperforms all the other refinement protocols and it is able to lower
all the R f ree statistics below the threshold value of 0.30, while maintaining reasonable
stereochemistry (data not shown). Improvements of more than 0.04 in both Rwork and R f ree
are observed for the pdb-entries 1N34, 1N36, 2E5L, 2UXB and 2ZM6. It should be noted
that for the pdb-entries 1N34 and 2UXB the ∆R, defined as the difference between the
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R f ree and the Rwork statistics, starts to be important (∼ 0.07) indicating a possible problem
of over-refinement. Nevertheless, since it is lower than the usually accepted maximum limit
of 0.08 for reliable structures, they are considered acceptable.
7.3 Analysis of B Factor Distributions from Default and Re-
refined Structures
7.3.1 Analysis of α and β Parameters from Fitted IGD*
The validation protocol for B factor distributions described in section 4.3 and extensively
tested for protein structure in chapter 5 was applied to the B factor distributions for the
phosphate atoms from the 16S rRNA moieties of the 30S ribosomal subunits before and
after application of the 13 refinement protocols. The models contain between 1472 (PDB
code 2UXD) and 1517 (PDB code 2E5L) phosphate atoms in the 16S rRNA. In the analysis,
for the models refined with TLS groups (refinement protocol 2) the equivalent isotropic B
factors were taken into consideration. The reason why phosphate atoms were taken into
account as representative is explained in section 4.6.2.
The distribution of the α IGD* parameter for each model from the default data sets and
five selected refinement protocols (the same used in Figure 7.1) is shown in Figure 7.2.
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Figure 7.2: Distribution of α parameter values for the models resulting from selected refinement
protocols. The same colour code and abbreviations as in Figure 7.1 are used for different refinement
protocols. The dashed gray line is used to highlight the lower bound limit of 1.5 for the α IGD*
parameter as described in section 5.3. If the IGD* that fits the B factor distribution is characterized
by an α parameter lower than 1.5, it is considered suspicious. The α parameters for the default
structures and for protocol 2 are highlighted by a solid line. The insert shows a box-plot of the
distribution of α parameter for the selected refinement protocols.
If α values of less than 1.5 are considered outliers as in the protein case (see section 5.3),
in the default data set the pdb-entry 2HHH is an outlier since the IGD* fitted to the B factor
distribution of phosphate atoms is characterized by an α parameter of 0.82. The reason
for such a low value is a strong tie at the lowest B factor (24 P atoms out of 1502 with
a B factor equal to 1 Å2) as shown in panel (c) of Figure 7.4. This is equivalent to what
was observed for protein outliers in group 1 of Figure 5.3 and discussed in section 5.3.1.
In fact, it has been observed that the presence of a strong tie at the lowest B factor value
considerably affects the α parameter of the fitted IGD* and usually reflects a problem also
for the distribution of the remaining B factors in the sample (see section 5.3.1).
The distribution of the α parameter for all the models obtained from refinement protocol
2 are characterized by acceptable α parameters (between 1.5 and 50, as proposed for the
protein data set analysis in section 5.3). The mean α from refinement protocol 2 is 5.68±
1.55 and the mean β is 347.25± 224.28. The mean α is very close to the average α in the
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all-chains data set of protein structures (i.e. 5.89) analysed in section 5.3. This positions
the models from protocol 2 in the allowed region for α parameters in Figure 5.3 obtained
from the analysis of a large data set of proteins structures at high resolution. The average
β is instead at least three times higher than the one observed in the all-chains data set of
protein structures (i.e. 96.15) in section 5.3. The reason for such a large difference for
the β parameter is due to the fact that the average B factor for the phosphate atoms in
ribosomal structures is much higher than the average B factor observed in the protein data
set (88.02 Å2 against 22.30 Å2). From equation (5.7) it becomes clear how the average B
factor affects the value of the β parameter:
β = (µ− γ)(α− 1)≈ (〈B〉 − γ)(α− 1).
The fact that the β parameter is proportional to the average B factor in the model explains
the observed difference between the protein and ribosome data sets. It should be noted
that also the γ parameter affects the final value of the β parameter. The mean γ parameter
is equal to 4.76 ± 4.19 and 18.83 ± 12.39 for the all-chains protein data set and riboso-
mal models from protocol 2, respectively. Thus, even if present in the equation for the β
parameter, it does not greatly affect the observed difference between the two data sets.
Looking at the distribution of the α parameter in function of the refinement protocol
used (box-plot insert in Figure 7.2) it is possible to observe that protocols 2 and 3, where
the individual ADP model was used in refinement, are characterized by α values on average
higher than protocols where a group B factor model was used (i.e. default, protocol8,
protocol9, protocol11, protocol12). This behaviour can be explained by the fact that the
type of B factor model and restraint used for the refinement of B factors affect their overall
distribution. On average, the stronger the restraint, the lower the corresponding variance
of B factors in the model. The effect of the variance of B factor distributions on the α
parameter is clear from equation (5.6):
α=
(µ− γ)2
σ2
+ 2≈ (〈B〉 − γ)
2
s2B
+ 2∝ 〈B〉 − γ
sB
.
This is in agreement with what is observed from the comparative analysis shown in the
insert of Figure 7.2. In fact, group B factors are usually not restrained at all and they result
in B factor distributions with the highest variances. Instead, individual B factors, at least in
phenix.refine program, are spatially restrained as described in reference [2]. This results in
B factor distributions with the lowest variances. In phenix.refine the cut-off distance used
to restrain individual ADP is set to 1.55 Å and to 5 Å depending if TLS groups are used
(protocol 2) or not (protocol 3), respectively. This is reflected in the distribution of the α
parameter. In fact, when TLS are not used (protocol 3) the effect of the restraints is stronger
(due to the longer distance cut-off), resulting in a lower variance of B factors and then in a
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higher α parameter.
From a methodological point of view it should be pointed out that in the analysis of B
factor distributions from protein structures discussed in chapter 5 the models refined with
TLS groups were explicitly discarded. This was done to avoid strong correlations between
B factors that could break the assumption of independence made in the statistical rationale
described in section 5.1. The fact that for the ribosomal structures from T. thermophilus
re-refined with protocol 2 the IGD* assumption is valid even in presence of TLS groups
can be explained by the fact that in phenix.refine program the TLS refinement is always
combined in two subsequent steps with individual ADP refinement [2] and by the fact that
only phosphate atoms are taken into account, which are not directly bound to each other.
Moreover the limited number of phosphate atoms in the 16S rRNA allows the KS-test to be
quite permissive in the validation of the distribution of B factors as discussed in section 5.9.
7.3.2 Analysis of P-value Statistics from KS-test
The distribution of p-values for each structure from the default data sets and five selected
refinement protocols (the same used in Figure 7.1) is shown in Figure 7.3.
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Figure 7.3: P-values from KS-test for P-atoms from 16S rRNA moieties. The same colour code and
abbreviations as in Figure 7.1 are used for different refinement protocols. The dashed gray line is
used to highlight the confidence level of 0.01 used to discriminate between acceptable (p-value ≥
0.01) and suspicious (p-value < 0.01) B factor distributions. P-values for the default structures and
for the protocol 2 are highlighted by a solid line. The insert with a box-plot of the distribution of the
p-values in functions of the selected refinement protocols is shown.
In the default data set 25 out of 29 ribosomal structures exhibit acceptable B factor
distributions for P-atoms in the 16S rRNA moiety. This is the case although for 18 structures
a strong tie is detected at the highest B factor value around 200 Å2 (pdb-entries 1FJG,
1HNW, 1HNX, 1HNZ, 1HR0, 1IBK, 1IBL, 1IBM, 1N32, 1XMO, 1XMQ, 1XNQ, 1XNR, 2E5L,
2UXB, 2UXC, 2UXD and 2ZM6). This is probably due to the introduction of a constraint
for B factor values at refinement stage and it has been observed also in protein structures.
Nevertheless, since the number of P-atoms is relatively low (around 1507, as discussed
above), the presence of a strong tie at the upper limit of the B factor distribution does
not considerably affect the outcome of the KS-test. In addition, as observed for in protein
structures, ties at the highest B factor value correspond to less severe problems in the B
factor distribution than ties at the lowest B factor value (see section 5.5).
It is worth noting that, as previously observed for the distribution of R factor statistics
in section 7.2, also for the distribution of p-values from the KS-test the refinement protocol
2 performs better than the other protocols. In fact it is the only protocol for which all B
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factor distributions from the 16S rRNA have a p-value higher than 0.01 after re-refinement
and thus they are all considered acceptable for the IGD* assumption. All four structures
(PDB codes 1N33, 1N34, 1N36 and 2HHH) that in the default data had a suspicious B
factor distribution, were rescued after re-refinement with protocol 2. Two examples (PDB
codes 1N33 and 2HHH) are shown in Figure 7.4 for which the highest ∆p-value (∼ 0.3)
was observed in the comparative analysis between the default data set and the data set
obtained from re-refinement with protocol 2.
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Figure 7.4: Example of B factor distributions for P atoms moved from suspicious (panels (a) and
(c)) to acceptable (panels (b) and (d)) after re-refinement with protocol 2 defined in section 4.5. For
a description of the plot generated by the validation protocol please refer to Figure 5.1.
The default model for PDB code 1N33 (panel (a) of Figure 7.4) is characterized by a
strong bimodal distribution probably due to a constraint for the maximum allowed B factor
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in the structure during refinement (around 200 Å2). After re-refinement with protocol 2
(panel (b) of Figure 7.4) the agreement between the empirical B factor distribution and
the fitted IGD* improves very considerably from 0.006 to 0.34 indicating that the B factor
distribution of the re-refined structure is acceptable.
The default model for PDB code 2HHH (panel (c) of Figure 7.4) is instead characterized
by a strong tie at the lowest B factor value as discussed in section 7.3.1. Similarly to the
pdb-entry 1N33, after re-refinement with protocol 2 the B factor distribution of P-atoms
becomes acceptable (panel (d) of Figure 7.4).
In contrast to what was observed for the distribution of R factor statistics in Figure 7.1,
refinement protocol 2 did not always lead to B factor distributions with lower p-values
than distributions from the default data set. This holds for the pdb-entries 1HNW, 1HNZ,
1HR0, 1XMQ, 1XNR, 2UU9, 2UUC and 2VQF, indicating a worsening of the fit between
the empirical distributions of B factors and the estimated IGD*. However it is the only
refinement protocol that guarantees that all B factor distributions for phosphate atoms are
acceptable.
7.4 Ensemble Analysis with ESCET
7.4.1 Choice of the Re-refined Set of Models
The 29 ribosomal models obtained from protocol 2 (hereafter referred to as re-refined data
set), which have the best R factor statistics (see section 7.2) and for which all B factor
distributions for the phosphate atoms of the 16S rRNA are acceptable (see section 7.3), and
the corresponding 29 deposited ribosomal models (hereafter referred to as default data set)
were chosen for a comparative ensemble analysis with ESCET as described in section 4.6.
All the parameters required for the error model implemented in ESCET were extracted
automatically from the pdb-file, with the exception of the pdb-enty 1XMO in the default
set, where the data completeness parameter was specified manually. For this structure
only 5% completeness was reported in the deposited PDB file, obviously impossible. The
completeness was thus set to 93.1% as reported in the accompanying paper [87].
The average of the mean estimated uncertainties went from 0.47 ± 0.17 Å to 0.40 ±
0.13 Å for the default and the re-refined data sets, respectively, indicating an improvement
in the precision of the atomic coordinates upon re-refinement. As shown in Table 7.2 for
26 out of 29 structures in the T. thermophilus data set the mean estimated uncertainty
decreased after re-refinement with protocol 2. Only for the pdb-entries 1XMQ, 2UU9 and
2HHH it slightly increased.
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7.4.2 Cluster Analysis
The CSI values computed for each pair of models in the data sets are presented in matrix
form in Figure 7.5. The average CSI for 406 pairwise comparisons (((29x29)− 29)/2) re-
sulted to be 0.939± 0.056 and 0.929± 0.064 for the two data sets, respectively, indicating
an increase in structural diversity in the re-refined data set with respect to the default set of
models. The increase is probably related to a similarly lower uncertainties in the re-refined
data set. This shows one of the features of the ESCET framework: when the models com-
pared are more reliable in terms of coordinate errors, smaller absolute differences become
more significant, reflecting an increase in the information content.
From the analysis of the∆CSI values (panels (e) and (f)) different patterns of variability
inside the data set after re-refinement emerge. In particular the pdb-entries 2UUB and
2UXD are the ones that increase most their structural diversity with the other structures in
the data set.
The similarity matrices based on the CSI pairwise analysis shown in panels (a) and (c)
of Figure 7.5 were then analysed by the hierarchical clustering algorithm implemented in
ESCET and the resulting dendrograms for the default and re-refined data sets are shown in
Figure 7.6.
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Figure 7.5: CSI matrix before (panels (a) and (c)) and after (panels (b) and (d)) clustering for
the default data set (panels (a) and (b)) and the re-refined data set (panels (c) and (d)). For
convenience, CSI-values were multiplied by 100. In panels (b) and (d) the clusters defined from the
clustering procedure and shown in Figure 7.6 are highlighted by yellow boxes. The ∆CSI, defined
as the difference between the matrix in panel (c) and the matrix in panel (a), is shown in panel (e)
in matrix form and in panel (d) in box-plot form for each PDB code in the data set.
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Figure 7.6: Dendrograms obtained from cluster analysis for default (panel (a)) and re-refined
(panel (b)) data sets. For each pdb-entry the PDB code and the mean estimated uncertainty for
phosphate atoms in Å are reported. Structures from the same cluster have the same colour. The
clusters that contain closed and open conformations are highlighted with green and blue dashed
boxes, respectively. A vertical red line is used to highlight the position at which the dendrograms
were cut by the adaptive cutting rule. The representative structures from each group that are used
in the rigid body analysis (see Figure 7.9) are highlighted with a black arrow. For the analysis of the
results please refer to text in section 7.4.2.
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For both default and re-refined data sets the two main branches of the dendrograms
correspond to closed and open conformations of the 30S ribosomal subunits from T. ther-
mophilus, respectively.
Further, the adaptive cutting rule [68] implemented in ESCET partitioned the ensemble
of ribosomal structures in four clusters of similar conformers: two clusters of structures
in closed conformation (clusters C1 and C2 in Figure 7.6) and two clusters of structures
in open conformation (clusters O1 and O2 in Figure 7.6). However some differences are
observed in the composition of the clusters when comparing the default data set to the
re-refined data set. The pdb-entries 2UUB and 2UXD, which were included in the cluster
C1 in the default data set, become singletons in the re-refined data set (clusters CS1 and
CS2 in panel (b) of Figure 7.6). In addition, the pdb-entry 1N33 moves from cluster C1 to
cluster C2 and the pdb-entries 1N34 and 1N36 move from cluster O2 to the cluster O1.
In the following sections the relationship between members of the different clusters is
discussed with respect to the molecular components contained in the respective structures
(see Table 7.3).
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CL PDB gr mRNA tRNA CG N-CG IF-1 SD PAR SCM SRY TAC PCY HYG KSG
CS1 2UUB XIV ￿ ￿ ￿† ￿
C1
2UUA XIV ￿ ￿ ￿† ￿
2UXC XV ￿ ￿ ￿† * ￿
2UXB XV ￿ ￿ ￿† ￿
1N32 VIII ￿ ￿ ￿ * ￿
2UU9 XIV ￿ ￿ ￿† * ￿
2UUC XIV ￿ ￿ ￿† ￿
1IBL VII ￿ ￿ ￿ ￿
1XMQ IX ￿ ￿ ￿† ￿
1XNQ X ￿ ￿ ￿† ￿
1XMO IX ￿ ￿ ￿† ￿
1XNR X ￿ ￿ ￿† ￿
CS2 2UXD XV ￿ ￿ ￿† ￿
C2
1N33 VIII ￿ ￿ ￿ * ￿
2VQE XVI ￿ ￿ ￿† ￿
1IBM VII ￿ ￿ ￿
2VQF XVI ￿ ￿ ￿† ￿
1HR0 V ￿
O1
1N34 VIII *
1N36 VIII *
2E5L XIII ￿
2ZM6 XVII
2HHH XII * ￿
O2
1FJG II ￿ ￿ ￿
1J5E I
1HNW IV ￿
1HNX IV ￿
1HNZ IV ￿
1IBK VII ￿
Table 7.3: Ligand content in 30S T. thermophilus ribosomal structures. CL stands for cluster name
(the same used in panel (b) of Figure 7.6), gr stands for group (the same used in Table 7.2),
mRNA stands for codon mRNA in the A site, tRNA stands for tRNA anticodon stem loop (tRNA
ASL), CG stands for cognate tRNA ASL, N-CG stands for near-cognate tRNA ASL, IF-1 stands for
initiation factor 1, SCM stands for SPECTINOMYCIN; SRY stands for STREPTOMYCIN; TAC stands
for TETRACYCLINE; PCY stands for PACTAMYCIN; HYG stands for HYGROMYCIN B; KSG stands for
KASUGAMYCIN, PAR stands for PAROMOMYCIN. The symbol ‘†’ is used to higlight those structures
where the ASL is not canonical or contain modified bases. The symbol ‘*’ is used to highlight those
structures where there is strong evidence in the electron density for a Shine-Dalgarno anti-Shine-
Dalgarno (SD-aSD) interaction but no model has been built inside the density. Only for the pdb-entry
2HHH the presence of the SD-aSD interaction was mentioned in the accompanying publication. The
order in which the pdb-entries are reported is the same of the dendrogram from cluster analysis
shown in panel (b) of Figure 7.6.
Cluster C1 – Closed Conformations
Starting from the branch of the dendrogram with structures in closed conformation (green
dashed boxes in Figure 7.6), the cluster C1 contains structures that show a most pro-
nounced closed conformation. All these structures contain a codon mRNA moiety in the
A site, a cognate or near-cognate tRNA ASL, and more importantly a molecule of paro-
momycin that it is known to facilitate 30S domain closure, resulting in better diffracting
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crystal and a better defined ASL density [45, 91]. As anticipated above, small differences
are detectable in the composition of the cluster C1 between the default and the re-refined
data sets. The major differences are in the moving of the structures 2UUB and 2UXD to two
distinct singletons (clusters CS1 and CS2 in Figure 7.6) and the moving of the pdb-entry
1N33 from the cluster C1 to the cluster C2 (discussed below).
Singleton CS1 – Closed Conformation
Regarding the PDB code 2UUB, already during the analysis of refinement statistics (see Fig-
ure 7.1) it became clear that the deposited structure did not show a good agreement with
the experimental data since the refinement protocol 12, in which only bulk solvent correc-
tion is performed, gave Rwork and R f ree statistics equal to 0.448 and 0.451, respectively (as
shown in table D.1 in Appendix D). Only protocols refining the atomic coordinates were
able to reduce the R factor statistics below 0.30 (see also Figure 7.1).
The movements of coordinates are reflected by an RMSD without superposition of
1.36 Å for the phosphate atoms in the 16S rRNA moieties before and after re-refinement
with protocol 2. This is very significant in comparison to the experimental uncertainties
for a typical structure at this resolution (∼ 0.40 Å). A comparative analysis of the default
and re-refined structures for 2UUB revealed that a global shift and a rotation comparable
to a rigid body movement of the whole 16S rRNA may have been occurred during the re-
refinement. This observation is surprising since in the re-refinement protocol 2 no rigid
body refinement was performed.
To cross validate the model obtained from protocol 2, the re-refined model was com-
pared with the one available in the PDB_REDO database for which a rigid body re-refine-
ment is always performed in the first stage of the refinement protocol. The RMSD without
superposition between the phosphate atoms in the two 16S rRNA moieties from the refine-
ment protocol 2 e from the PDB_REDO project is 0.32 Å, less than the coordinate error. If
these two 16S rRNA moieties are analysed with ESCET they result to be identical within
the error and one single rigid body is found, as shown in panel (a) of Figure 7.7. This is an
interesting observation given that two different routes for refinement were taken. In fact,
in the PDB_REDO project no simulated annealing refinement is performed and a different
refinement program (REFMAC) is used.
Furthermore, if ESCET is instead used to compare the re-refined model from protocol
2 and the deposited model for 2UUB, besides the body and the head domain that form a
unique rigid body, two rigid bodies are identified in the shoulder and the platform, respec-
tively, and a concerted motion of the shoulder and platform domains is detected as shown
in panel (b) of Figure 7.7.
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Figure 7.7: Rigid body analysis with ESCET of different models of PDB code 2UUB. Panel (a) shows
the result of the analysis for the 16S rRNA moieties from protocol 2 and PDB_REDO. Panel (b) shows
the result of the analysis for the 16S rRNA from protocol 2 and the deposited model. The decoding
A site is highlighted with a red circle.
In particular, if the deposited structure is taken as reference, the shoulder domain moves
away from the A site, while the platform moves towards from the A site. This can explain
why after re-refinement the structure increases its structural diversity compared to the other
structures in closed conformation.
Singleton CS2 – Closed Conformation
Similarly to 2UUB, also the pdb-entry 2UXD after re-refinement shows a larger conforma-
tional diversity when compared to the other structures belonging to cluster C1. A possible
explanation can be found in the decrease in the mean estimated standard uncertainty value
after re-refinement with protocol 2 (as shown in Table 7.2), in fact one of the largest de-
creases observed in the data set. It moves from 0.48 Å in the deposited model to 0.34 Å in
the re-refined model. This significantly lowers the coordinate uncertainties in the model
and makes smaller structural differences more significant in the ensemble comparison.
Even if not as obvious as for the pdb-entry 2UUB (see above), probably during re-refinement
the accumulation of many small differences possibly related to bias due to the incomplete-
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ness of the model (it contains 1472 phosphate atoms against an average of 1507 in the
data set) increased its structural diversity with the other models in closed conformation of
cluster C1. The combination of the variations in atomic coordinates and the decrease in the
coordinate uncertainties explains why after re-refinement the pdb-entry 2UXD becomes a
singleton.
Cluster C2 – Closed Conformations
The cluster C2 contains structures that show a less closed conformation. In contrast to what
is observed for the cluster C1, the composition of this group in terms of ligand content is
more heterogeneous. In fact, in both data sets it contains structures with (pdb-entries 2VQE
and 2VQF) and without paromomycin (pdb-entries 1IBM and 1HR0). As shown in Table 7.3
both pdb-entries 2VQE and 2VQF contain a codon mRNA in the A site, a modified tRNA
ASL, and a molecule of paromomycin, while the pdb-entry 1IBM contains a codon mRNA
in the A site and a tRNA ASL, and the pdb-entry 1HR0 contains only one molecule of IF1.
In the clustering results from the re-refined data set this cluster contains also the pdb-entry
1N33, which in the default data set is located in the cluster C1. Similarly to pdb-entries
2VQE and 2VQF, the pdb-entry 1N33 contains a codon mRNA in the A site, a near-cognate
tRNA ASL, and a molecule of paromomycin.
Even if the composition of cluster C2 is slightly heterogeneous, the results are in agree-
ment with the data from the literature. It is in fact known that the recognition of the correct
codon-anticodon base pair requires a change from an open to a closed conformation of the
30S ribosomal subunit and that the magnitude of the closure is smaller if paromomycin is
not present in the crystal structure (pdb-entry 1IBM) [91]. A similar closure of the 30S
subunit was observed if the IF1 was present in the crystal structure. Pdb-entries 2VQE and
2VQF should be in cluster C1 for their ligand content. Nevertheless, it has been reported
that the 5’ of the tRNA ASL in these structures is not visible in the electron density map,
indicating a certain degree of disorder. This could be related to a reduced closure of the 30S
subunit. The same holds for the pdb-entry 1N33 for which in the presence of paromomycin
the affinity between the codon and near-cognate tRNA is lower than for the pdb-entry 1N32
(included in cluster C1) [93]. This would be in agreement with the observation that after
re-refinement, the model 1N33 moved from cluster C1 to cluster C2.
Cluster O1 – Open Conformations
Taking now into consideration the branch of the dendrogram that includes 30S structures
in open conformation (blue dashed boxes in Figure 7.6), the cluster O1 contains 30S riboso-
mal subunit crystallized with a Shine-Dalgarno anti-Shine-Dalgarno (SD-aSD) interaction.
In the default data set it includes pdb-entries 2E5L, 2HHH and 2ZM6, while in the re-refined
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data set also the pdb-entries 1N34 and 1N36 are included.
2E5L was solved to study the SD-aSD interaction in the ribosome (see panel (a) in
Figure 7.8). In 2HHH a SD-aSD was not modelled in the electron density but reported in
the accompanying article (see panel (b) in Figure 7.8). 2ZM6 instead is a dubious case since
no accompanying publication is present and it has been solved by molecular replacement
from 2E5L. Nevertheless no SD-aSD interaction is visible in the electron density map (see
panel (c) in Figure 7.8). Instead electron density is clearly visible for the 3’ rRNA folded
back along the mRNA path even if not modelled (see panel (d) in Figure 7.8). It is worth
noting that this structure should be in the O2 cluster (see below), but in both default and
re-refined data set it is in the O1 cluster. It is not clear if this is an example of structural bias
that the re-refinement protocol was not able to fix (since it does not contain the SD-aSD
interaction) or instead an alternative form of open conformation.
As anticipated before, in the dendrogram obtained from the re-refined data set the pdb-
entries 1N34 and 1N36 are also included in the cluster O1. An analysis of the electron
density maps revealed that they both show clear density for a helix in the cavity where
usually the SD-aSD is observed although it is not modelled here (see panels (e) and (f) in
Figure 7.8).
It is then reasonable to assume that this a successful example of structural de-bias thanks
to the re-refinement procedure. In fact in the default data set these two structures are in
the O2 cluster (discussed below) that contains also the pdb-entry 1J5E that was used to
solve both 1N34 and 1N36 structures by difference Fourier method (see Table 7.1). In
the accompanying paper the authors state that no density is visible for the near-cognate
tRNA ASL but the head moves to a similar extent as with cognate ASL and no movement is
observed in the shoulder. This movement would be consistent with conformationally disor-
dered binding in the A site [93]. In light of the results obtained with ESCET it is reasonable
to assume that the observed movement of the head is also affected by the presence of a
SD-aSD-like interaction on the cavity between the head and the shoulder, where the canon-
ical SD-aSD interaction is expected. This is supported by the fact that after re-refinement
the 1N34 and 1N36 structures are structurally more similar to structures that contain the
SD-aSD interaction than to structures in a closed (clusters C1 or C2) or completely open
conformation (cluster O2). Surprisingly, the authors do not mention the presence of clear
electron density for a SD-aSD interaction in the accompanying paper [93].
It should be noted that clear density for the SD-aSD interaction is visible also in the
electron density maps for pdb-entries 1N32 (cluster C1 in the re-refined data set) and
1N33 (cluster C2 in the refined data set) that contain the same near-cognate of 1N34 and
1N36, respectively, but in presence of paromomycin (see panels (g) and (h) in Figure 7.8).
Since no specific SD sequence was added during the crystallization procedure, a possible
explanation for the observed unmodelled electron density in the SD-aSD pocket is that
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the near cognate tRNA ASL, with which the crystals were soaked, hybridizes with the aSD
sequence on the 3’ of the 16S rRNA.
To test this hypothesis, the hybridization energy between the aSD sequence CCUUUCU
on the 3’ of the 16S rRNA and the two near-cognate tRNA ASLs CUACCUUGAGGUGGUAG
(present in the pdb-entries 1N32 and 1N34) and CACGCCUGGAAAGUGUG (present in the
pdb-entries 1N33 and 1N36) was computed using the IntaRNA web server [29]. The hy-
bridization energy obtained for the first near-cognate is -3 kcal/mol while for the second
is -4.3 kcal/mol, indicating a favorable energy of hybridization between the two oligonu-
cleotides. The computed favorable energy of hybridization makes then plausible the hy-
pothesis of an interaction between the near-cognate tRNA moieties and the aSD sequence
on the 3’ of the 16S rRNA.
Since the presence of the SD-aSD like interaction in the pdb-codes 1N32 and 1N33 did
not affect the closure of the 30S subunit in presence of paromomycin it is reasonable to
assume that when the antibiotic is present in the crystal it masks the effect of any SD-aSD
interaction, similarly to how paromomycin masks any difference in the closure of the 30S
subunit between cognate and near-cognate tRNA (as shown in cluster C1).
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(a) PDB 2E5L, SD-aSD (b) PDB 2HHH, SD-aSD
(c) PDB 2ZM6, SD-aSD (d) PDB 2ZM6, P site
(e) PDB 1N34, SD-aSD (f) PDB 1N36, SD-aSD
(g) PDB 1N32, SD-aSD (h) PDB 1N33, SD-aSD
Figure 7.8: Electron density maps of selected cases. The blue density is the σ-weighted electron
density map 2mFo-DFc contoured at +1.6 σ, the green and the red densities are the σ-weighted
electron density maps 2mFo-DFc contoured at +3.0 σ and -3.0 σ, respectively. The rRNA and
protein moieties are shown in ribbon representation and a different colour is used for each chain.
These figures were made with Coot program [49].
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Cluster O2 – Open Conformations
The cluster O2 contains structures in the classical open conformation. These models do not
contain any mRNA or tRNA moieties, but they contain different types of antibiotics (pdb-
entries 1FJG, 1HNW, 1HNX, 1HNZ and 1IBK) or are empty (pdb-entry 1J5E). In contrast
to the models in cluster O1, in all the models in the cluster O2 the 3’ of the 16S rRNA is
folded back along the mRNA path in the P site. The main difference in the composition of
this cluster between the default and the re-refined data sets is the moving of the pdb-entries
1N34 and 1N36 to the cluster O1 as described above. Also in this case the results are in
agreement with the literature since it has been observed that the antibiotics alone are not
sufficient to induce a closure of the small subunit [23,32,91,134].
7.4.3 Rigid Body Analysis
The representative models from each group determined by the cluster analysis (pdb-entries
highlighted with a black arrow in Figure 7.6) were then used by the genetic algorithm to
identify rigid bodies and flexible regions on the 16S rRNA. The results for the default and
the re-refined data sets obtained by using a εlow of 1.5 are shown in Figure 7.9 (panel (a)
and (b), respectively).
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Figure 7.9: Identification of rigid bodies on the 16S rRNAs from the 30S data set before (panel (a))
and after re-refinement (panel (b)). In the center of each panel a schematic view of the 16S rRNA
is shown with a cartoon representation. Each rigid body is coloured with a different colour, while
flexible regions are light grey coloured. The decoding A site is highlighted with a red circle. For
each rigid body, the superposition of the 29 fragments from each structure in the data set is shown
in a ribbon representation together with the number of nucleotides and the average CSI for all 406
pair-wise comparisons.
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In the default data set ESCET identified four rigid bodies from the comparison of the
representative pdb-entries 2UUB, 2VQE, 2E5L and 1FJG. The first rigid body (blue frag-
ment in panel (a) of Figure 7.9) consists of 575 nucleotides and includes the body and the
shoulder domains. The second rigid body (green fragment in panel (a) of Figure 7.9) com-
prises 431 nucleotides and includes the head domain. The third rigid body (cyan fragment
in panel (a) of Figure 7.9) consists of 296 nucleotides and corresponds to the platform do-
main. The fourth rigid body (slate blue fragment in panel (a) of Figure 7.9) consists of 29
nucleotides and includes the terminal part of the beak of the head domain. The presence
of the beak as a rigid body is an artefact due to the fact that this region of the 16S rRNA is
usually highly disordered and consequently is characterized by the highest B factor values
in the structure. This affects the weighted distance matrix and it results in the identification
of the beak as a rigid body. This is anyway consistent with the definition of rigid body in ES-
CET as conformationally invariant region (i.e. a region for which all interatomic distances
are identical within the error) [110–112].
In the re-refined data set ESCET identified five rigid bodies from the comparison of the
representative pdb-entries 2UUB, 2UUA, 2UXD, 2VQE, 2E5L and 1FJG. The first rigid body
(blue fragment in panel (b) of Figure 7.9) consists of 510 nucleotides and includes the body
domain and fragments of helices from the shoulder domain (H17 and H18), the platform
domain (H21 and H26a) and the head (H36 and H40), as shown in Figure 7.10. The second
rigid body (green fragment in panel (b) of Figure 7.9) consists of 394 nucleotides and
includes the head domain. The third rigid body (cyan fragment in panel (b) of Figure 7.9)
comprises 282 nucleotides and corresponds to the platform domain. The fourth rigid body
(yellow fragment in panel (b) of Figure 7.9) consists of 106 nucleotides and corresponds
to the shoulder domain. The fifth rigid body (salmon fragment in panel (b) of Figure 7.9)
comprises 65 nucleotides and includes part of helix 44 (nucleotides 1401-1413, 1416-1417,
1482-1489) that is important for the interaction with the 50S subunit in the 70S ribosome
complex. Other fragments of this rigid body are located in the body domain. Given its
relatively small size and its fragmentation it is probably due to some bias introduced by
one of the representative structures (i.e. by removing the pdb-entry 2E5L the fifth rigid
body appears only on the H44 without any other fragment on the body domain).
Moving from the default data set to the re-refined data set a new rigid body appears
on the shoulder of the 16S rRNA, the rigid body on the beak (fourth rigid body on panel
(a) of Figure 7.9) disappears and a new rigid body appears on the H44 (fifth rigid body on
panel (b) of Figure 7.9). While these two small rigid bodies (on the beak and on the helix
44) can be considered as artifact due to noisy regions (i.e. high B factors or local structural
differences in one of the representative structures) the new rigid body on the shoulder is in
agreement to what was previously observed in the literature (see below). This corresponds
to a gain of structural information after the re-refinement. In fact, as previously discussed
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in section 7.4.2, when the models compared are more reliable, smaller absolute differences
become more significant, reflecting an increase in the information content.
Moreover if the distribution of rigid bodies is mapped on the secondary structure of the
16S rRNA as shown in Figure 7.10, the location of the rigid bodies from the re-refined data
set shows a good agreement with the modern nomenclature for domains on the 16S rRNA.
The first (blue) and the fourth (yellow) rigid bodies, which in the classical nomenclature
correspond to the body and the shoulder domain respectively, include the majority of the 5’
domain. The second rigid body (green), which in the classical nomenclature corresponds
to the head domain, includes the majority of the 3’ major domain. The third rigid body
(cyan), which in the classical nomenclature corresponds to the platform domain, includes
the majority of the central domain. From the analysis of the mapping of the rigid bodies
on the secondary structure in panel (b) of Figure 7.10 it emerges also that there is a strong
correspondence between the definition of a rigid body and the patterns of base-base and
base-backbone interactions in the 16S rRNA, although these interactions are not directly
used in the rigid body analysis.
Figure 7.10: Mapping of the rigid body obtained from ESCET (panel (a)) on the secondary structure
obtained from the comparative RNA web (CRW) site [30] (panel (b)). In panel B both classical
names (body, shoulder, platform and head) and modern names (5’ domain, central domain, 3’ minor
domain and 3’ major domain) for the different 16S rRNA domains are given. In panel (b) the light
blue and red lines represent the base-base and base-backbone interactions, respectively.
The four main rigid bodies mapped to the body, the shoulder, the platform and the head
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of the small subunit correspond to domains that have been observed to undergo conforma-
tional changes during the decoding process.
Looking at the results obtained from ESCET on the models from protocol 2 and using
the pdb-enty 1J5E (empty structure in open conformation) as the reference, all the models
in the cluster C1 and the singletons CS1 and CS1 show the strongest closure of the 16S
rRNA. This conformational change involves that, with respect to their position in the empty
form (PDB code 1J5E), the head, the shoulder and the platform domains move towards
the A site, where the decoding process takes place. A rotation angle of 2.0◦, 1.6◦, 1.0◦ is
measured if the representative conformer 1IBL is compared to the fully open conformer
1J5E for the head, platform and shoulder domains, respectively, in relation to the body
domain. As previously reported all these structures contain a molecule of the antibiotic
paromomycin. Its property of enhancing the closure of the small subunit was observed in
2001 with the pdb-entry 1IBL [91] and thereafter it has been used extensively in structural
studies where the codon-anticodon interaction was investigated [45, 86, 87, 93, 132]. It
should be noted that in the accompanying paper of the pdb-entries 1N32 and 1N33, only
the movement of the head and the shoulder is reported, while from the results obtained
with ESCET also a discrete movement of the platform is observed, in agreement with the
other models in the cluster C1.
Similarly to cluster C1, taking as reference the empty 30S structure (PDB code 1J5E)
also the conformational changes observed from the cluster analysis for models in the C2
cluster are in agreement with those reported in the accompanying publications. For all
the models in this group the closure movement of the shoulder, the head and the platform
towards the A site is still present but it is not as pronounced as for models in cluster C1.
A rotation angle of 1.0◦, 1.1◦, 0.7◦ is measured if the representative conformer 2VQE is
compared to the fully open conformer 1J5E for the head, platform and shoulder domains,
respectively, in relation to the body domain. Even if for the pdb-entries 1N33, 2VQE and
VQF a molecule of paromomycin is present in the crystal complex, the codon-anticodon
interaction is not strong enough to induce the strongest closure conformation [76, 93].
These conformational changes are of the same magnitude of those observed in pdb-entries
1IBM and 1HR0 where no paromomycin is present, but only mRNA and cognate tRNA (for
the PDB code 1IBM) or initiation factor I (for the PDB code 1HR0).
As previously discussed, the cluster O1 contains 30S ribosomal models that contain the
SD-aSD interaction. However in the accompanying publications no global conformational
changes are described [67, 108]. From the results obtained with ESCET, it is possible to
observe that in the re-refined models for the pdb-entries 2HHH and 2E5L, which were
solved with a specific SD sequence, the shoulder domain moves towards the A site while
the head and the platform move backwards towards the pocket on the back side of the 16S
rRNA, between the head and the platform. The head domain is also affected by a lateral
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translation towards the platform domain. Similar conformational changes are observed
for the pdb-entries 1N34 and 1N36, in agreement with the result of the clustering in sec-
tion 7.4.2. In these models the head domain shows a more pronounced movement toward
the A site, probably due to the presence of a disordered near-cognate tRNA ASL in the A
site as suggested by the authors [93]. A rotation angle of 2.5◦, 2.3◦, 0.4◦ is measured if the
representative conformer 2E5L is compared to the fully open conformer 1J5E for the head,
platform and shoulder domains, respectively, in relation to the body domain. It should be
noted that only after re-refinement the conformational changes observed for the pdb-entries
1N34 and 1N36 are of the same nature as those observed for the pdb-entries 2HHH and
2E5L where the SD-aSD interaction is documented. The reliability of these findings is fur-
ther supported by the fact that after re-refinement the R factors for 1N34 and 1N36 greatly
improved (as shown in Figure 7.1), indicating a better agreement between the models and
their experimental data.
The cluster O2 contains models in the classical open conformation for which the pdb-
entry 1J5E is the representative model [134]. For some of these models only small confor-
mational changes are detectable. Pdb-entries 1HNW (which binds tetracycline) and 1HNX
(which binds pactamycin) do not show significant conformational changes and are very
similar to 1J5E. In the pdb-entry 1HNZ (which binds hygromycin) instead the head, the
shoulder and the platform move slightly towards the A site (not reported in the accompa-
nying publication). This can be due to the fact that hygromycin binds close to the top of
helix 44, in a region that contains the A, P and E sites for tRNA [23]. It is probable that
its presence is sensed by the three domains (head, shoulder and platform). Very similar
conformational changes are observed for the pdb-entry 1IBK (not observed in the accom-
panying paper), which binds only paromomycin that is known to bind the 16S rRNA in the
major groove of helix 44 and to flip out bases A1492 and A1493 involved in the sensing
of the first two positions of the codon-anticodon interaction [32,91]. Even if the presence
of paromomycing is not sufficient to induce a closed conformation of the small subunit, it
looks like it prepares the 16S in a conformation favorable for the closure of the subunit. In
pdb-entry 1FJG (which binds streptomycin, spectinomycin and paromomycin) the shoulder
and platform tilt forward the A site while the head tilts back away from it, in agreement
with what is reported in the accompanying publication [32].

Chapter 8
Conclusions and Perspectives
8.1 Validation of B Factor Distributions
In chapter 5 by means of a Bayesian approach it was hypothesised that the distribution
of isotropic B factors in a crystallographic model should follow an IGD*. Since the major-
ity of the B factor distributions in the large data set of 15998 protein models fulfilled the
IGD* assumption at different hierarchical levels (whole asymmetric unit cell content, single
chains and single domains), the IGD* can be considered a valid reference distribution for B
factor distributions and it can be used for their validation as implemented in the protocol
described in section 4.3. The time required by the validation protocol to validate a distri-
bution of B factors varies in function of the number of atoms, but it has been found to be in
the order of seconds, allowing the use of the protocol in routine validation procedures. Fur-
thermore the fact that all the protein models analysed are at a resolution equal to or higher
than 2 Å ensures that, given the high data-to-parameter ratio, the observed B factors reflect
more the experimental diffraction data than the restraints applied during refinement. This
observation guarantees that the IGD* is a property itself of the B factors and not an artefact
produced by the restraints used in refinement.
The strong correlation observed between the estimates of the α and β parameters can
be used to identify, group and categorise outliers in function of extreme values for the α
and β IGD* parameters. In section 5.3 it was found that models in a given group of out-
liers are characterized by peculiar common artefacts. These artefacts include strong ties at
the lowest B factor value (see sections 5.3.1 and 5.3.4), too low variances of the B factors
probably due to too tight restraints (see section 5.3.2), or mean square displacements 〈u2〉
saved in the coordinate files instead of B factor values (see section 5.3.3). These observa-
tions can be used in the future to automatically flag a newly determined structure if the α
and β parameters of the IGD* fitted to its B factor distribution lie in one of these groups.
The p-value obtained from the KS-test is the main measure used to flag a given empirical
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B factor distribution as suspicious (if p-value < 0.01) or acceptable (if p-value ≥ 0.01). The
analysis should be performed at different hierarchical level: whole asymmetric unit content,
single chains, single domains. It was in fact observed that several B factor distributions in a
crystal model are affect by a strong multimodality due to a different packing environment.
This strong multimodality usually can be solved by taking into account single chains or
single domains. If the p-value remains lower than 0.01 then the B factor distribution is likely
to be affected by some strong artefact. The orthogonal statistics introduced in section 5.5
can then be used to find the reasons that caused the distribution under analysis to be
suspicious.
A standard re-refinement procedure resulted to be a valid approach to rescue those
structures with a suspicious B factor distribution (see section 5.4.5). Those models whose
B factor distribution was suspicious and could not be explained by the hierarchical model
proposed, even after re-refinement, corresponded usually to cases with serious problems
with the deposited atomic coordinates or structure factors. If the B factor distribution
remains suspicious even after re-refinement of the structural model, then a more detailed
analysis is required to understand the deviance from the expected IGD*.
As shown in chapter 6, the validation protocol for B factor distributions can be useful
in an ensemble analysis performed with ESCET. In fact, it allows to check the quality of the
distribution of B factors from the models in the ensemble under analysis and it allows the
identification of strong artefacts in the B factor distribution that can affect the results of
the rigid body analysis. Moreover a standard re-refinement protocol is observed to improve
the quality of the results of the ensemble analysis performed with the ESCET framework if
the starting data set contains models with suspicious B factor distributions. These results
confirm that the reliability of the outcome of a comparative structural analysis strongly
depends on the reliability of the models under analysis in the starting ensemble. Since each
macromolecular model deposited into the PDB is one of several possible interpretations
of the diffraction data, before any comparative analysis it is important to use validation
methods to judge its reliability and to maximise its agreement with the experimental data
and with the prior information available in structural databases.
8.2 Ensemble Analysis of Ribosomal Structures
The large number of ribosomal structures available in the PDB allowed the definition of
a working set of 29 structures of the small subunit from T. thermophilus for testing the
validation protocols for B factor distributions and the ESCET framework on RNA structures.
Since the presence of structural bias due to the phasing method used was suspected,
and since some models were found to have suspicious B factors, 13 re-refinement protocols
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were applied to the selected data set of ribosomal structures. Amongst the re-refinement
protocols applied, the protocol 2, which combines individual ADP refinement with TLS
refinement, is the one that outperforms all the others, confirming, as already observed in
the PDB_REDO project, that TLS refinement on average gives better refinement statistics.
In addition, protocol 2 is the only refinement protocol that produced acceptable B factor
distributions for all the models in the data set.
The large differences in R factor statistics and p-values from the KS-test between models
obtained from different re-refinement protocols highlight how at low resolution different
refinement parameterisations can greatly affect the final refinement statistics and the dis-
tribution of B factors. Therefore at low resolution the application of the same re-refinement
protocol to all the structures in an ensemble before any comparative analysis can be used
as a normalisation procedure, with effects at both coordinates and B factors levels. In ad-
dition, at low resolution there could be issues of structural bias if all the structures in the
data set were solved by molecular replacement using the same searching model. These sus-
pects were confirmed by the results obtained from the cluster analysis (see below) applied
to the ensemble of ribosomal structures. In these cases an aggressive refinement protocol
(e.g. simulated annealing refinement) can be used in the attempt of de-biasing as much as
possible the models in the data set.
The comparative analysis of the IGD* parameters computed by the validation method
for B factor distributions applied to the models obtained from different refinement protocols
allowed to detect a correlation between the magnitude of the α parameter and the model
used to refine the B factors. On average it has been observed that the stronger the restraint
used the higher is the α IGD* parameter estimated. In the particular case of the data set
of models obtained with TLS refinement, the α parameter shows a distribution similar to
the one observed in the analysis of the protein data set (shown in Figure 5.3), while the β
parameters are at least three times higher than the corresponding values. This difference
has been attributed to a higher average B factor in ribosomal structures.
Moving to the results obtained with the ESCET framework, the cluster analysis was con-
firmed as an effective way to automatically rationalise the structural information content of
the data set of ribosomal structures. In fact structures grouped together in the same cluster
resulted to have similar conformations as a result of the ligand content, for a total of two
clusters containing small ribosomal subunits in closed conformation (clusters C1 and C2
in Figure 7.6) and two clusters containing small ribosomal subunits in open conformation
(clusters O1 and O2 in Figure 7.6).
Besides being effective in rationalising the information content in an ensemble of struc-
tures, from the comparative analysis of the results of the cluster analysis on the data set
of models as deposited into the PDB and after re-refinement with protocol 2 (which pro-
duced the best models in terms of refinement statistics and B factor distribution), the ESCET
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framework resulted also a useful tool in discovering unexpected features of the data and
extracting new information that can be used for the formulation of new hypothesis (see
section 7.4.2). The observation that after re-refinement the pdb-entries 1N34 and 1N36
moved from cluster O2 (containing structures in fully open conformation) to cluster O1
(containing structures in open conformation and with a modelled Shine-Dalgarno / anti-
Shine-Dalgarno interaction) led to the discovery of new electron density in these structures
in correspondence of the Shine-Dalgarno / anti-Shine-Dalgarno (SD-aSD) interaction site.
This density was not modelled in the deposited structures and not mentioned in the ac-
companying paper. Since these pdb-entries were obtained by molecular replacement from
the pdb-entry 1J5E (contained in the cluster O2), the change of cluster after re-refinement
confirmed the existence of structural bias in the deposited ribosomal structures. This find-
ing brought also to the discovery of other models with unexpected electron density for the
SD-aSD interaction as shown in Figure 8.1.
(a) PDB 2UU9, SD-aSD (b) PDB 2UXC, SD-aSD
Figure 8.1: Electron density maps of selected cases. The blue density is the σ-weighted electron
density map 2mFo-DFc contoured at +1.6 σ, the green and the red densities are the σ-weighted
electron density maps 2mFo-DFc contoured at +3.0 σ and -3.0 σ, respectively. The rRNA and
protein moieties are shown in ribbon representation and a different colour is used for each chain.
These figures were made with Coot program [49].
The interaction between the anti-Shine-Dalgarno sequence on the 3’ of the 16S rRNA
and the near-cognate tRNA has been proposed as the possible cause for the presence of
not modelled electron density in correspondence of the SD-aSD interaction site. A SD-aSD
interaction was found also in pdb-entries 2UXC, 1N32, 1N33 and 2UU9 but no movement
to different clusters was observed for these models after re-refinement with protocol 2. It
has been hypothesised that the absence of change of cluster is due to the presence of the
antibiotic paromomycin that is known to enhance the closure of the small subunit and to
mask the structural differences between the presence of cognate or near-cognate tRNA ASL.
Also the results from the rigid body analysis improved after re-refinement of the ri-
bosomal models with protocol 2, resulting in the description by a different rigid body of
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each of the four classical domains of the 30S subunit (i.e. body, platform, head and shoul-
der domains) as shown in figures 7.9 and 7.10. All these domains are known to undergo
structural movements upon codon-anticodon interaction as discussed in section 7.4.3. The
observation that after re-refinement with protocol 2 a new rigid body appeared on the
shoulder domain of the ribosome is explained by the fact that when the models compared
are more reliable (all models with better refinement statistics and with acceptable B factor
distributions), smaller absolute differences become more significant. This is also reflected
by a decrease in the average CSI computed across the models in the ensemble, indicating
an increase in detectable structural diversity.
8.3 Perspectives
The validation protocol for B factor distribution described here can be used in the future for
the validation of models already deposited into the PDB or of newly solved macromolecular
structures prior to the deposition in the PDB. Moreover, it can be integrated in frameworks
for structural analysis, such as the ESCET framework, and used for the evaluation of the
quality of the distribution of B factors in an ensemble of models before performing any
analysis.
Following the classification of quality indicators reviewed in [70], the proposed method
can be considered a global validation statistic, since it gives information about the overall
distribution of B factors in a protein model. At the same time, since the IGD* assumption is
not used in any step of refinement, it would be considered a ‘strong’ validation criterion.
Because the IGD* assumption was satisfied by the majority of protein structures at high
resolution analysed in chapter 6 it can be used in refinement under the form of prior infor-
mation as source of restraints for B factors. The refinement of structures at low resolution
will particularly benefit of this new type of restraint for the reason that at low resolution
there are no sufficient observations to allow the refinement of B factors at atomic level.
Moreover, due to the fact that the α and β IGD* parameters are highly correlated, the
knowledge of one of these parameters is sufficient to estimate the second, with computa-
tional advantages. In case the IGD* assumption is used in refinement as source of restraints
for B factors, the proposed validation method will be considered a ‘weak’ validation cri-
terion [70] since it will just check the consistency between the observed distribution of B
factors and the prior information used to restrain them.
The statistical model behind the IGD* validation method is based in strong assumptions
like the independence between B factors in a model and their belonging to the same IGD*.
This limits its applicability in case TLS refinement (except particular cases like the ensemble
analysis of ribosomal structures, where only phosphate atoms where taken into account).
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In the future more complex statistical models should be introduced in order to consider
the correlations between B factors, extending the applicability of the validation tool to
structures refined with TLS groups.
The results of the analyses showed in the presented work confirm the importance of the
availability of the experimental data. In fact for both protein (see chapters 5 and 6) and
ribosomal (see chapter 7) data sets an automated re-refinement procedure has been shown
to be sufficient to improve the quality of the models in terms of refinement statistics and B
factor distributions, normalizing the models and allowing the extraction of more and new
structural information from the ensemble of models.
When experimental data are available, it is possible to rebuild and re-refine models with
the current best technology/knowledge. This is not only useful for individual models but
also for the analysis of ensemble of models, producing a broad picture of the structural
properties of the macromolecule under investigation and providing new information that
can bring new knowledge on the relation between the structure of the macromolecule and
its function.
Appendices
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# Bvalid.R, an R script for the validation of B factor distributions. The main function if Bvalid().
# To use this script open an R session and type: source("/<path_to_script>/Bvalid.R")
#
# Created by Jacopo Negroni.
# Copyright (c) 2011 EMBL. All rights reserved.
# Importing required packages
library(pscl) # Available in Cran (http://mirrors.softliste.de/cran/)
library(flexmix) # Available in Cran (http://mirrors.softliste.de/cran/)
library(bio3d) # Not available in Cran. Please visit: http://mccammon.ucsd.edu/~bgrant/bio3d/
# Function to compute a selection vector for residue ID.
# -Input: 1) a bio3d atom structure
# 2) a vector with the residue codes to be selected
# -Output: 1) a boolean vector of the same length of the bio3d atom structure given in input
selectResid <- function (atom.struct, code) {
selection <- rep(FALSE,length(atom.struct[,"resid"]))
for (i in code) {
selection <- selection | as.character(atom.struct[,"resid"]) == i
}
selection
}
# Function to compute a selection vector for atom name.
# -Input: 1) a bio3d atom structure
# 2) a vector with the atom types to be selected
# -Output: 1) a boolean vector of the same length of the bio3d atom structure given in input
selectElety <- function (atom.struct, elety) {
selection <- rep(FALSE,length(atom.struct[,"elety"]))
for (i in elety) {
selection <- selection | as.character(atom.struct[,"elety"]) == i
}
selection
}
# Function to select hydrogen atoms in a Bio3D atom structure.
# -Input: 1) a bio3d atom structure
# -Output: 1) a boolean vector of the same length of the bio3d atom structure given in input
selectHydrogens <- function(atom.struct) {
selection <- rep(FALSE,length(atom.struct[,"elety"]))
for (i in 1:length(selection)) {
elety <- substr(atom.struct[i,"elety"],1,1)
if (elety == "H") {
selection[i] <- TRUE
}
}
selection
}
# Vectors of IUPAC codes for amino- and nucleic-acids. Only unambiguous codes are taken into
# account (e.g: each code identifies only a single chemical compound).
# Vector of IUPAC three letter aminoacid nomenclature. Source:
# http://www.ncbi.nlm.nih.gov/Class/MLACourse/Modules/MolBioReview/iupac_aa_abbreviations.html
aa.codes <- c("ALA", "ARG", "ASN", "ASP", "CYS", "GLU", "GLN", "GLY", "HIS", "ILE",
"LEU", "LYS", "MET", "PHE", "PRO", "SER", "THR", "TRP", "TYR", "VAL"
)
# Vector of IUPAC three letter nucleic acid nomenclature. Source:
# http://www.ncbi.nlm.nih.gov/Class/MLACourse/Modules/MolBioReview/iupac_nt_abbreviations.html
nn.codes <- c("U", "A", "T", "C", "G")
# Vector of atom types for backbone atoms.
backbone.elety <- c("CA", "C", "O","N")
# Function for the computation of the alpha and beta parameters of an Inverse-Gamma Distribution
# (IGD).
# -Input: 1) a vector x of positive and non-zero numeric values
# -Output: 1) a vector with the alpha and beta IGD parameters computed from x
igdParams <- function(x) {
alpha <- (((mean(x))^2)/var(x)) + 2
beta <- mean(x)*(alpha - 1)
parameters <- c(alpha,beta)
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parameters
}
# Function to compute the vector of partial first derivatives of the negative log likelihood
# function for a shifted Inverse-Gamma Distribution (IGD*).
# -Input: 1) alpha IGD* parameter
# 2) beta IGD* parameter
# 3) gamma IGD* parameter
# 4) a vector x of positive and non-zero numeric values.
# -Output: 1) vector of partial first derivatives
sigdLogLikFD <- function(alpha, beta, gamma, x) {
n <- length(x)
dp <- vector(len=3)
dp[1] <- -n*log(beta) +sum(log(x+gamma)) + n*digamma(alpha)
dp[2] <- -n*alpha/beta + sum(1/(x+gamma))
dp[3] <- (1+alpha)*sum(1/(x+gamma)) - beta*sum(1/(x+gamma)^2)
return(dp)
}
# Function to compute the matrix of second derivatives of the negative log likelihood function
# -Input: 1) alpha IGD* parameter
# 2) beta IGD* parameter
# 3) gamma IGD* parameter
# 4) a vector x of positive and non-zero numeric values.
# -Output: 1) vector of partial second derivatives
sigdLogLikSD <- function(alpha, beta, gamma, x) {
n <- length(x)
dp2 <- matrix(vector(len=9),nrow=3)
dp2[1,1] <- n*trigamma(alpha)
dp2[1,2] <- -n/beta
dp2[1,3] <- sum(1/(x+gamma))
dp2[2,3] <- -sum(1/(x+gamma)^2)
dp2[2,1] <- dp2[1,2]
dp2[3,1] <- dp2[1,3]
dp2[3,2] <- dp2[2,3]
dp2[2,2] <- n*alpha/beta^2
dp2[3,3] <- -(1+alpha)*sum(1/(x+gamma)^2) + 2*beta*sum(1/(x+gamma)^3)
return(dp2)
}
# Function to compute the average negative log likelihood for a IGD*.
# -Input: 1) a vector with the three alpha, beta and gamma IGD* parameters
# 2) a vector with positive values for which compute the average negative log likelihood.
# -Output: 1) the computed average negative log likelihood for a IGD*
avrgSigdLogLik <- function(sigd.params, x) {
n <- length(x)
alpha <- sigd.params[1]
beta <- sigd.params[2]
gamma <- sigd.params[3]
x <- x + gamma
avrg.sigd.log.lik <- -alpha*log(beta) + lgamma(alpha) + ((alpha+1)*sum(log(x)) + beta*sum(1/x))/n
return(avrg.sigd.log.lik)
}
# Function to compute a robust MLE to fit a IGD* to a given vector of positive values.
# -Input: 1) a vector x of positive and non-zero numeric values.
# 2) a boolean value to switch the select as best fit the one with the lowest
# mean variance of the estimated IGD* parameters (default to FALSE).
# -Output: 1) a list with the following elements:
# 1.a) alpha = alpha parameter of the estimated IGD* that best fits the data
# 1.b) beta = beta parameter of the estimated IGD* that best fits the data
# 1.c) gamma = gamma parameter of the estimated IGD* that best fits the data
# 1.d) dp2 = matrix of the partial second derivatives
# 1.e) stdev.params = vector of the estimated standard deviations of the estimated IGD*
# parameters
# 1.f) igd.loglik = average negative log-likelihood value
robustMLE <- function (y, filter.variances=FALSE) {
max.gamma <- 0.01
if (min(y) > max.gamma) {
max.gamma <- (min(y)-0.01)
}
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gamma.starts <- seq(0.01,max.gamma,2)
if (gamma.starts[length(gamma.starts)] < max.gamma) {
gamma.starts <- c(gamma.starts, max.gamma)
}
# Variables used to store different statistics computed during the MLE for different values of gamma
sigd.log.liks <- vector(length=(length(gamma.starts)))
sigd.mean.stdev.strict <- vector(length=(length(gamma.starts)))
final.alphas <- vector(length=(length(gamma.starts)))
final.betas <- vector(length=(length(gamma.starts)))
final.gammas <- vector(length=(length(gamma.starts)))
final.analytical.hessian.strict <- list()
final.stdev.strict <- list()
list.mles <- list()
for (gamma.start in (1:length(gamma.starts))) {
y.start <- y - gamma.starts[gamma.start]
alpha.start <- igdParams(y.start)[1]
beta.start <- igdParams(y.start)[2]
control <- list(maxit=500, ndeps=c(1e-3, 1e-3, 1e-3))
sigd.mle <- optim(
c(alpha.start, beta.start, -gamma.starts[gamma.start]),
avrgSigdLogLik,
x=y,
method="L-BFGS-B",
lower=c(0.01, 0.01, -(min(y) -0.0001)),
upper=c(Inf, Inf, 0),
control=control,
hessian = TRUE)
list.mles[[gamma.start]] <- sigd.mle
final.alphas[gamma.start] <- sigd.mle$par[1]
final.betas[gamma.start] <- sigd.mle$par[2]
final.gammas[gamma.start] <- sigd.mle$par[3]
sigd.log.liks[gamma.start] <- sigd.mle$value
final.analytical.hessian.strict[[gamma.start]] <- sigdLogLikSD(sigd.mle$par[1],
sigd.mle$par[2],
sigd.mle$par[3],
y)
final.stdev.strict[[gamma.start]] <- estimStandardError(final.analytical.hessian.strict[[gamma.start]])
sigd.mean.stdev.strict[gamma.start] <- Inf
if (sum(is.na(final.stdev.strict[[gamma.start]])) == 0) {
sigd.mean.stdev.strict[gamma.start] <- mean(final.stdev.strict[[gamma.start]])
}
}
index.min.log.lik <- which.min(sigd.log.liks)
index.min.stdev <- which.min(sigd.mean.stdev.strict)
alpha.estim <- NA
beta.estim <- NA
gamma.estim <- NA
dp2.strict <- NA
stdev.params.strict <- NA
igd.loglik <- NA
if (filter.variances) {
alpha.estim <- final.alphas[index.min.stdev]
beta.estim <- final.betas[index.min.stdev]
gamma.estim <- final.gammas[index.min.stdev]
dp2.strict <- final.analytical.hessian.strict[[index.min.stdev]]
stdev.params.strict <- final.stdev.strict[[index.min.stdev]]
igd.loglik <- sigd.log.liks[index.min.stdev]
}
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else {
alpha.estim <- final.alphas[index.min.log.lik]
beta.estim <- final.betas[index.min.log.lik]
gamma.estim <- final.gammas[index.min.log.lik]
dp2.strict <- final.analytical.hessian.strict[[index.min.log.lik]]
stdev.params.strict <- final.stdev.strict[[index.min.log.lik]]
igd.loglik <- sigd.log.liks[index.min.log.lik]
}
return(list(alpha=alpha.estim,
beta=beta.estim,
gamma=gamma.estim,
dp2=dp2.strict,
stdev.params=stdev.params.strict,
igd.loglik=igd.loglik
)
)
}
# Function to compute the standard errors of the alpha, beta, gamma estimates from the inversion of
# the Hessian matrix
# -Input: 1) an Hessian matrix
# -Output: 1) a vector with the standard deviations for the diagonal elements of the Hessian matrix
estimStandardError <- function(Hessian) {
if (det(Hessian) != 0) {
return(sqrt(diag(solve(Hessian))))
}
else {
return(rep(NA, length(diag(Hessian))))
}
}
# Function to compute the average p-value from a parametric bootstrapped KS-test
# -Input: 1) the number of iterations for the bootstrap procedure
# 2) a vector x of positive and non-zero numeric values
# 3) alpha IGD* parameter
# 4) beta IGD* parameter
# 5) gamma IGD* parameter
# 6) boolean value for the computation of an exact p-value (please see help page for
# ks.test() function for further information)
# 7) seed number for the number random generator
# -Output: 1) a list with the following elements:
# 1.a) bootstrap estimator for the p-value from the KS-test
# 1.b) variance of the bootstrap estimator
kspvalue <- function(iterations, x, alpha, beta, gamma, exact=NULL, seed=3){
set.seed(seed)
ks <- vector(len=iterations)
for (i in 1:iterations) {
ks[i] <- ks.test(x,rigamma(length(x),alpha,beta)-gamma,exact=exact)$p.value
}
return(list(mean=mean(ks), var=var(ks)))
}
# Function to validate the distribution of isotropic B factors in crystallographic models deposited
# into the PDB.
Bvalid <- function(
pdb, # A valid PDB code or filename.
download=FALSE, # Whether to download the PDB model.
water=FALSE, # Whether water should be taken into account.
hydrogen=FALSE, # Whether hydrogen atoms should be taken into account.
chain="", # The chain Id to analyse. "" corresponds to all chains.
compound=c("p","n","PN"), # Compound to analyse. "p" stands for protein, "n" stands
# for nucleic acids. "PN" stands for both (default="p").
selection=c("all","backbone","P","CA"), # Selection for the atom type (default="all").
plot=TRUE, # Whether to plot the validation histogram.
to.screen=TRUE, # Whether to plot to screen.
output.pdf.filename=NULL, # Filename of the pdf file to use to save the histogram.
plot.header=NULL, # String to use as header in the plot (default = pdb)
seed=3, # Seed for the random numbers generator.
ties.mult=9, # Multiplicative factor for the z-score used to detect
# strong ties in the distribution of B factors.
mult.B.const=NULL, # Multiplicative constant for B factors (used fo <u^2>).
ks.iterations=1000) { # Number of iterations for the bootstrapped KS-test
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pdb.repository <- "ftp://ftp.wwpdb.org/pub/pdb/data/structures/all/pdb/"
fullPath <- c()
if (download) {
downloadString <- paste("wget ", pdb.repository, "pdb",tolower(pdb),".ent.gz",sep="")
gunzipString <- paste("gunzip pdb", tolower(pdb), ".ent.gz",sep="")
system(downloadString)
system(gunzipString)
fullPath <- paste("pdb", tolower(pdb), ".ent",sep="")
}
else {
fullPath <- pdb
pdb <- sub(".*/","",pdb,perl=TRUE) # Selecting only the file name. Not the path to the file.
}
compound <- match.arg(compound)
selection <- match.arg(selection)
# Performing some consistency checks for selections
if (((compound == "p") & (selection == "P")) | ((compound == "n") & (selection == "CA"))) {
stop(paste("Consistency error! Impossible to select CA in RNA/DNA moieties or\n",
"P in protein moieties. Please check the parameters.", sep=""))
}
if (compound == "n" & selection == "backbone") {
stop(paste("Error! At the moment it is possible to select backbone only for protein moieties.\n",
"Sorry for the inconvinience. Hopefully it will be added soon.", sep=""))
}
# Uploading all atoms, including water (het2atom=TRUE). The HETATM records are
# converted to ATOM records to simplify the data structure to analyse.
pdbContent <- c()
if (download) {
pdbContent <- read.pdb(fullPath, het2atom=TRUE, maxlines=1000000,rm.alt=FALSE)
}
else {
pdbContent <- read.pdb(fullPath, het2atom=TRUE, maxlines=1000000,rm.alt=FALSE)
}
upAtoms <- pdbContent$atom
lengthRawUploadedAtoms <- length(upAtoms[,"b"])
cat(paste("\nTotal uploaded atoms: ",lengthRawUploadedAtoms , "\n\n", sep=""))
# Extracting chains from uploaded atoms
chains <- unique(upAtoms[,"chain"])
chains[is.na(chains)] <- " "
if ((sum(chains == chain) == 0) & (chain != "")) {
stop(paste("Error! The chain you selected is not present in the structure.\n",
"Please remember that the chain selection is case sensitive.",,sep=""))
}
# Creating a boolean vector for the selection of desired subsets
selectionVector <- rep(TRUE,lengthRawUploadedAtoms)
# Dealing with hydrogen atoms
selectionHydrogen <- rep(TRUE,lengthRawUploadedAtoms)
for (i in 1:length(selectionHydrogen)) {
elety <- substr(upAtoms[i,"elety"],1,1)
if (elety == "H") {
selectionHydrogen[i] <- FALSE
}
}
cat(paste("\nTotal hydrogen atoms: ", sum(!selectionHydrogen) , "\n\n", sep=""))
if ((!hydrogen) & (sum(!selectionHydrogen) > 0)) {
selectionVector <- selectionVector & selectionHydrogen
cat(paste(" -- The hydrogen atoms have been discarded from the analysis\n\n", sep=""))
}
else {
cat(paste(" -- The hydrogen atoms have been included in the analysis\n\n", sep=""))
}
# Selecting only atoms with occupancy == 1
occupancySel <- as.double(upAtoms[,"o"]) == 1
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outOccupancy <- !occupancySel & selectionVector
cat(paste("Number of atoms with occupancy not equal to 1: ", sum(outOccupancy), "\n\n", sep=""))
if (sum(outOccupancy) >= 1) {
cat("**** !!!Warning!!! The following atoms have an occupancy value different from 1 ****\n\n")
print(upAtoms[outOccupancy,c("eleno","elety","resid","chain","resno","o","b")])
cat("\n\n")
}
selectionVector <- selectionVector & occupancySel # Updating selection vector
# Applying chain selection
chainSelection <- c()
if (chain != "") {
chainSelection <- upAtoms[,"chain"] == chain
}
else {
chainSelection <- rep(TRUE,lengthRawUploadedAtoms)
}
selectionVector <- selectionVector & chainSelection # Updating selection vector
if (chain == "") {
cat(paste(" -- Number of atoms from all chains: ",
sum(selectionVector,na.rm=TRUE), "\n\n", sep=""))
}
else {
cat(paste(" -- Number of atoms from chain ", chain, ": ",
sum(selectionVector,na.rm=TRUE), "\n\n", sep=""))
}
# Applying compound selection
compoundSelection <- c()
if (compound == "p") {
compoundSelection <- selectResid(upAtoms, aa.codes)
}
else if (compound == "n") {
compoundSelection <- selectResid(upAtoms, nn.codes)
}
else if (compound == "PN") {
compoundSelection <- selectResid(upAtoms, c(aa.codes,nn.codes))
}
selectionVector <- selectionVector & compoundSelection # Updating selection vector
cat(paste(" -- Number of atoms from selection ", compound,
": ", sum(selectionVector, na.rm=TRUE), "\n\n", sep=""))
# Applying selection criteria
selectionOpt <- c()
if (selection == "backbone") {
selectionOpt <- selectElety(upAtoms, backbone.elety)
}
else if (selection == "CA") {
selectionOpt <- selectElety(upAtoms, c("CA"))
}
else if (selection == "P") {
selectionOpt <- selectElety(upAtoms, c("P"))
}
else if (selection == "all") {
selectionOpt <- rep(TRUE, lengthRawUploadedAtoms)
}
selectionVector <- selectionVector & selectionOpt # Updating selection vector
cat(paste(" -- Number of atoms from selection ", selection, ": ",
sum(selectionVector, na.rm=TRUE), "\n\n", sep=""))
# Selecting water molecules... If requested.
waterSelection <- c()
waterSelection <- selectResid(upAtoms, c("HOH"))
if (water) {
cat(paste(" -- Number of water molecules included into the analysis: ",
sum(waterSelection), "\n\n", sep=""))
selectionVector <- selectionVector | waterSelection
}
else {
cat(paste(" -- Number of water molecules excluded from the analysis: ",
sum(waterSelection), "\n\n", sep=""))
selectionVector <- selectionVector & !(waterSelection)
}
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# Selecting only atoms with B-factor higher than zero
bfacSelection <- as.double(upAtoms[,"b"]) > 0
nullBfactors = sum(!bfacSelection & selectionVector)
cat(paste("Number of atoms with B-factor values equal to zero (or less...): ",
nullBfactors, "\n\n", sep=""))
if (nullBfactors >= 1) {
cat("**** !!!Warning!!!: found atoms with B-factors values equal to zero (or less...) ****\n\n")
print(upAtoms[!bfacSelection & selectionVector,c("eleno","elety","resid","chain","resno","o","b")])
cat("\n\n")
}
selectionVector <- selectionVector & bfacSelection # Updating selection vector
cat(paste("Number of atoms with occupancy equal to one and Bfactor values higher than zero: ",
sum(selectionVector), "\n\n", sep=""))
bFactors <- as.double(upAtoms[selectionVector,"b"])
# If mult.B.const is not null, all the B factors in the sample are multiplied by a constant
if (!(is.null(mult.B.const))) {
bFactors = bFactors * mult.B.const
}
uniqueBfactors <- unique(bFactors)
rawBfacStat <- getBfactorStatistics(bFactors)
# Computation of IGD parameters by MLE
cat("Computing Inverse-Gamma parameters by Maximum Likelihood Estimation\n\n")
mlestimation <- robustMLE(bFactors, filter.variances=FALSE)
alphaML <- mlestimation$alpha
betaML <- mlestimation$beta
gammaML <- mlestimation$gamma
# Computation of a parametric bootrstrapped two-sided two-sample Kolmogorov-Smirnov test
cat("Computing Kolmogorov-Smirnov test p-value\n")
ksTwoSidedMLPvalue <- kspvalue(ks.iterations, bFactors, alphaML, betaML, gammaML, seed=seed)
cat(paste("Kolmogorov-Smirnov test p-value: ",
signif(ksTwoSidedMLPvalue[["mean"]],4),"\n\n",sep=""))
# computation of graphical parameters
print("Computing graphical parameters")
breakswidth <- signif(((rawBfacStat$max*1.1 - rawBfacStat$min*0.1)/500),3)
xML <- seq((rawBfacStat$min+gammaML)*0.1, (rawBfacStat$max+gammaML)*1.1, breakswidth)
inverseGammaML <- densigamma(xML, alphaML, betaML)
smoothedBML <- density(bFactors,kernel="gaussian",from=rawBfacStat$min*0.1,
to=rawBfacStat$max*1.1,n=length(xML))
# Looking for ties in the data
sigmaMultiplier <- ties.mult
ta <- getTiesStatistics(bFactors, sigmaMultiplier)
if (ta$mean > 2 & sqrt(ta$var) > 0) {
cat(paste("Number of strong ties detetected with a treshold of ", sigmaMultiplier, " sigma: ",
paste(ta$outliers.counts,collapse=" "),"\n",sep=""))
if (ta$outliers.counts > 0) {
cat(paste(" -- B-factor values at which the ties have been detected: ",
paste(round(ta$outliers.bfactors,2),collapse=" "),"\n",sep=""))
cat(paste(" -- Corresponding pecentiles: ",
paste(round(ta$outliers.percentiles,2),collapse=" "),"\n",sep=""))
}
}
# Plotting section
if (plot) {
histInfo <- hist(bFactors, breaks="FD", plot=FALSE, freq=FALSE)
histMax <- max((histInfo$density),(inverseGammaML),(smoothedBML$y), na.rm=TRUE)*1.01
if (max(inverseGammaML, na.rm=TRUE) > 2*max((histInfo$density),(smoothedBML$y))) {
histMax <- max((histInfo$density),(smoothedBML$y)) * 1.5
}
# Checking for outliers in ties distribution
selectionTiesOutliers <- ta$mean > 2 & sqrt(ta$var) > 0
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selectionHistCol <- rep("white",length(histInfo$mids))
if (selectionTiesOutliers) {
for (i in ta$outliers.bfactors) {
index <- min(which(histInfo$breaks >= i))
if (index == 1) {
selectionHistCol[min(which(histInfo$breaks >= i))] <-"blue"
}
else {
selectionHistCol[(min(which(histInfo$breaks >= i)) - 1)] <-"blue"
}
}
}
# opening devices
if (to.screen & plot) {
X11()
}
if ((!is.null(output.pdf.filename)) & (!to.screen)) {
pdf(paste(output.pdf.filename, "_", pdb,"_Bfactors_distribution.pdf",sep=""),
width = 8.2, height = 11.6, colormodel="cmyk", paper="a4")
par(mfrow=c(3,2))
}
histCol <- "gray"
if (ksTwoSidedMLPvalue[["mean"]] < 0.01) {
histCol <- "orange"
}
chains = ""
if (chain != "") {
chains = chain
}
else {
chains = paste(unique(upAtoms[selectionVector,"chain"]),collapse=", ",sep="")
}
par(
mar=c(4.5,6,5,2),
las = 1,
yaxs="i",
xaxs="i",
tcl = -0.3,
font.axis=1,
font.main=1,
font.lab=1,
cex.axis=1.5,
mgp=c(4, 1, 0.2)
)
xrange <- c(0, rawBfacStat$max*1.1)
yrange <- c(0, histMax)
header = pdb
if (!is.null(plot.header)) {
header = plot.header
}
hist(
bFactors,
breaks="FD",
freq=FALSE,
main=NULL,
xlab=NULL,
ylab=NULL,
col=selectionHistCol,
border=histCol,
ylim=yrange,
xlim=xrange
)
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# Drawing y axis label
mtext("Density", side=2, font=1, line=4.5, las=3, cex=1 )
# Drawing x axis labels
mtext("B factors", side=1, font=1, line=3, cex=1)
# Drawing main title
title_igd=header
mtext(title_igd, side=3, font=2, line=3.2, cex=1)
# Drawing IGD estimates
IGD_parameters = as.expression(substitute(list(alpha == a, ~~beta == b, ~~gamma == c),
list(a = round(mlestimation$alpha,2), b = round(mlestimation$beta,2),
c = round(- mlestimation$gamma,2))))
mtext(IGD_parameters, side=3, font=1, line=0.1, cex=0.7)
# Drawing orthogonal statistics
orthogonal_stats=paste("p-value = ", signif(ksTwoSidedMLPvalue[["mean"]],2), ", null Bs = ",
nullBfactors, ", non-H atoms = ", length(bFactors), sep="")
mtext(orthogonal_stats, side=3, font=1, line=1, cex=0.7)
# Drawing chain selection:
chain_selection = paste( "chains: ", chains, sep="")
mtext(chain_selection, side=3, font=1, line=2, cex=0.7)
# Plotting the density function of the derived Inverse Gamma distribution
lines(smoothedBML$x,smoothedBML$y,col="black", lwd=2)
lines(xML-gammaML,inverseGammaML,col="red",lwd=2)
if ((!is.null(output.pdf.filename)) & (!to.screen)) {
dev.off()
}
}
if (download) {
rmString <- paste("rm pdb", tolower(pdb), ".ent",sep="")
system(rmString)
}
return(
list(
B.factors.stats=rawBfacStat,
ta=ta,
p.value=ksTwoSidedMLPvalue,
sigd.mle=mlestimation,
tot.null.B=nullBfactors,
length=length(bFactors)
)
)
}
# Function to compute the number of times a given number is present in a vector
# -Input: 1) a vector x of numerical values
# -Output: 1) a list with two elements:
# 1.a) vector of unique values
# 1.b) vector of how many times each unique value has been counted in the original x vector
checkTies <- function (x) {
# Converting Bfactors values to double entities
x <- as.double(x)
# Obtaining the vector of unique values
uniqueValues <- unique(x)
counts <- vector(len=length(uniqueValues))
# counting how many times each doubled value appears in the original data vector x
for (i in 1:length(uniqueValues)){
counts[i] <- length(which(x == uniqueValues[i]))
}
list(unique=uniqueValues, counts=counts)
}
# Function to compute the percentile values for a vector of values in a data set.
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# -Input: 1) a vector x of numerical values (the population o values)
# 2) a vector y of selected values from x for which compute the correspoding percentiles
# -Output: 1) a vector of percentiles
getPercentile <- function(x,y) {
percentiles <- vector(length=length(y))
for (i in 1:length(y)) {
percentiles[i] <- round((sum(x <= y[i], na.rm=TRUE)/length(x))*100,2)
}
percentiles
}
# Function to compute several statistics on ties, if present in the data.
# -Input: 1) a vector x of numerical values
# 2) a costant k to be used for the detection of strong ties in the data set x. All the
# ties counts that are higher than the mean values plus k times the standard deviation
# are considered outliers
# -Output: 1) a list with several stastistics computed from the population x
getTiesStatistics <- function (x,k=3) {
# Extracting ties data
tiesData <- checkTies(x)
# Extracting number of unique Bfact
uniqueBfact <- tiesData$unique
numberUniqueBfact <- length(uniqueBfact)
# Extracting number of counts for each unique B-factor value
# and computing theis mean and variance
counts <- tiesData$counts
counts.mean <- mean(counts)
counts.var <- var(counts)
counts.max <- max(counts)
counts.firstIqr <- quantile(counts,1/4)
counts.median <- median(counts)
counts.thirdIqr <- quantile(counts,3/4)
# Extracting minimum value from ties count
minTies <- 1
if (sum(counts > 1) != 0) {
minTies <- min(counts[counts > 1])
}
# Extracting maximum value from ties count
maxTies <- 1
if (sum(counts > 1) != 0) {
maxTies <- max(counts[counts > 1])
}
# Extracting average number of duplicated values (for counts > 1)
avrgTies <- 1
if (sum(counts > 1) != 0) {
avrgTies <- mean(counts[counts > 1])
}
# Extracting variance value duplicated values (for counts > 1)
varTies <- 0
if (sum(counts > 1) > 1) {
varTies <- var(counts[counts > 1])
}
# Extracting first interquartile for ties data
firstIQties <- 1
if (sum(counts > 1) != 0) {
firstIQties <- quantile(counts[counts > 1],1/4)
}
# Extracting median for ties data
medianTies <- 1
if (sum(counts > 1) != 0) {
medianTies <- median(counts[counts > 1])
}
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# Extracting third interquartile for ties data
thirdIQties <- 1
if (sum(counts > 1) != 0) {
thirdIQties <- quantile(counts[counts > 1],3/4)
}
counts.selectionOut <- (counts > (counts.mean + k*sqrt(counts.var)))
counts.outNumber <- sum(counts.selectionOut)
counts.tiedBfact <- NA
counts.tiedCounts <- 0
counts.tiedPercentiles <- NA
if (counts.outNumber > 0 & length(counts) > 0) {
counts.tiedBfact <- uniqueBfact[counts.selectionOut]
counts.tiedCounts <- counts[counts.selectionOut]
counts.tiedPercentiles <- getPercentile(x,counts.tiedBfact)
}
selectionOut <- (counts > (avrgTies + k*sqrt(varTies)))
outNumber <- sum(selectionOut)
tiedBfact <- NA
tiedCounts <- 0
tiedPercentiles <- NA
if (outNumber > 0 & length(counts) > 0) {
tiedBfact <- uniqueBfact[selectionOut]
tiedCounts <- counts[selectionOut]
tiedPercentiles <- getPercentile(x,tiedBfact)
}
list(firstQ=firstIQties[[1]],
median=medianTies,
min=minTies,
max=maxTies,
mean=round(avrgTies,2),
var=round(varTies,4),
counts=counts,
counts.mean=counts.mean,
counts.var=counts.var,
counts.max=counts.max,
counts.median=counts.median,
counts.firstQ=counts.firstIqr[[1]],
counts.thirdQ=counts.thirdIqr[[1]],
counts.outNumber=counts.outNumber,
counts.tiedBfact=counts.tiedBfact,
counts.tiedCounts=counts.tiedCounts,
counts.tiedPercentiles=round(counts.tiedPercentiles,2),
thirdQ=thirdIQties[[1]],
outliers.number=outNumber,
outliers.bFactors=tiedBfact,
outliers.counts=tiedCounts,
outliers.k=k,
outliers.percentiles=round(tiedPercentiles,2),
number.uniqueBfact=numberUniqueBfact
)
}
# Function to compute several parametric and non-parametric statistics from a vector of numerical values
# -Input: 1) a vector x of numerical values
# -Output: 1) a list with parametric and non-parametric statistics
getxtatistics <- function (x) {
list(min=round(min(x),2),
firstQ=round(quantile(x,1/4),2),
median=round(median(x),2),
mean=round(mean(x),2),
var=round(var(x),4),
thirdQ=round(quantile(x,3/4),2),
max=round(max(x),2))
}
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Let x be a sample of size n drawn from a population having distribution D. The sample
mean is then defined as:
〈x〉= 1
n
n￿
i=1
xi (B.1)
and the sample variance as:
s2x =
1
n− 1
n￿
i=1
(xi − 〈x〉)2 (B.2)
By definition the sample mean 〈x〉 and sample variance s2x are respectively related to pop-
ulation mean µ and population variance σ2 as follows
µ= lim
n→inf〈x〉= limn→inf
1
n
n￿
i=1
xi (B.3)
σ2 = lim
n→inf s
2
x = limn→inf
1
n− 1
n￿
i=1
(xi − 〈x〉)2 = lim
n→inf
1
n
n￿
i=1
(xi −µ)2 (B.4)
Let now define a multiplicative constant a and an additive constant b. From (B.1) we
obtain:
〈ax + b〉= 1
n
n￿
i=1
(axi + b) =
a
n
n￿
i=1
xi +
nb
n
= a〈x〉+ b (B.5)
and from (B.2) we obtain:
s2ax+b =
1
n− 1
n￿
i=1
￿
(axi + b)− (a〈x〉+ b)￿2
=
1
n− 1
n￿
i=1
￿
a(xi − 〈x〉￿)2
=
1
n− 1
n￿
i=1
a2(xi − 〈x〉)2
=
a2
n− 1
n￿
i=1
(xi − 〈x〉)2 = a2s2ax+b (B.6)
Similarly, from equations (B.5) and (B.3)
lim
n→inf〈ax + b〉= aµ+ b (B.7)
and from equations (B.6) and (B.4)
lim
n→inf s
2
ax+b = a
2σ2 (B.8)
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Let a be a multiplicative constant and α￿ the α parameter of the IGD* whose sample
values were multiplied by a. From the combination of equation (3.21) with equations
(B.7) and (B.8) we obtain:
α￿ =
￿
a(µ+ γ)
￿2
a2σ2
+ 2=
a2(µ− γ)2
a2σ2
+ 2=
(µ− γ)2
σ2
+ 2= α. (C.1)
Similarly, let be β ￿ the β parameter of the IGD* whose sample values were multiplied by a.
From the combination of equation (3.22) with equation (B.7) we obtain
β ￿ = a(µ− γ)(α− 1) = aβ . (C.2)
It follows that if we multiply an IGD* by a constant a, only the β parameter is affected
(equation (C.2)), while the α parameter remains constant (equation (C.1)).
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Table E.1: List of ribosomal structures retrieved in the PDB at a resolution higher than or equal to
4 Å.
PDB code organism subunit SF resolution Rwork R f ree date split codes
1 2ZJR D.radiodurans 50S yes 2.91 0.28 0.31 3/8/08
2 1NKW D.radiodurans 50S no 3.10 0.24 0.27 1/5/03
3 1JZX D.radiodurans 50S no 3.10 0.27 0.30 9/17/01
4 3CF5 D.radiodurans 50S yes 3.30 0.28 0.32 3/2/08
5 1NWY D.radiodurans 50S no 3.30 0.28 0.30 2/7/03
6 2ZJQ D.radiodurans 50S yes 3.30 0.30 0.34 3/8/08
7 2O44 D.radiodurans 50S no 3.30 0.33 12/3/06
8 1Y69 D.radiodurans 50S no 3.33 0.28 0.34 12/4/04
9 2D3O D.radiodurans 50S no 3.35 0.30 0.32 9/30/05
10 1OND D.radiodurans 50S yes 3.40 0.26 0.31 2/27/03
11 1P9X D.radiodurans 50S no 3.40 0.27 0.34 5/13/03
12 1SM1 D.radiodurans 50S no 3.42 0.28 0.35 3/8/04
13 1NJP D.radiodurans 50S no 3.50 0.24 0.30 1/2/03
14 2AAR D.radiodurans 50S yes 3.50 0.25 0.32 7/14/05
15 3DLL D.radiodurans 50S yes 3.50 0.26 0.28 6/27/08
16 1JZY D.radiodurans 50S no 3.50 0.27 0.30 9/17/01
17 1J5A D.radiodurans 50S no 3.50 0.27 0.32 3/6/02
18 1K01 D.radiodurans 50S no 3.50 0.28 0.32 9/17/01
19 2OGM D.radiodurans 50S yes 3.50 0.28 0.33 1/7/07
20 1NWX D.radiodurans 50S no 3.50 0.28 0.31 2/7/03
21 1XBP D.radiodurans 50S no 3.50 0.29 0.36 8/31/04
22 2OGN D.radiodurans 50S yes 3.56 0.28 0.34 1/7/07
23 1NJM D.radiodurans 50S no 3.60 0.28 0.31 1/2/03
24 2O43 D.radiodurans 50S no 3.60 0.34 12/3/06
25 2O45 D.radiodurans 50S no 3.60 0.36 12/3/06
26 2OGO D.radiodurans 50S yes 3.66 0.26 0.33 1/7/07
27 1NJO D.radiodurans 50S no 3.70 0.28 0.30 1/2/03
28 1NJN D.radiodurans 50S no 3.70 0.28 0.31 1/2/03
29 2ZJP D.radiodurans 50S yes 3.70 0.30 0.34 3/7/08
30 3FWO D.radiodurans 50S yes 3.71 0.28 0.34 1/19/09
31 1JZZ D.radiodurans 50S no 3.80 0.21 0.27 9/17/01
32 1Z58 D.radiodurans 50S no 3.80 0.27 0.37 3/17/05
33 3I1M E.coli 30S yes 3.19 0.20 0.25 6/27/09 3I1M,3I1N,3I1O,3I1P
34 3I1N E.coli 50S yes 3.19 0.20 0.25 6/27/09 3I1M,3I1N,3I1O,3I1P
35 3I1O E.coli 30S yes 3.19 0.20 0.25 6/27/09 3I1M,3I1N,3I1O,3I1P
36 3I1P E.coli 50S yes 3.19 0.20 0.25 6/27/09 3I1M,3I1N,3I1O,3I1P
37 2QAL E.coli 30S yes 3.21 0.27 0.31 6/15/07 2QAL,2QAM,2QAN,2QAO
38 2QAM E.coli 50S yes 3.21 0.27 0.31 6/15/07 2QAL,2QAM,2QAN,2QAO
39 2QAN E.coli 30S yes 3.21 0.27 0.31 6/15/07 2QAL,2QAM,2QAN,2QAO
40 2QAO E.coli 50S yes 3.21 0.27 0.31 6/15/07 2QAL,2QAM,2QAN,2QAO
41 2I2P E.coli 30S yes 3.22 0.29 0.32 8/16/06 2I2P,2I2T,2I2U,2I2V
42 2I2T E.coli 50S yes 3.22 0.29 0.32 8/16/06 2I2P,2I2T,2I2U,2I2V
43 2I2U E.coli 30S yes 3.22 0.29 0.32 8/16/06 2I2P,2I2T,2I2U,2I2V
44 2I2V E.coli 50S yes 3.22 0.29 0.32 8/16/06 2I2P,2I2T,2I2U,2I2V
45 2QBD E.coli 30S yes 3.30 0.28 0.30 6/16/07 2QBD,2QBE,2QBF,2QBG
46 2QBE E.coli 50S yes 3.30 0.28 0.30 6/16/07 2QBD,2QBE,2QBF,2QBG
47 2QBF E.coli 30S yes 3.30 0.28 0.30 6/16/07 2QBD,2QBE,2QBF,2QBG
48 2QBG E.coli 50S yes 3.30 0.28 0.30 6/16/07 2QBD,2QBE,2QBF,2QBG
49 1VS5 E.coli 30S yes 3.46 0.28 0.33 8/4/06 1VS5,1VS6,1VS7,1VS8
50 1VS6 E.coli 50S yes 3.46 0.28 0.33 8/4/06 1VS5,1VS6,1VS7,1VS8
51 1VS7 E.coli 30S yes 3.46 0.28 0.33 8/4/06 1VS5,1VS6,1VS7,1VS8
52 1VS8 E.coli 50S yes 3.46 0.28 0.33 8/4/06 1VS5,1VS6,1VS7,1VS8
53 2AVY E.coli 30S yes 3.46 0.28 0.33 8/30/05 2AVY,2AW4,2AW7,2AWB
54 2AW4 E.coli 50S yes 3.46 0.28 0.33 8/31/05 2AVY,2AW4,2AW7,2AWB
55 2AW7 E.coli 30S yes 3.46 0.28 0.33 8/31/05 2AVY,2AW4,2AW7,2AWB
56 2AWB E.coli 50S yes 3.46 0.28 0.33 8/31/05 2AVY,2AW4,2AW7,2AWB
57 2QOY E.coli 30S yes 3.50 0.26 0.31 7/21/07 2QOY,2QOZ,2QP0,2QP1
58 2QOZ E.coli 50S yes 3.50 0.26 0.31 7/21/07 2QOY,2QOZ,2QP0,2QP1
59 2QP0 E.coli 30S yes 3.50 0.26 0.31 7/21/07 2QOY,2QOZ,2QP0,2QP1
60 2QP1 E.coli 50S yes 3.50 0.26 0.31 7/21/07 2QOY,2QOZ,2QP0,2QP1
61 3DF1 E.coli 30S yes 3.50 0.27 0.32 6/11/08 3DF1,3DF2,3DF3,3DF4
62 3DF2 E.coli 50S yes 3.50 0.27 0.32 6/11/08 3DF1,3DF2,3DF3,3DF4
63 3DF3 E.coli 30S yes 3.50 0.27 0.32 6/11/08 3DF1,3DF2,3DF3,3DF4
64 3DF4 E.coli 50S yes 3.50 0.27 0.32 6/11/08 3DF1,3DF2,3DF3,3DF4
65 2QB9 E.coli 30S yes 3.54 0.28 0.32 6/16/07 2QB9,2QBA,2QBB,2QBC
66 2QBA E.coli 50S yes 3.54 0.28 0.32 6/16/07 2QB9,2QBA,2QBB,2QBC
67 2QBB E.coli 30S yes 3.54 0.28 0.32 6/16/07 2QB9,2QBA,2QBB,2QBC
68 2QBC E.coli 50S yes 3.54 0.28 0.32 6/16/07 2QB9,2QBA,2QBB,2QBC
69 3I1Z E.coli 30S yes 3.71 0.23 0.27 6/28/09 3I1Z,3I20,3I21,3I22
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70 3I20 E.coli 50S yes 3.71 0.23 0.27 6/28/09 3I1Z,3I20,3I21,3I22
71 3I21 E.coli 30S yes 3.71 0.23 0.27 6/28/09 3I1Z,3I20,3I21,3I22
72 3I22 E.coli 50S yes 3.71 0.23 0.27 6/28/09 3I1Z,3I20,3I21,3I22
73 2VHM E.coli 50S yes 3.74 0.26 0.32 11/22/07 2VHM,2VHN,2VHO,2VHP
74 2VHN E.coli 50S yes 3.74 0.26 0.32 11/22/07 2VHM,2VHN,2VHO,2VHP
75 2VHO E.coli 30S yes 3.74 0.26 0.32 11/22/07 2VHM,2VHN,2VHO,2VHP
76 2VHP E.coli 30S yes 3.74 0.26 0.32 11/22/07 2VHM,2VHN,2VHO,2VHP
77 3I1Q E.coli 30S yes 3.81 0.21 0.25 6/27/09 3I1Q,3I1R,3I1S,3I1T
78 3I1R E.coli 50S yes 3.81 0.21 0.25 6/27/09 3I1Q,3I1R,3I1S,3I1T
79 3I1S E.coli 30S yes 3.81 0.21 0.25 6/27/09 3I1Q,3I1R,3I1S,3I1T
80 3I1T E.coli 50S yes 3.81 0.21 0.25 6/27/09 3I1Q,3I1R,3I1S,3I1T
81 2QOU E.coli 30S yes 3.93 0.26 0.31 7/21/07 2QOU,2QOV,2QOW,2QOX
82 2QOV E.coli 50S yes 3.93 0.26 0.31 7/21/07 2QOU,2QOV,2QOW,2QOX
83 2QOW E.coli 30S yes 3.93 0.26 0.31 7/21/07 2QOU,2QOV,2QOW,2QOX
84 2QOX E.coli 50S yes 3.93 0.26 0.31 7/21/07 2QOU,2QOV,2QOW,2QOX
85 2QBH E.coli 30S yes 4.00 0.26 0.30 6/17/07 2QBH,2QBI,2QBJ,2QBK
86 2QBI E.coli 50S yes 4.00 0.26 0.30 6/17/07 2QBH,2QBI,2QBJ,2QBK
87 2QBJ E.coli 30S yes 4.00 0.26 0.30 6/17/07 2QBH,2QBI,2QBJ,2QBK
88 2QBK E.coli 50S yes 4.00 0.26 0.30 6/17/07 2QBH,2QBI,2QBJ,2QBK
89 1VQO H.marismortui 50S yes 2.20 0.22 0.25 12/16/04
90 1VQ8 H.marismortui 50S yes 2.20 0.22 0.25 12/16/04
91 1VQP H.marismortui 50S yes 2.25 0.22 0.25 12/16/04
92 1VQM H.marismortui 50S yes 2.30 0.21 0.25 12/16/04
93 1VQK H.marismortui 50S yes 2.30 0.22 0.25 12/16/04
94 1VQL H.marismortui 50S yes 2.30 0.22 0.25 12/16/04
95 1S72 H.marismortui 50S yes 2.40 0.19 0.22 1/28/04
96 1JJ2 H.marismortui 50S yes 2.40 0.19 0.22 7/3/01
97 1YHQ H.marismortui 50S yes 2.40 0.19 0.23 1/10/05
98 3CC2 H.marismortui 50S yes 2.40 0.20 0.23 2/23/08
99 1VQN H.marismortui 50S yes 2.40 0.21 0.25 12/16/04
100 1VQ9 H.marismortui 50S yes 2.40 0.22 0.26 12/16/04
101 1FFK H.marismortui 50S yes 2.40 0.25 0.26 7/25/00
102 1VQ7 H.marismortui 50S yes 2.50 0.21 0.24 12/16/04
103 3CCM H.marismortui 50S yes 2.55 0.20 0.24 2/26/08
104 1YIJ H.marismortui 50S yes 2.60 0.18 0.22 1/12/05
105 1VQ5 H.marismortui 50S yes 2.60 0.20 0.24 12/16/04
106 1YI2 H.marismortui 50S yes 2.65 0.18 0.21 1/11/05
107 3CC7 H.marismortui 50S yes 2.70 0.18 0.23 2/25/08
108 3CCJ H.marismortui 50S yes 2.70 0.18 0.23 2/26/08
109 3G6E H.marismortui 50S yes 2.70 0.19 0.23 2/6/09
110 1VQ4 H.marismortui 50S yes 2.70 0.19 0.23 12/16/04
111 3CPW H.marismortui 50S yes 2.70 0.19 0.23 4/1/08
112 1VQ6 H.marismortui 50S yes 2.70 0.19 0.23 12/16/04
113 3CC4 H.marismortui 50S yes 2.70 0.20 0.24 2/24/08
114 2OTL H.marismortui 50S yes 2.70 0.20 0.25 2/8/07
115 3CCE H.marismortui 50S yes 2.75 0.18 0.23 2/25/08
116 3CD6 H.marismortui 50S yes 2.75 0.19 0.24 2/26/08
117 1YIT H.marismortui 50S yes 2.80 0.18 0.22 1/13/05
118 3CCU H.marismortui 50S yes 2.80 0.18 0.22 2/26/08
119 1M90 H.marismortui 50S yes 2.80 0.18 0.22 7/26/02
120 1YJ9 H.marismortui 50S yes 2.80 0.18 0.24 1/13/05
121 3CMA H.marismortui 50S yes 2.80 0.19 0.24 3/21/08
122 3G71 H.marismortui 50S yes 2.85 0.19 0.23 2/9/09
123 3CCL H.marismortui 50S yes 2.90 0.17 0.22 2/26/08
124 1YJW H.marismortui 50S yes 2.90 0.17 0.22 1/15/05
125 3CCV H.marismortui 50S yes 2.90 0.18 0.22 2/26/08
126 3CCQ H.marismortui 50S yes 2.90 0.19 0.23 2/26/08
127 3I56 H.marismortui 50S yes 2.90 0.19 0.24 7/3/09
128 2OTJ H.marismortui 50S yes 2.90 0.19 0.24 2/8/07
129 1QVG H.marismortui 50S yes 2.90 0.20 0.26 8/27/03
130 2QEX H.marismortui 50S yes 2.90 0.20 0.24 6/26/07
131 3CCS H.marismortui 50S yes 2.95 0.18 0.24 2/26/08
132 3CME H.marismortui 50S yes 2.95 0.20 0.26 3/21/08
133 1Q81 H.marismortui 50S yes 2.95 0.21 0.26 8/20/03
134 1Q82 H.marismortui 50S yes 2.98 0.21 0.25 8/20/03
135 1YJN H.marismortui 50S yes 3.00 0.17 0.23 1/14/05
136 1NJI H.marismortui 50S yes 3.00 0.18 0.21 12/31/02
137 3CCR H.marismortui 50S yes 3.00 0.18 0.25 2/26/08
138 1N8R H.marismortui 50S no 3.00 0.20 0.24 11/21/02
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139 1K9M H.marismortui 50S yes 3.00 0.22 0.26 10/29/01
140 1KD1 H.marismortui 50S yes 3.00 0.22 0.27 11/12/01
141 1K8A H.marismortui 50S yes 3.00 0.23 0.26 10/23/01
142 1Q86 H.marismortui 50S yes 3.00 0.23 0.26 8/20/03
143 2QA4 H.marismortui 50S yes 3.00 0.24 0.29 6/14/07
144 1FG0 H.marismortui 50S yes 3.00 7/26/00
145 3CXC H.marismortui 50S yes 3.00 4/24/08
146 1KC8 H.marismortui 50S yes 3.01 0.20 0.24 11/7/01
147 1K73 H.marismortui 50S yes 3.01 0.21 0.25 10/18/01
148 1KQS H.marismortui 50S yes 3.10 0.17 0.22 1/7/02
149 1QVF H.marismortui 50S yes 3.10 0.20 0.24 8/27/03
150 3I55 H.marismortui 50S yes 3.11 0.21 0.26 7/3/09
151 1M1K H.marismortui 50S yes 3.20 0.21 0.25 6/19/02
152 3G4S H.marismortui 50S yes 3.20 0.22 0.29 2/4/09
153 1Q7Y H.marismortui 50S yes 3.20 0.22 0.28 8/20/03
154 1FFZ H.marismortui 50S yes 3.20 7/26/00
155 1W2B H.marismortui 50S no 3.50 0.19 0.27 7/1/04
156 2VQE T.thermophilus 30S yes 2.50 0.26 0.28 3/13/08
157 2UUB T.thermophilus 30S yes 2.80 0.22 0.24 3/1/07
158 2J00 T.thermophilus 30S yes 2.80 0.27 0.31 7/31/06 2J00,2J01,2J02,2J03
159 2J01 T.thermophilus 50S yes 2.80 0.27 0.31 7/31/06 2J00,2J01,2J02,2J03
160 2J02 T.thermophilus 30S yes 2.80 0.27 0.31 7/31/06 2J00,2J01,2J02,2J03
161 2J03 T.thermophilus 50S yes 2.80 0.27 0.31 7/31/06 2J00,2J01,2J02,2J03
162 2UXC T.thermophilus 30S yes 2.90 0.22 0.26 3/28/07
163 2UUA T.thermophilus 30S yes 2.90 0.22 0.25 3/1/07
164 2VQF T.thermophilus 30S yes 2.90 0.22 0.26 3/14/08
165 1FJG T.thermophilus 30S yes 3.00 0.22 0.26 8/8/00
166 1XMQ T.thermophilus 30S yes 3.00 0.22 0.24 10/4/04
167 1N32 T.thermophilus 30S yes 3.00 0.23 0.27 10/25/02
168 3F1E T.thermophilus 30S yes 3.00 0.28 0.32 10/27/08 3F1E,3F1F,3F1G,3F1H
169 3F1F T.thermophilus 50S yes 3.00 0.28 0.32 10/27/08 3F1E,3F1F,3F1G,3F1H
170 3F1G T.thermophilus 30S yes 3.00 0.28 0.32 10/27/08 3F1E,3F1F,3F1G,3F1H
171 3F1H T.thermophilus 50S yes 3.00 0.28 0.32 10/27/08 3F1E,3F1F,3F1G,3F1H
172 3KNH T.thermophilus 30S yes 3.00 0.25 0.27 11/12/09 3KNH,3KNI,3KNJ,3KNK
173 3KNI T.thermophilus 50S yes 3.00 0.25 0.27 11/12/09 3KNH,3KNI,3KNJ,3KNK
174 3KNK T.thermophilus 50S yes 3.00 0.25 0.27 11/12/09 3KNH,3KNI,3KNJ,3KNK
175 1J5E T.thermophilus 30S yes 3.05 0.21 0.25 4/8/02
176 1XNQ T.thermophilus 30S yes 3.05 0.23 0.27 10/5/04
177 2UUC T.thermophilus 30S yes 3.10 0.21 0.24 3/1/07
178 1XNR T.thermophilus 30S yes 3.10 0.23 0.27 10/5/04
179 2UU9 T.thermophilus 30S yes 3.10 0.23 0.27 3/1/07
180 2UXB T.thermophilus 30S yes 3.10 0.30 0.33 3/28/07
181 2X9R T.thermophilus 30S yes 3.10 0.22 0.26 3/24/10 2X9R,2X9S,2X9T,2X9U
182 2X9S T.thermophilus 50S yes 3.10 0.22 0.26 3/24/10 2X9R,2X9S,2X9T,2X9U
183 2X9T T.thermophilus 30S yes 3.10 0.22 0.26 3/24/10 2X9R,2X9S,2X9T,2X9U
184 2X9U T.thermophilus 50S yes 3.10 0.22 0.26 3/24/10 2X9R,2X9S,2X9T,2X9U
185 3HUW T.thermophilus 30S yes 3.10 0.25 0.30 6/15/09 3HUW,3HUX,3HUY,3HUZ
186 3HUX T.thermophilus 50S yes 3.10 0.25 0.30 6/15/09 3HUW,3HUX,3HUY,3HUZ
187 3HUY T.thermophilus 30S yes 3.10 0.25 0.30 6/15/09 3HUW,3HUX,3HUY,3HUZ
188 3HUZ T.thermophilus 50S yes 3.10 0.25 0.30 6/15/09 3HUW,3HUX,3HUY,3HUZ
189 3I8F T.thermophilus 50S yes 3.10 0.22 0.26 7/9/09 3I8F,3I8G,3I8H,3I8I
190 3I8G T.thermophilus 30S yes 3.10 0.22 0.26 7/9/09 3I8F,3I8G,3I8H,3I8I
191 3I8H T.thermophilus 30S yes 3.10 0.22 0.26 7/9/09 3I8F,3I8G,3I8H,3I8I
192 3I8I T.thermophilus 50S yes 3.10 0.22 0.26 7/9/09 3I8F,3I8G,3I8H,3I8I
193 1IBL T.thermophilus 30S yes 3.11 0.23 0.28 3/28/01
194 3KNJ T.thermophilus 30S yes 3.15 0.25 0.27 11/12/09 3KNH,3KNI,3KNJ,3KNK
195 1I94 T.thermophilus 30S no 3.20 0.20 0.24 3/18/01
196 1HR0 T.thermophilus 30S yes 3.20 0.22 0.26 12/20/00
197 2UXD T.thermophilus 30S yes 3.20 0.24 0.28 3/28/07
198 3D5A T.thermophilus 30S yes 3.21 0.29 0.32 5/16/08 3D5A,3D5B,3D5C,3D5D
199 3D5B T.thermophilus 50S yes 3.21 0.29 0.32 5/16/08 3D5A,3D5B,3D5C,3D5D
200 3D5C T.thermophilus 30S yes 3.21 0.29 0.32 5/16/08 3D5A,3D5B,3D5C,3D5D
201 3D5D T.thermophilus 50S yes 3.21 0.29 0.32 5/16/08 3D5A,3D5B,3D5C,3D5D
202 1XMO T.thermophilus 30S yes 3.25 0.23 0.28 10/4/04
203 1HNZ T.thermophilus 30S yes 3.30 0.22 0.26 12/8/00
204 2E5L T.thermophilus 30S yes 3.30 0.26 0.30 12/21/06
205 2ZM6 T.thermophilus 30S yes 3.30 0.29 0.32 4/11/08
206 1FKA T.thermophilus 30S no 3.30 0.30 0.30 8/9/00
207 2WDI T.thermophilus 50S yes 3.30 0.22 0.27 3/24/09 2WDG,2WDH,2WDI,2WDJ
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Table E.1: List of ribosomal structures retrieved in the PDB at a resolution higher than or equal to
4 Å.
PDB code organism subunit SF resolution Rwork R f ree date split codes
208 2WDJ T.thermophilus 50S yes 3.30 0.22 0.27 3/24/09 2WDG,2WDH,2WDI,2WDJ
209 2WDG T.thermophilus 30S yes 3.30 0.22 0.27 3/24/09 2WDG,2WDH,2WDI,2WDJ
210 2WDH T.thermophilus 30S yes 3.30 0.22 0.27 3/24/09 2WDG,2WDH,2WDI,2WDJ
211 3KIQ T.thermophilus 30S yes 3.30 0.22 0.25 11/2/09 3KIQ,3KIR,3KIS,3KIT
212 3KIR T.thermophilus 50S yes 3.30 0.22 0.25 11/2/09 3KIQ,3KIR,3KIS,3KIT
213 3KIS T.thermophilus 30S yes 3.30 0.22 0.25 11/2/09 3KIQ,3KIR,3KIS,3KIT
214 3KIT T.thermophilus 50S yes 3.30 0.22 0.25 11/2/09 3KIQ,3KIR,3KIS,3KIT
215 1IBK T.thermophilus 30S yes 3.31 0.23 0.28 3/28/01
216 1IBM T.thermophilus 30S yes 3.31 0.23 0.29 3/28/01
217 1N33 T.thermophilus 30S yes 3.35 0.22 0.28 10/25/02
218 2HHH T.thermophilus 30S yes 3.35 0.26 0.29 6/28/06
219 1HNW T.thermophilus 30S yes 3.40 0.22 0.26 12/8/00
220 1HNX T.thermophilus 30S yes 3.40 0.23 0.28 12/8/00
221 2WH1 T.thermophilus 30S yes 3.45 0.21 0.26 4/30/09 2WH1,2WH2,2WH3,2WH4
222 2WH2 T.thermophilus 50S yes 3.45 0.21 0.26 4/30/09 2WH1,2WH2,2WH3,2WH4
223 2WH3 T.thermophilus 30S yes 3.45 0.21 0.26 4/30/09 2WH1,2WH2,2WH3,2WH4
224 2WH4 T.thermophilus 50S yes 3.45 0.21 0.26 4/30/09 2WH1,2WH2,2WH3,2WH4
225 3KNL T.thermophilus 30S yes 3.45 0.22 0.27 11/12/09 3KNL,3KNM,3KNN,3KNO
226 3KNM T.thermophilus 50S yes 3.45 0.22 0.27 11/12/09 3KNL,3KNM,3KNN,3KNO
227 3KNN T.thermophilus 30S yes 3.45 0.22 0.27 11/12/09 3KNL,3KNM,3KNN,3KNO
228 3KNO T.thermophilus 50S yes 3.45 0.22 0.27 11/12/09 3KNL,3KNM,3KNN,3KNO
229 2V46 T.thermophilus 30S yes 3.50 0.26 0.33 6/28/07 2V46,2V47,2V48,2V49
230 2V47 T.thermophilus 50S yes 3.50 0.26 0.33 6/28/07 2V46,2V47,2V48,2V49
231 2V48 T.thermophilus 30S yes 3.50 0.26 0.33 6/28/07 2V46,2V47,2V48,2V49
232 2V49 T.thermophilus 50S yes 3.50 0.26 0.33 6/28/07 2V46,2V47,2V48,2V49
233 2WDK T.thermophilus 30S yes 3.50 0.21 0.26 3/24/09 2WDK,2WDL,2WDM,2WDN
234 2WDL T.thermophilus 50S yes 3.50 0.21 0.26 3/24/09 2WDK,2WDL,2WDM,2WDN
235 2WDM T.thermophilus 30S yes 3.50 0.21 0.26 3/24/09 2WDK,2WDL,2WDM,2WDN
236 2WDN T.thermophilus 50S yes 3.50 0.21 0.26 3/24/09 2WDK,2WDL,2WDM,2WDN
237 3I9B T.thermophilus 30S yes 3.50 0.21 0.25 7/10/09 3I9B,3I9C,3I9D,3I9E
238 3I9C T.thermophilus 50S yes 3.50 0.21 0.25 7/10/09 3I9B,3I9C,3I9D,3I9E
239 3I9D T.thermophilus 30S yes 3.50 0.21 0.25 7/10/09 3I9B,3I9C,3I9D,3I9E
240 3I9E T.thermophilus 50S yes 3.50 0.21 0.25 7/10/09 3I9B,3I9C,3I9D,3I9E
241 2WRI T.thermophilus 30S yes 3.60 0.23 0.26 9/1/09 2WRI,2WRJ,2WRK,2WRL
242 2WRJ T.thermophilus 50S yes 3.60 0.23 0.26 9/1/09 2WRI,2WRJ,2WRK,2WRL
243 2WRK T.thermophilus 30S yes 3.60 0.23 0.26 9/1/09 2WRI,2WRJ,2WRK,2WRL
244 2WRL T.thermophilus 50S yes 3.60 0.23 0.26 9/1/09 2WRI,2WRJ,2WRK,2WRL
245 2WRN T.thermophilus 30S yes 3.60 0.28 0.32 9/1/09 2WRN,2WRO,2WRQ,2WRR
246 2WRO T.thermophilus 50S yes 3.60 0.28 0.32 9/1/09 2WRN,2WRO,2WRQ,2WRR
247 2WRQ T.thermophilus 30S yes 3.60 0.28 0.32 9/1/09 2WRN,2WRO,2WRQ,2WRR
248 2WRR T.thermophilus 50S yes 3.60 0.28 0.32 9/1/09 2WRN,2WRO,2WRQ,2WRR
249 3KIU T.thermophilus 30S yes 3.60 0.22 0.24 11/2/09 3KIU,3KIW,3KIX,3KIY
250 3KIW T.thermophilus 50S yes 3.60 0.22 0.24 11/2/09 3KIU,3KIW,3KIX,3KIY
251 3KIX T.thermophilus 30S yes 3.60 0.22 0.24 11/2/09 3KIU,3KIW,3KIX,3KIY
252 3KIY T.thermophilus 50S yes 3.60 0.22 0.24 11/2/09 3KIU,3KIW,3KIX,3KIY
253 3MR8 T.thermophilus 30S yes 3.62 0.26 0.29 4/29/10 3MR8,3MRZ,3MS0,3MS1
254 3MRZ T.thermophilus 50S yes 3.62 0.26 0.29 4/29/10 3MR8,3MRZ,3MS0,3MS1
255 3MS0 T.thermophilus 30S yes 3.62 0.26 0.29 4/29/10 3MR8,3MRZ,3MS0,3MS1
256 3MS1 T.thermophilus 50S yes 3.62 0.26 0.29 4/29/10 3MR8,3MRZ,3MS0,3MS1
257 1N36 T.thermophilus 30S yes 3.65 0.26 0.32 10/25/02
258 1VSA T.thermophilus 50S yes 3.71 0.35 0.35 2/15/07 1VSA,2OW8
259 2OW8 T.thermophilus 30S yes 3.71 0.35 0.35 2/15/07 1VSA,2OW8
260 1N34 T.thermophilus 30S yes 3.80 0.24 0.31 10/25/02
261 2F4V T.thermophilus 30S no 3.80 0.26 0.32 11/24/05
262 1VSP T.thermophilus 50S yes 3.83 0.33 0.35 7/18/07 1VSP,2QNH
263 2QNH T.thermophilus 30S yes 3.83 0.33 0.35 7/18/07 1VSP,2QNH
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